col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


1097 Results       Page 1

 [1] 
Oxford University Press: Clinical Infectious Diseases
  original article Date Title Authors   All Authors
1 [GO] 2026―Feb―28 IDSA 2025 Guidelines on the use of vaccines for the prevention of seasonal COVID-19, Influenza, and RSV infections in immunocompromised patients Anoma Nellore, Paul Goepfert, Chen Sabrina Tan, Kristina Bajema, Katherine Belden, Dean Blumberg, et al. (+12)
2 [GO] 2026―Jan―30 Integrating genomic data into test-negative designs for estimating lineage-specific COVID-19 vaccine effectiveness Kevin C Ma, Diya Surie, Natalie Dean, Clinton R Paden, Natalie J Thornburg, Fatimah S Dawood
3 [GO] 2026―Jan―06 Target Trial Emulation of Oral Antivirals for B-Cell-Depleted COVID-19 Patients-Reply to Chen et al Xiaofeng F Wang, Cassandra Calabrese, Leonard Calabrese
4 [GO] 2025―Nov―22 Effective Antivirals in Pandemic Preparedness: Past Mistakes, Future Needs Antonios-Periklis Panagiotopoulos, Cleo Anastassopoulou, Athanasios Tsakris, John P A Ioannidis
5 [GO] 2025―Oct―31 International Collaboration to Develop and Harmonize Drug Interaction Guidance for Nirmatrelvir/Ritonavir During COVID-19: Lessons Learned for Future Pandemic Preparedness Safia Kuriakose, Alice Tseng, Sarita Boyd, Sara Gibbons, Justin Chiong, Fiona Marra, et al. (+39)
6 [GO] 2025―Oct―30 Recalibrating COVID-19 Booster Policy: Lessons From Hybrid Immunity and Global Equity Gaps Nathkapach K Rattanapitoon, Nav La, Chutharat Thanchonnang, Schawanya K Rattanapitoon
7 [GO] 2025―Oct―29 Real-World Effectiveness of Nirmatrelvir-Ritonavir in Preventing Coronavirus Disease 2019-Associated Hospitalization: A Population-Based Cohort Study in the Province of Québec, Canada Jean-Luc Kaboré, Benoît Laffont, Mamadou Diop, Melanie R Tardif, Alexis F Turgeon, Jeannot Dumaresq, et al. (+7)
8 [GO] 2025―Oct―29 Retraction and replacement of: Real-World Effectiveness of Nirmatrelvir/Ritonavir on Coronavirus Disease 2019-Associated Hospitalization Prevention: A Population-based Cohort Study in the Province of Q, Canada
9 [GO] 2025―Oct―23 Effectiveness of Nirmatrelvir/Ritonavir or Molnupiravir Use in Immunocompromised Patients on B-Cell-Depleting Therapy With COVID-19: A Target Trial Emulation Study Cassandra Calabrese, Yifan Wang, Abhijit Duggal, Shuaiqi Huang, Yiying Fan, Shravan Kethireddy, et al. (+3)
10 [GO] 2025―Oct―14 Analysis of Antibody Markers as Immune Correlates of Risk of Severe COVID-19 in the PREVENT-19 Efficacy Trial of the NVX-CoV2373 Recombinant Protein Vaccine Youyi Fong, Yunda Huang, Ying Huang, Wayne Woo, Alice McGarry, Germán Áñez, et al. (+36)
11 [GO] 2025―Oct―10 Baptism in a Pandemic: Infectious Diseases Clinical Research Consortium Network Design for Readiness and Response Jodie A Dionne, James D Campbell, Jodi Salim, Robert L Atmar, C Mary Healy, Christine M Posavad, et al. (+4)
12 [GO] 2025―Oct―10 Emerging and Pandemic Pathogens: Lessons Learned From a Clinical Research Network Robert L Atmar, Getahun Abate, Meagan E Deming, Sarah L George, Andrew Fleming, Sharon E Frey, et al. (+4)
13 [GO] 2025―Sep―29 Effectiveness of COVID-19 vaccination and prior infections to reduce long COVID risk during the pre-Omicron and Omicron periods Sara Carazo, Jonathan Phimmasone, Danuta M Skowronski, Katia Giguère, Manale Ouakki, Denis Talbot, et al. (+4)
14 [GO] 2025―Sep―27 Retreatment With Nirmatrelvir/Ritonavir Following Return of COVID-19 Symptoms and SARS-CoV-2 Positivity Wuyan Zhang, Steven G Terra, Edward Alan Weinstein, Candace Bramson, Heidi Leister-Tebbe, Mary Lynn Baniecki, et al. (+5)
15 [GO] 2025―Sep―25 COVID-19 and Bacterial Pneumonia: Protective Effect or Diagnostic Bias? Duygu Aydın, Oğuz Karcıoğlu, Ömrüm Uzun
16 [GO] 2025―Sep―09 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Abatacept Nandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, Kathleen Chiotos, Amy L Dzierba, Arthur Y Kim, et al. (+23)
17 [GO] 2025―Sep―02 The Indispensable Value of Small-Molecule Antivirals in Epidemic and Pandemic Preparedness Ruxandra Draghia-Akli, Nina M Hill, Bruce Altevogt, Kenneth Bradley, Kelly Chibale, Tomas Cihlar, et al. (+3)
18 [GO] 2025―Aug―28 Interferon-α Nasal Spray Prophylaxis Reduces COVID-19 in Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial Michelle K Yong, Karin Thursky, Megan Crane, Tim Spelman, Robert K Mahar, Julie A Simpson, et al. (+15)
19 [GO] 2025―Aug―20 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Infliximab Nandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, Kathleen Chiotos, Amy L Dzierba, Arthur Y Kim, et al. (+23)
20 [GO] 2025―Aug―19 Immunogenicity and Safety of the COVID-19 mRNA Vaccine Coadministered with Influenza and 23-valent Pneumococcal Polysaccharide Vaccines Omid Rezahosseini, Jens Ulrik Stæhr Jensen, Hana Khajeh Rahimi, Nikoline Erland Jensen, Charlotte Sværke Jørgensen, Thea K Fischer, et al. (+4)
21 [GO] 2025―Aug―19 Evaluation of Coronavirus Disease 2019 and Influenza-like Illness Surveillance Case Definitions in a Prospective Cohort of Healthcare Personnel in Peru Denisse Vega Ocasio, Neha N Patel, Eva Leidman, Perrine Marcenac, Joseph Daniel Carreon, Chelsea Iwamoto, et al. (+14)
22 [GO] 2025―Aug―04 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness Adarsh Bhimraj, Yngve Falck-Ytter, Lindsey R Baden, Roger Bedimo, Kelly Cawcutt, Vincent Chi-Chung Cheng, et al. (+23)
23 [GO] 2025―Jul―22 Efficacy and Safety of Obeldesivir in High-Risk Nonhospitalized Patients with COVID-19 (BIRCH): a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Anca Streinu-Cercel, Antonella Castagna, Shan-Chwen Chang, Yao-Shen Chen, Yiannis Koullias, Afsaneh Mozaffarian, et al. (+18)
24 [GO] 2025―Jul―22 Genomic Surveillance of SARS-CoV-2 in Ibadan, Oyo State, Nigeria Elizabeth T Akande, Adeola A Fowotade, Erkison Ewomazino Odih, Anderson O Oaikhena, Olasunkanmi Olisa, Gabriel Temitope Sunmonu, et al. (+5)
25 [GO] 2025―Jul―22 Immunogenicity and Safety of Heterologous Versus Homologous Prime-Boost Regimens With BBIBP-CorV and Ad26.COV2.S COVID-19 Vaccines: A Multicentric, Randomized, Observer-Blinded Non-inferiority Trial in Madagascar and Mozambique Patrícia Ramgi, Mohamadou Siribie, Njariharinjakamampionona Rakotozandrindrainy, Odete Bule, Harshvardhan Shrivastava, Lígia Chambule, et al. (+34)
26 [GO] 2025―Jul―22 Importance of Targeted Communication Strategies During COVID-19 Vaccination Campaigns in Mozambique: Results of a Mixed-Methods Acceptability Study Caroline De Schacht, Igor Ubisse Capitine, Carlota Lucas, Ana Muteerwa, Paula Paulo, Alvaro Manhiça, et al. (+6)
27 [GO] 2025―Jul―22 COVID-19 Surveillance in Madagascar and Urban Burkina Faso: Addressing Underreporting of Disease Burden Through Integrative Analysis of Diverse Data Streams Njariharinjakamampionona Rakotozandrindrainy, Sophie S Y Kang, Lady R Wandji Nana, Jonathan D Sugimoto, Yi-Ting Wang, Ndrainaharimira Rakotozandrindrainy, et al. (+15)
28 [GO] 2025―Jul―22 Overcoming Vaccine Inequities and Research Gaps in Africa: Challenges and Opportunities Identified During the COVID-19 Pandemic Cara Lynn Kim, Thaint Thaint Thwe, Ligia M Cruz Espinoza, Jonathan D Sugimoto, Mosoka P Fallah, Hyon Jin Jeon, et al. (+7)
29 [GO] 2025―Jul―22 Enhancing Clinical Trial Sites in Low- and Middle-Income Countries to Facilitate Product Development in Response to the COVID-19 Pandemic Sophie S Y Kang, Birkneh Tilahun Tadesse, Hyon Jin Jeon, Mosoka P Fallah, Nebiyu Dereje, Olayinka Stephen Ilesanmi, et al. (+19)
30 [GO] 2025―Jul―22 Real-world Evaluation of the Effectiveness of Sinopharm COVID-19 Vaccine Against Symptomatic COVID-19 in an Omicron-Dominant Setting in Mozambique: A Test-Negative, Case-Control Study Igor Ubisse Capitine, Asma Binte Aziz, Alvaro Manhiça, Inês Tivane, Absalão Zumba, Milton Nhumba, et al. (+23)
31 [GO] 2025―Jul―16 Protracted SARS-CoV-2 Infection in B-cell Depleted Patients: Immunologic and Viral Characteristics and Response to Dual and Extended Antiviral Therapy Jessica S Little, Gregory E Edelstein, Zoe Swank, Manish C Choudhary, Ella Borberg, Cameron T Nutt, et al. (+19)
32 [GO] 2025―Jul―16 Antibody Response in Healthcare Workers During the Severe Acute Respiratory Syndrome Coronavirus 2 Gamma Variant Outbreak in Manaus, Brazil Charlene Siza, Mateusz Plucinski, Fernanda C Lessa, Evelyn Campelo, Maria Clara Padoveze, Antonio R Vieira, et al. (+22)
33 [GO] 2025―Jul―14 Combination Therapy for Protracted COVID-19: When More is More Shmuel Shoham, M Veronica Dioverti
34 [GO] 2025―Jul―14 Five-Year Longitudinal Assessment of Self-reported COVID-19-Related Chemosensory Dysfunction Paolo Boscolo-Rizzo, Giacomo Spinato, Rebecca De Colle, Antonino Maniaci, Luigi Angelo Vaira, Enzo Emanuelli, Giancarlo Tirelli
35 [GO] 2025―Jun―28 The East Africa Infection Prevention and Control (IPC) Learning Network: An Approach to Improving IPC Competencies and Practices During the COVID-19 Pandemic, 2020-2023 Getachew Kassa, Irene Ogongo, Miriam Rabkin, Elizabeth Bancroft, Rick Mitchell, Laura Block, et al. (+6)
36 [GO] 2025―Jun―27 The Effect of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection on Long-Term Symptoms in the Innovative Support for Patients With SARS-CoV-2 Infections Registry (INSPIRE) John J Openshaw, Ji Chen, Robert Rodriguez, Michael Gottlieb, Kalyani McCullough, Michelle Santangelo, et al. (+17)
37 [GO] 2025―Jun―25 SARS-CoV-2 infection increases long-term risk of pneumonia in an urban population: an observational cohort study up to 46 months post-infection Katie S Duong, Sonya S Henry, Tim Q Duong
38 [GO] 2025―Jun―25 Infection Prevention and Control Knowledge, Attitudes, and Practices of Healthcare Workers in Tertiary Care Hospitals in Bangladesh During COVID-19: A Multicenter Cross-sectional Survey Md Golam Dostogir Harun, Shariful Amin Sumon, Md Mahabub Ul Anwar, Tahrima Mohsin Mohona, Aninda Rahman, Syed Abul Hassan Md Abdullah, et al. (+5)
39 [GO] 2025―Jun―20 Incidence of and Risk Factors for SARS-CoV-2 Infection Among Vaccinated Healthcare Workers During Emergence of SARS-CoV-2 Gamma Variant in the Amazon Region, Brazil, 2021 Gemma Parra, Fernanda C Lessa, Evelyn Campelo, Tatyana C Amorim Ramos, Antonio R Vieira, Pritesh Lalwani, et al. (+21)
40 [GO] 2025―Jun―20 Assessing Coronavirus Disease 2019 Vaccination Uptake and Incident Infections Among Ethiopian Healthcare Workers, Addis Ababa-2022: Implications for Public Health Preparedness Gadissa Bedada Hundie, Tigistu Adamu Ashengo, Stacie C Stender, Mebratu Abraha, Abrham Getachew, Sisay Sirgu, et al. (+3)
41 [GO] 2025―Jun―20 Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence, Illness Recall, and Work Absenteeism Among Healthcare Workers: A Facility-Based Cross-Sectional Study in the Philippines, 2021 Maria Tricia Subido-Cariño, Morgane Donadel, Lea D Asi, Mary Shiela Ariola-Ramos, Vina Lea Arguelles, Stephanie N Co, et al. (+7)
42 [GO] 2025―Jun―19 COVID-19 Exposure, Protective Measures, Symptom Assessment, and Risk Perception Among Healthcare Workers in Peru: A Longitudinal Cohort Study (2020-2021) Diana Ponce, Matthew Westercamp, Giselle Soto, Fernanda C Lessa, Perrine Marcenac, Candice Romero, et al. (+8)
43 [GO] 2025―Jun―10 Effectiveness and safety of Autologous Virus-Specific T Cell Therapy for Persistent COVID-19 in People with Immunocompromise: A Clinical Trial Study Raeseok Lee, Nayoun Kim, Won-Bok Kim, Keon-Il Im, Dukhee Nho, Sung-Yeon Cho, et al. (+6)
44 [GO] 2025―Jun―03 Sociodemographic and Occupational Factors Associated With COVID-19 Vaccine and Influenza Vaccine Uptake Among Healthcare Workers, in Albania, 2022-2023: A Multicenter Study Anisa Xhaferi, Silvia Bino, Rovena Daja, Adela Vasili, Jonilda Sulo, Nana Mebonia, et al. (+12)
45 [GO] 2025―May―24 Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY) Cameron R Wolfe, Jonathan Cohen, Kathryn Mahoney, Anna Holmes, Natalia Betancourt, Deepali Gupta, et al. (+11)
46 [GO] 2025―May―22 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Vilobelimab Nandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, Kathleen Chiotos, Amy L Dzierba, Arthur Y Kim, et al. (+23)
47 [GO] 2025―May―13 “I Didn’t Know Him Before the Pandemic… Now He's on My Speed Dial”: Strengthening Collaboration Between Infectious Diseases Physicians and State and Local Public Health for Future Public Health Emergencies Diana Valencia, Leslie Edwards, Libby Horter, Hannah Turner, Manpreet Kaur, Maitri Vaidya, et al. (+15)
48 [GO] 2025―May―12 HIV Infection and Long COVID: A RECOVER Program, Electronic Health Record Based Cohort Study Kellie L Hawkins, Dima Dandachi, Zoe Verzani, M Daniel Brannock, Colby Lewis, Sajjad Abedian, et al. (+208)
49 [GO] 2025―Apr―29 Impact of a Collaboration-Focused Intervention to Prevent Healthcare-Associated Infections Before and During the Coronavirus Disease 2019 Pandemic Karen M Jones, M Todd Greene, Jennifer Meddings, Julia Mantey, Sarah L Krein, Molly Harrod, et al. (+3)
50 [GO] 2025―Apr―26 Into the Unknown: Practical Remdesivir Restriction in the Era of Widespread SARS-CoV-2 Seropositivity Alyssa Christensen, Zachary Nelson, Sally Gustafson, Rachel Stoecker, Brent Footer, Nicole Trower, et al. (+6)
51 [GO] 2025―Apr―10 Target Trial Emulation of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Versus No Infection and Risk of Post-Coronavirus Disease 2019 Conditions in the Omicron Variant Versus Prior Eras George N Ioannou, Kristin Berry, Nallakkandi Rajeevan, Yuli Li, Lei Yan, Yuan Huang, et al. (+23)
52 [GO] 2025―Apr―10 Shifting the Focus in Acute SARS-CoV-2 Management to Include Prevention of Long COVID Lao-Tzu Allan-Blitz, Jeffrey D Klausner
53 [GO] 2025―Apr―03 The dynamic impact of community social vulnerability on COVID-19 outcomes: A census tract-level analysis of Fulton County, GA Kamini Doraivelu, Steve Williams, Mallory Hazell, Sasha Smith, Allison T Chamberlain, Neel R Gandhi, et al. (+2)
54 [GO] 2025―Mar―14 Annual Variant-Targeted Vaccination to Prevent Severe Coronavirus Disease 2019 in Cohorts With Vaccine-Derived and Hybrid Immunity J Daniel Kelly, Katherine J Hoggatt, Nathan C Lo, Samuel Leonard, W John Boscardin, Hye Sun Kim, et al. (+7)
55 [GO] 2025―Mar―14 Utilizing Whole Genome Sequencing to Investigate a COVID-19 Cluster Among Healthcare Workers in a Tertiary Care Facility in the Philippines: Insights and Implications for Infection Prevention and Control Gina de Guzman Betito, Reed Magleby, Janice C Caoili, Jason Caravas, Mark Lemuel Ybañez, Kara Moser, et al. (+15)
56 [GO] 2025―Mar―11 A systematic review and meta-analysis of the effectiveness of remdesivir to treat SARS-CoV-2 infection in hospitalized patients: have the guidelines evolved with the evidence? Michele Bartoletti, Essy Mozaffari, Alpesh N Amin, Yohei Doi, Paul Loubet, Christina G Rivera, et al. (+9)
57 [GO] 2025―Mar―04 Effects of the COVID-19 Pandemic on TB Outcomes in the United States: A Bayesian Analysis Nicole A Swartwood, Ted Cohen, Suzanne M Marks, Andrew N Hill, Garrett R Beeler Asay, Julie Self, et al. (+4)
58 [GO] 2025―Feb―17 Antiviral Trials-Navigating the Shifting Sands of a Pandemic Beatrice Z Sim, Cameron R Wolfe
59 [GO] 2025―Feb―17 Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial Anne F Luetkemeyer, Kara W Chew, Stuart Lacey, Michael D Hughes, Linda J Harrison, Eric S Daar, et al. (+16)
60 [GO] 2025―Feb―05 Long COVID Incidence Proportion in Adults and Children Between 2020 and 2024: An Electronic Health Record-Based Study From the RECOVER Initiative Hannah Mandel, Yun J Yoo, Andrea J Allen, Sajjad Abedian, Zoe Verzani, Elizabeth W Karlson, et al. (+40)
61 [GO] 2025―Jan―30 Anti-SARS-CoV-2 Immunoglobulin G Antibody Titers in Contemporary Lots of Intravenous Immunoglobulin and Fresh Frozen Plasma Compared With COVID-19 Convalescent Plasma Ethan A Smith, Ginny M Javier, Ashrit Multani, Omer Eugene Beaird, Pryce Gaynor, Lauren Yanagimoto-Ogawa, et al. (+6)
62 [GO] 2025―Jan―17 Ongoing Symptoms After Acute SARS-CoV-2 or Influenza Infection in a Case-Ascertained Household Transmission Study: 7 US Sites, 2021-2023 Ayla Bullock, Alexandra F Dalton, Melissa S Stockwell, Son H McLaren, Ellen Sano, Huong Q Nguyen, et al. (+19)
63 [GO] 2025―Jan―10 Predicting the risk of intensive care unit admission in patients with COVID-19 presenting in the emergency room: Development and evaluation of the CROSS score Weiwei Xiang, Fridolin Steinbeis, Kiret Dhindsa, Florian Kurth, Tilman Lingscheid, Charlotte Thibeault, et al. (+22)
64 [GO] 2024―Dec―18 Relationship Between Acute SARS-CoV-2 Viral Clearance and Long COVID-19 (Long COVID) Symptoms: A Cohort Study Carly Herbert, Annukka A R Antar, John Broach, Colton Wright, Pamela Stamegna, Katherine Luzuriaga, et al. (+4)
65 [GO] 2024―Dec―10 Bivalent Boosters and Risk of Postacute Sequelae Following Vaccine-Breakthrough SARS-CoV-2 Omicron Infection: A Cohort Study Liang En Wee, Jue Tao Lim, Mayank Goel, Muhammad Ismail Abdul Malek, Calvin J Chiew, Benjamin Ong, et al. (+2)
66 [GO] 2024―Nov―27 HIV/AIDS and COVID-19: Shared Lessons From 2 Pandemics Anthony S Fauci, Gregory K Folkers
67 [GO] 2024―Nov―26 Optimal Annual COVID-19 Vaccine Boosting Dates Following Previous Booster Vaccination or Breakthrough Infection Jeffrey P Townsend, Hayley B Hassler, Alex Dornburg
68 [GO] 2024―Nov―25 COVID-19 Antiviral Medication Use Among Pregnant and Recently Pregnant US Outpatients Annette K Regan, Stacey L Rowe, Sheena G Sullivan, Matthew M Coates, Flor M Muñoz, Onyebuchi A Arah
69 [GO] 2024―Nov―20 Association between use of a voluntary isolation centre and reduced household SARS-CoV-2 transmission: A matched cohort study from Toronto, Canada Kevin A Brown, Ana Cecilia Ulloa, Sarah A Buchan, Nick Daneman, Effie Gournis, Rachel Laxer, et al. (+2)
70 [GO] 2024―Nov―15 Correction to: Development of an Effective Immune Response in Adults With Down Syndrome After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination
71 [GO] 2024―Nov―13 In-hospital Outcomes of Healthcare-associated Coronavirus Disease 2019 (Omicron) Versus Healthcare-associated Influenza: A Retrospective, Nationwide Cohort Study in Switzerland Rebecca Grant, Marlieke E A de Kraker, Niccolò Buetti, Holly Jackson, Mohamed Abbas, Jonathan Aryeh Sobel, et al. (+26)
72 [GO] 2024―Nov―11 Alleviation of COVID-19 Symptoms and Reduction in Healthcare Utilization Among High-risk Patients Treated With Nirmatrelvir/Ritonavir (NMV/R): A Phase 3 Randomized Trial Jennifer Hammond, Heidi Leister-Tebbe, Annie Gardner, Paula Abreu, Weihang Bao, Wayne Wisemandle, et al. (+6)
73 [GO] 2024―Nov―01 Virologic Response and Safety of Ibuzatrelvir, A Novel SARS-CoV-2 Antiviral, in Adults With COVID-19 Mahta Mortezavi, Abigail Sloan, Ravi Shankar P Singh, Luke F Chen, Jin Hyang Kim, Negin Shojaee, et al. (+7)
74 [GO] 2024―Oct―29 2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Management of COVID-19: Anti-SARS-CoV-2 Neutralizing Antibody Pemivibart for Pre-exposure Prophylaxis Adarsh Bhimraj, Yngve Falck-Ytter, Arthur Y Kim, Jonathan Z Li, Lindsey R Baden, Steven Johnson, et al. (+20)
75 [GO] 2024―Oct―25 Public Health Benefits of Applying Evidence-Based Best Practices in Managing Patients Hospitalized for COVID-19 Andre C Kalil, Aastha Chandak, Luke S P Moore, Neera Ahuja, Martin Kolditz, Roman Casciano, et al. (+6)
76 [GO] 2024―Oct―24 Remdesivir for Patients Hospitalized with COVID-19: Evidence of Effectiveness from Cohort Studies in the Omicron Era Daniel R Kuritzkes
77 [GO] 2024―Oct―17 Management of vulnerable patients hospitalized for COVID-19 with remdesivir: a retrospective comparative effectiveness study of mortality in US hospitals Essy Mozaffari, Aastha Chandak, Mark Berry, Paul E Sax, Paul Loubet, Yohei Doi, et al. (+5)
78 [GO] 2024―Oct―16 Propensity score methods for confounding control in observational studies of therapeutics for COVID-19 infection Kathleen E Hurwitz, Nuvan Rathnayaka, Kayla Hendrickson, M Alan Brookhart
79 [GO] 2024―Oct―15 Remdesivir-associated survival outcomes among immunocompromised patients hospitalized for COVID-19: real-world evidence from the Omicron dominant era Essy Mozaffari, Aastha Chandak, Robert L Gottlieb, Chidinma Chima-Melton, Mark Berry, Alpesh N Amin, et al. (+2)
80 [GO] 2024―Oct―15 Remdesivir Effectiveness in Reducing the Risk of 30-Day Readmission in Vulnerable Patients Hospitalized for COVID-19: A Retrospective US Cohort Study Using Propensity Scores Essy Mozaffari, Aastha Chandak, Robert L Gottlieb, Andre C Kalil, Heng Jiang, Thomas Oppelt, et al. (+3)
81 [GO] 2024―Sep―25 Correction to: Changes in the Appropriateness of US Outpatient Antibiotic Prescribing After the COVID-19 Outbreak: An Interrupted Time series Analysis of 2017-2021 Data
82 [GO] 2024―Sep―20 Lower mortality risk associated with remdesivir + dexamethasone versus dexamethasone alone for the treatment of patients hospitalized for COVID-19 Essy Mozaffari, Aastha Chandak, Robert L Gottlieb, Chidinma Chima-Melton, Mark Berry, Thomas Oppelt, et al. (+5)
83 [GO] 2024―Sep―19 Remdesivir for COVID-19 in 2024 and beyond: checking the expiry date of the milk carton Todd C Lee
84 [GO] 2024―Sep―12 Impact of baseline SARS-CoV-2 load in plasma and upper airways on the incidence of acute extrapulmonary complications of COVID-19: a multicentric, prospective, cohort study Tomas O Jensen, Katrina Harper, Shaili Gupta, Sean T Liu, Nila J Dharan, Jason V Baker, et al. (+8)
85 [GO] 2024―Aug―26 A phase III randomized controlled trial of plitidepsin, a marine derived compound, in hospitalized adults with moderate COVID-19 Pedro Landete, Olga-Adriana Caliman-Sturdza, Jose A Lopez-Martin, Liliana Preotescu, Mihaela-Catalina Luca, Anastasia Kotanidou, et al. (+27)
86 [GO] 2024―Aug―20 Association Between SARS-CoV-2 Infection During Pregnancy and Gestational Diabetes: A Claims-based Cohort Study Oscar Rincón-Guevara, Bailey Wallace, Lyudmyla Kompaniyets, Catherine E Barrett, Lara Bull-Otterson
87 [GO] 2024―Aug―08 Single monoclonal antibodies should not be used for COVID-19 therapy: a call for antiviral stewardship Arturo Casadevall, Daniele Focosi, Liise-anne Pirofski, Shmuel Shoham
88 [GO] 2024―Aug―07 Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, October 18, 2023-March 9, 2024 Kevin C Ma, Diya Surie, Adam S Lauring, Emily T Martin, Aleda M Leis, Leigh Papalambros, et al. (+55)
89 [GO] 2024―Jul―24 Validating Combination Throat-Nasal Swab Specimens for Coronavirus Disease 2019 Tests Would Improve Early Detection, Especially for the Most Vulnerable Alexander Viloria Winnett, Timothy Stenzel, Rustem F Ismagilov
90 [GO] 2024―Jul―17 Severe Acute Respiratory Syndrome Coronavirus 2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With Coronavirus Disease 2019 Nikolaus Jilg, Mark J Giganti, Kara W Chew, Katy Shaw-Saliba, Justin Ritz, Carlee Moser, et al. (+9)
91 [GO] 2024―Jul―10 Effects of Losartan on Patients Hospitalized for Acute Coronavirus Disease 2019: A Randomized Controlled Trial Karen C Tran, Pierre Asfar, Matthew Cheng, Julien Demiselle, Joel Singer, Terry Lee, et al. (+93)
92 [GO] 2024―Jun―26 Impact of RNase in Patients With Severe Fatigue Related to Post-Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Guangting Zeng, Yuchi Zhou
93 [GO] 2024―Jun―26 Risks of Severe Acute Respiratory Syndrome Coronavirus 2 JN.1 Infection and Coronavirus Disease 2019-Associated Emergency Department Visits/Hospitalizations Following Updated Boosters and Prior Infection: A Population-Based Cohort Study Cheryl Chong, Liang En Wee, Xuan Jin, Mengyang Zhang, Muhammad Ismail Abdul Malek, Benjamin Ong, et al. (+3)
94 [GO] 2024―Jun―26 Remdesivir for Treatment of Coronavirus Disease 2019 Requiring Oxygen Support: A Cross-Study Comparison From 2 Large, Open-Label Studies Dahlene Fusco, Ivana Malenica, Huldrych F Günthard, Samir K Gupta, Dax Kurbegov, Bindu Balani, et al. (+12)
95 [GO] 2024―Jun―24 Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for Coronavirus Disease 2019 Pneumonia: A Randomized Clinical Trial Meghan E Sise, Jose Ramon Santos, Jason D Goldman, Katherine R Tuttle, J Pedro Teixeira, Allan F Seibert, et al. (+137)
96 [GO] 2024―Jun―05 Correction to: Repurposing Revisited: Exploring the Role of Metformin for Treatment of Coronavirus Disease 2019
97 [GO] 2024―Jun―03 How Immunocompromised Hosts Were Left Behind in the Quest to Control the Covid-19 Pandemic Michael Boeckh, Steven A Pergam, Ajit P Limaye, Janet Englund, Lawrence Corey, Joshua A Hill
98 [GO] 2024―Jun―02 The impact of prior COVID-19 on non-infectious endothelial complications following allogeneic hematopoietic stem cell transplantation Chiara Oltolini, Giovanna Travi, Malgorzata Mikulska
99 [GO] 2024―Jun―01 Acute Endothelial Complications Post-Allogeneic Hematopoietic Cell Transplant in Patients with Pre-Cellular Therapy SARS-CoV-2 Infection Ila Nimgaonkar, Patrick W Flaherty, Masumi Ueda Oshima, Joshua A Hill
100 [GO] 2024―May―28 Development of Next-Generation COVID-19 Vaccines: Biomedical Advanced Research and Development Authority (BARDA­)-Supported Phase 2b Study Designs Daniel N Wolfe, Elizabeth Arangies, Gloria L David, Brian Armstrong, Theresa Z Scocca, Janel Fedler, et al. (+11)
101 [GO] 2024―May―27 SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study Joshua A Hill, Michael J Martens, Jo-Anne H Young, Kavita Bhavsar, Jianqun Kou, Min Chen, et al. (+24)
102 [GO] 2024―May―15 Is there room for metformin at COVID-19’s dinner table? Updated Analysis of Clinical Trials Todd C Lee, David R Boulware
103 [GO] 2024―May―13 Doff Thy Gown - Shedding Contact Precautions for COVID-19 Alexander S Rabin, Linsey C Marr, Henry M Blumberg
104 [GO] 2024―May―10 Assessment of the Impact of RNase in Patients With Severe Fatigue Related to Post-Acute Sequelae of SARS-CoV-2 Infection (PASC): A Randomized Phase 2 Trial of RSLV-132 James S Andrews, Jim B Boonyaratanakornkit, Eva Krusinska, Suzanne Allen, James A Posada
105 [GO] 2024―May―03 The Effect of COVID-19 Vaccination on Outpatient Antibiotic Prescribing in Older Adults: A Self-Controlled Risk-Interval Study Sarah C J Jorgensen, Kevin Brown, Anna E Clarke, Kevin L Schwartz, Colleen Maxwell, Nick Daneman, et al. (+2)
106 [GO] 2024―May―01 Favorable Antiviral Effect of Metformin on SARS-CoV-2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of COVID-19 Carolyn T Bramante, Kenneth B Beckman, Tanvi Mehta, Amy B Karger, David J Odde, Christopher J Tignanelli, et al. (+107)
107 [GO] 2024―May―01 Repurposing Revisited: Exploring the Role of Metformin for Treatment of COVID-19 Mark J Siedner, Paul E Sax
108 [GO] 2024―Apr―30 Correction to: Differential Cytokine Signatures of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Infection Highlight Key Differences in Pathobiology
109 [GO] 2024―Apr―30 Correction to: Impact of Seasonal Coronavirus Antibodies on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responses in Solid Organ Transplant Recipients
110 [GO] 2024―Apr―22 Changes in the Appropriateness of US Outpatient Antibiotic Prescribing After the COVID-19 Outbreak: An Interrupted Time Series Analysis of 2016-2021 Data Kao-Ping Chua, Michael A Fischer, Moshiur Rahman, Jeffrey A Linder
111 [GO] 2024―Apr―15 Correction to: Discordant Antibody and T-Cell Responses to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in Coronavirus Disease 2019 Messenger RNA Vaccine Recipients
112 [GO] 2024―Apr―11 Increased Pediatric Respiratory Syncytial Virus Case Counts Following the Emergence of SARS-CoV-2 Can Be Attributed to Changes in Testing Brittany A Petros, Carly E Milliren, Pardis C Sabeti, Al Ozonoff
113 [GO] 2024―Apr―08 COVID-19 vaccine efficacy in participants with weakened immune systems from four randomized-controlled trials Amy Sherman, Jessica Tuan, Valeria D Cantos, Oladunni Adeyiga, Scott Mahoney, Ana M Ortega-Villa, et al. (+24)
114 [GO] 2024―Apr―04 Rapid Guidelines to Address the Changing COVID-19 Pandemic
115 [GO] 2024―Mar―29 Cardiac Adverse Events and Remdesivir in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19): A Post Hoc Safety Analysis of the Randomized DisCoVeRy Trial Vida Terzić, Joe Miantezila Basilua, Nicolas Billard, Lucie de Gastines, Drifa Belhadi, Claire Fougerou-Leurent, et al. (+163)
116 [GO] 2024―Mar―29 True DisCoVeRy of COVID-19 Disease Burden Versus Speculated Antiviral Cardiovascular Risk Requires a Control Group Robert L Gottlieb, Andre C Kalil
117 [GO] 2024―Mar―26 Household Transmission Dynamics of Asymptomatic SARS-CoV-2-Infected Children: A Multinational, Controlled Case-Ascertained Prospective Study Anna Funk, Todd A Florin, Nathan Kuppermann, Yaron Finkelstein, Alissa Kazakoff, Michael Baldovsky, et al. (+17)
118 [GO] 2024―Mar―13 Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Serologic Testing Mary K Hayden, Ibrahim K El Mikati, Kimberly E Hanson, Janet A Englund, Romney M Humphries, Francesca Lee, et al. (+13)
119 [GO] 2024―Mar―11 Effectiveness of the 2023-2024 Formulation of the COVID-19 Messenger RNA Vaccine Nabin K Shrestha, Patrick C Burke, Amy S Nowacki, Steven M Gordon
120 [GO] 2024―Mar―11 Pre-existing Immunocompromising Conditions and Outcomes of Acute COVID-19 Patients Admitted for Pediatric Intensive Care Courtney M Rowan, Brenna LaBere, Cameron C Young, Laura D Zambrano, Margaret M Newhams, Suden Kucukak, et al. (+133)
121 [GO] 2024―Mar―11 Hybrid Immunity and SARS-CoV-2 Antibodies: Results of the HEROES-RECOVER Prospective Cohort Study James K Romine, Huashi Li, Melissa M Coughlin, Jefferson M Jones, Amadea Britton, Harmony L Tyner, et al. (+24)
122 [GO] 2024―Mar―07 Reflections on COVID-19: Solitude and Isolation Richard P Wenzel
123 [GO] 2024―Mar―06 Clinical and Virological Outcome of Monoclonal Antibody Therapies Across SARS-CoV-2 Variants in 245 Immunocompromised Patients: A Multicenter Prospective Cohort Study Sammy Huygens, Corine GeurtsvanKessel, Arvind Gharbharan, Susanne Bogers, Nathalie Worp, Marjan Boter, et al. (+9)
124 [GO] 2024―Mar―01 Outcomes in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T Cell Therapy Recipients with Pre-Cellular Therapy SARS-CoV-2 Infection Ila Nimgaonkar, Leah H Yoke, Pavitra Roychoudhury, Patrick W Flaherty, Masumi Ueda Oshima, Amelia Weixler, et al. (+6)
125 [GO] 2024―Feb―27 Combined protection of vaccination and nirmatrelvir-ritonavir against hospitalization in adults with COVID-19 Melisa M Shah, Brendan Joyce, Ian D Plumb, Sam Sahakian, Leora R Feldstein, Eric Barkley, et al. (+5)
126 [GO] 2024―Feb―20 Exploring the infectious contribution to intussusception causality using the effects of COVID-19 lockdowns in Australia: An ecological study Benjamin Townley, Deniz Akin, Gerardo Luis Dimaguila, Rana Sawires, Gonzalo Sepulveda Kattan, Sebastian King, et al. (+4)
127 [GO] 2024―Feb―20 Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19 Neil R Aggarwal, Jacquie Nordwall, Dominique L Braun, Lucy Chung, Jordan Coslet, Tatyana Der, et al. (+1429)
128 [GO] 2024―Feb―20 Viral, Host Factors or Both as COVID-19 Biomarkers Marius Trøseid
129 [GO] 2024―Feb―19 Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 Vaccine Dean Follmann, Allyson Mateja, Michael P Fay, Craig A Magaret, Yunda Huang, Youyi Fong, et al. (+7)
130 [GO] 2024―Feb―17 COVID-19 Clinical Trials: Are Adaptive Methodologies the Solution? Rocio Montejano, Jose Ramon Arribas
131 [GO] 2024―Feb―15 COVID-19: find the right questions to be answered Andrea Giacomelli, Spinello Antinori, Andrea Gori, Alessandro Cozzi-Lepri
132 [GO] 2024―Feb―14 Project NexGen: Developing the Next Generation of COVID-19 Vaccines and Therapeutics to Respond to the Present and Prepare for the Future Kimberly A Hofmeyer, Christy L Ventura, Aaron C Bandremer, John H Beigel, Timothy T Belski, Ruben O Donis, et al. (+13)
133 [GO] 2024―Feb―06 Early Mortality After the First Dose of COVID-19 Vaccination: A Target Trial Emulation Kevin W McConeghy, Kwan Hur, Issa J Dahabreh, Rong Jiang, Lucy Pandey, Walid F Gellad, et al. (+6)
134 [GO] 2024―Jan―16 Integrated Genomic and Social Network Analyses of SARS-CoV-2 Transmission in the Healthcare Setting Jocelyn Keehner, Shira R Abeles, Christopher A Longhurst, Lucy E Horton, Frank E Myers, Lindsay Riggs-Rodriguez, et al. (+61)
135 [GO] 2024―Jan―04 Reducing Diagnostic Bias Through Multiplex Polymerase Chain Reaction (PCR) Testing for SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus Pontus Hedberg, John Karlsson Valik, Lina Abdel Halim, Tobias Alfvén, Pontus Naucler
136 [GO] 2024―Jan―04 Outcomes of SARS-CoV-2 Omicron Variant, Influenza, and Respiratory Syncytial Virus on the Dissecting Table: Is Further Dissection Required? Zitta Barrella Harboe, Jon Gitz Holler, Mads Frederik Eiberg, Casper Roed, Omid Rezahosseini
137 [GO] 2023―Dec―30 Nirmatrelvir and Ritonavir Combination in COVID-19 Patients With Advanced Chronic Kidney Disease Emmanuel Lafont, Damien Blez, Marc-Antoine Bildan, David Veyer, Hélène Péré, Julien Puech, et al. (+6)
138 [GO] 2023―Dec―30 SARS-CoV-2 Antiviral Prescribing Gaps Among Nonhospitalized High-Risk Adults Matthew E Levy, Evanette Burrows, Vanessa Chilunda, Pamala A Pawloski, Phillip R Heaton, Joseph Grzymski, et al. (+15)
139 [GO] 2023―Dec―20 Evaluating Quality Management and Diagnostics Microbiology Performance Within an International External Quality Assessment (EQA) Program Serving National One Health Sector Reference Laboratories Across Asia: Experience Amid the Coronavirus Disease 2019 (COVID-19) Pandemic Freshwork Ayalew Abegaz, Patrícia Teixeira dos Santos, Ondari D Mogeni, Tobin Guarnacci, Nimesh Poudyal, Jinhui Hong, et al. (+9)
140 [GO] 2023―Dec―20 Utility and Evaluation of Applied Project Management Processes Within a Large Multicountry Health Systems Development Project Conducted During the Coronavirus Disease 2019 (COVID-19) Pandemic Soo Young Kwon, Sanjay Gautam, Kritika Poudel, Hasini Banneheke, Delfim Ferreira, Manish Gautam, et al. (+15)
141 [GO] 2023―Dec―19 The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing (December 2023) Mary K Hayden, Kimberly E Hanson, Janet A Englund, Mark J Lee, Mark Loeb, Francesca Lee, et al. (+14)
142 [GO] 2023―Dec―12 Viral dynamics of the SARS-CoV-2 Omicron Variant in Paediatric Patients; A prospective cohort study Michelle Science, Julia Orkin, Bryan Maguire, Ari Bitnun, Laura Bourns, Antoine Corbeil, et al. (+9)
143 [GO] 2023―Dec―07 Unlinking time zero from test-negative controls exaggerates risk from COVID-19 Anil N Makam
144 [GO] 2023―Dec―07 Unlinking time zero from test-negative date does not influence risk estimates of long-term cardiovascular complications due to COVID-19 Jue Tao Lim, Wee Liang En, An Ting Tay, Deanette Pang, Calvin J Chiew, Benjamin Ong, et al. (+2)
145 [GO] 2023―Dec―07 Age-specific resurgence in invasive pneumococcal disease incidence in the COVID-19 pandemic era and its association with respiratory virus and pneumococcal carriage dynamics: a time series analysis Alexis Rybak, Zein Assad, Corinne Levy, Stephane Bonarcorsi, Stéphane Béchet, Andreas Werner, et al. (+7)
146 [GO] 2023―Dec―07 COVID-19 Vaccination: Safeguarding Against Post-COVID Cardiovascular Complications Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan, Kaeshaelya Thiruchelvam
147 [GO] 2023―Nov―22 Protection conferred by COVID-19 vaccination, prior SARS-CoV-2 infection, or hybrid immunity against Omicron-associated severe outcomes among community-dwelling adults Nelson Lee, Lena Nguyen, Peter C Austin, Kevin A Brown, Ramandip Grewal, Sarah A Buchan, et al. (+7)
148 [GO] 2023―Nov―16 When Someone Should Do Something About This: How a Cryptococcal Clinical Trialist Became Involved With the COVID-19 Pandemic David R Boulware
149 [GO] 2023―Nov―15 Differential Viral Dynamics by Sex and Body Mass Index During Acute SARS-CoV-2 Infection: Results from a Longitudinal Cohort Study Carly Herbert, Yukari C Manabe, Andreas Filippaios, Honghuang Lin, Biqi Wang, Chad Achenbach, et al. (+12)
150 [GO] 2023―Nov―14 Symptoms, viral loads, and rebound among COVID-19 outpatients treated with nirmatrelvir/ritonavir compared to propensity score matched untreated individuals Sarah E Smith-Jeffcoat, Jessica E Biddle, H Keipp Talbot, Kerry Grace Morrisey, Melissa S Stockwell, Yvonne Maldonado, et al. (+31)
151 [GO] 2023―Nov―14 Viral Suppression Trajectories Destabilized After Coronavirus Disease 2019 Among US People With Human Immunodeficiency Virus: An Interrupted Time Series Analysis Matthew A Spinelli, Katerina A Christopoulos, Carlos V Moreira, Jennifer P Jain, Nadra Lisha, David V Glidden, et al. (+10)
152 [GO] 2023―Nov―11 Review: The Landscape of Antiviral Therapy for COVID-19 in the Era of Widespread Population Immunity and Omicron-Lineage Viruses Eric A Meyerowitz, Yijia Li
153 [GO] 2023―Nov―09 Hostility Unmasked: Scientists on the Frontlines of the COVID-19 Pandemic Krutika Kuppalli
154 [GO] 2023―Nov―07 Clinical Laboratory Experiences During the COVID-19 Pandemic Romney Humphries, Susan Sefers, Jonathan Schmitz, Adam Seegmiller
155 [GO] 2023―Nov―06 Coronavirus Disease (COVID) and the Fog of War Michael S Saag
156 [GO] 2023―Oct―27 Letter to the editor: Positive effects of cognitive-behavioral therapy targeting severe fatigue following COVID-19 are sustained up to one year after treatment Tanja A Kuut, Fabiola Müller, Irene Csorba, Annemarie M J Braamse, Pythia Nieuwkerk, Chantal P Rovers, Hans Knoop
157 [GO] 2023―Oct―25 Outcomes of SARS-CoV-2 Omicron Variant Infections Compared with Seasonal Influenza and Respiratory Syncytial Virus Infections in Adults Attending the Emergency Department: A Multicentre Cohort Study Pontus Hedberg, John Karlsson Valik, Lina Abdel Halim, Tobias Alfvén, Pontus Naucler
158 [GO] 2023―Oct―24 The Current Mismatch between COVID-19 Clinical Trial Design and The Evolving Profile of Hospitalized Patients: A Retrospective Cohort Analysis Rocio Montejano, Alfredo Soler-Carracedo, Alberto M Borobia, Alejandro Martin-Quiros, David Grandioso, Carlos Cañada, et al. (+2)
159 [GO] 2023―Oct―23 A Systematic Review of Predictor Composition, Outcomes, Risk of Bias, and Validation of COVID-19 Prognostic Scores Katharina S Appel, Ramsia Geisler, Daniel Maier, Olga Miljukov, Sina M Hopff, Jörg J Vehreschild
160 [GO] 2023―Oct―18 The Pandemic Babies Matthew Shou Lun Lee
161 [GO] 2023―Oct―12 Infection Control and Prevention During the COVID-19 Pandemic Vivek Jain
162 [GO] 2023―Oct―10 Heatwaves and Dengue Outbreak in Bangladesh After the Pandemic- An Urgent Call for Climate-Driven Early Warning Systems Jahirul Islam, Wenbiao Hu
163 [GO] 2023―Oct―05 A randomised controlled trial to study the transmission of SARS-CoV-2 and other respiratory viruses during indoor clubbing events (ANRS0066s ITOC study) Liem B Luong Nguyen, Jeanne Goupil de Bouillé, Lola Menant, Marion Noret, Audrey Dumas, Maud Salmona, et al. (+15)
164 [GO] 2023―Oct―04 SARS-CoV-2 Exposures in a Large Gathering Event and Acquisition of COVID-19 in the Post-Vaccintion Era: A Randomized Trial is Possible During the Pandemic John M Conly, Mark Loeb
165 [GO] 2023―Oct―04 Just Breathe: My First 12 Hours as a Clinician Patient With COVID-19 Nichole N Regan
166 [GO] 2023―Oct―04 Our Parents Were Never Home: Seeing the Pandemic Through Children's Eyes Giovanni E Marcelin, Nathaniel L Marcelin, Jasmine R Marcelin, Alberto Marcelin
167 [GO] 2023―Sep―30 Voices of ID: Dealing with a Pandemic When You’re the Only ID Doctor in Town Abayomi "Yomi" A Agbebi
168 [GO] 2023―Sep―29 Isolated and Lonely in a Nursing Home During the COVID 19 Pandemic: A Deadly Combination for My Mom Debra A Goff
169 [GO] 2023―Sep―27 Effects of BNT162b2 Messenger RNA Vaccine and ChAdOx1 Adenovirus Vector Vaccine on Deaths From Coronavirus Disease 2019 in Adults Aged ≥70 Years Jamie Lopez Bernal, Nick Andrews, Charlotte Gower, Julia Stowe, Elise Tessier, Ruth Simmons, Mary Ramsay
170 [GO] 2023―Sep―26 The New Normal: Delayed Peak SARS-CoV-2 Viral Loads Relative to Symptom Onset and Implications for COVID-19 Testing Programs Jennifer K Frediani, Richard Parsons, Kaleb B McLendon, Adrianna L Westbrook, Wilbur Lam, Greg Martin, Nira R Pollock
171 [GO] 2023―Sep―25 Long-term Cardiovascular, Cerebrovascular, and Other Thrombotic Complications in COVID-19 Survivors: A Retrospective Cohort Study Jue Tao Lim, Wee Liang En, An Ting Tay, Deanette Pang, Calvin J Chiew, Benjamin Ong, et al. (+2)
172 [GO] 2023―Sep―23 SARS-CoV-2 Infection and Postacute Risk of Non-Coronavirus Disease 2019 Infectious Disease Hospitalizations: A Nationwide Cohort Study of Danish Adults Aged ≥50 Years Niklas Worm Andersson, Emilia Myrup Thiesson, Ria Lassaunière, Jørgen Vinsløv Hansen, Anders Hviid
173 [GO] 2023―Sep―12 Description of Cryptococcosis following SARS-CoV-2 infection: A disease survey through the Mycosis Study Group Education and Research Consortium (MSG-19) Jeremey Walker, Todd McCarty, Gerald McGwin, Eloy E Ordaya, Paschalis Vergidis, Luis Ostrosky-Zeichner, et al. (+37)
174 [GO] 2023―Sep―08 High burden of COVID-19-associated pulmonary aspergillosis (CAPA) in severely immunocompromised patients requiring mechanical ventilation Simon Feys, Katrien Lagrou, Hanne Moon Lauwers, Koen Haenen, Cato Jacobs, Marius Brusselmans, et al. (+13)
175 [GO] 2023―Sep―07 Timing and Predictors of Loss of Infectivity Among Healthcare Workers With Mild Primary and Recurrent COVID-19: A Prospective Observational Cohort Study Stefania Dzieciolowska, Hugues Charest, Tonya Roy, Judith Fafard, Sara Carazo, Ines Levade, et al. (+8)
176 [GO] 2023―Aug―29 The Socio-Economic and Demographic Risk Factors for SARS-CoV-2 Seropositivity Among Healthcare Workers in a UK Hospital: A Prospective Cohort Study Tanya Lam, Anja Saso, Arturo Torres Ortiz, James Hatcher, Marc Woodman, Shruthi Chandran, et al. (+89)
177 [GO] 2023―Aug―23 Clinical epidemiology and risk factors for critical outcomes among vaccinated and unvaccinated adults hospitalized with COVID-19-VISION Network, 10 States, June 2021-March 2023 Eric P Griggs, Patrick K Mitchell, Victoria Lazariu, Manjusha Gaglani, Charlene McEvoy, Nicola P Klein, et al. (+40)
178 [GO] 2023―Aug―23 Characteristics and outcomes of US Veterans with immunocompromised conditions at high risk of severe SARS-CoV-2 infection with or without receipt of oral antiviral agents Chris A Gentry, Phoi N Nguyen, Sharanjeet K Thind, George Kurdgelashvili, Riley J Williams
179 [GO] 2023―Aug―10 Impact of SARS-CoV-2 Arrival Surveillance Screening by Nucleic Acid Amplification Versus Rapid Antigen Detection on Subsequent COVID-19 Infections in Military Trainees Daniel J Cybulski, Zachary Matthews, John F Kieffer, Theresa M Casey, Angela B Osuna, Korey Kasper, et al. (+4)
180 [GO] 2023―Aug―09 The cost-effectiveness of universal asymptomatic preoperative SARS-CoV-2 PCR screening: a cost-utility analysis Shunsuke Uno, Rei Goto, Kimiko Honda, Sho Uchida, Yoshifumi Uwamino, Ho Namkoong, et al. (+6)
181 [GO] 2023―Aug―08 Remdesivir reduced mortality in immunocompromised patients hospitalized for COVID-19 across variant waves: Findings from routine clinical practice. Essy Mozaffari, Aastha Chandak, Robert L Gottlieb, Chidinma Chima-Melton, Stephanie H Read, Heng Jiang, et al. (+5)
182 [GO] 2023―Aug―03 Impact of the COVID-19 Pandemic on Inpatient Antibiotic Use in the United States, January 2019 through July 2022 Erin N O’Leary, Melinda M Neuhauser, Arjun Srinivasan, Heather Dubendris, Amy K Webb, Minn M Soe, et al. (+4)
183 [GO] 2023―Aug―02 Safety Profile and Clinical and Virological Outcomes of Nirmatrelvir-Ritonavir Treatment in Patients With Advanced Chronic Kidney Disease and Coronavirus Disease 2019 (COVID-19) Gordon Chun Kau Chan, Grace Chung Yan Lui, Candy Ngai Sze Wong, Sindy Sin Ting Yip, Timothy Chun Man Li, Catherine Siu King Cheung, et al. (+3)
184 [GO] 2023―Aug―01 Impact of SARS-CoV-2 Prevention Measures on Non-SARS-CoV-2 Hospital-Onset Respiratory Viral Infections: An Incidence Trend Analysis from 2015-2023 Selina Ehrenzeller, Tom Chen, Vineeta Vaidya, Chanu Rhee, Meghan A Baker, Michael Klompas
185 [GO] 2023―Jul―21 Association between duration of SARS-CoV-2 positivity and long COVID Chiara Pozzi, Riccardo Sarti, Riccardo Levi, Maximiliano Mollura, Elena Azzolini, Riccardo Barbieri, et al. (+2)
186 [GO] 2023―Jul―20 Lack of zoonotic coronavirus species detected among children hospitalized with pneumonia in the Philippines Yusuke Sayama, Michiko Okamoto, Mayuko Saito, Raita Tamaki, Mariko Saito-Obata, Reynaldo Frederick Negosa Quicho, et al. (+3)
187 [GO] 2023―Jul―19 Impact of Molnupiravir Treatment on Patient-Reported Coronavirus Disease 2019 (COVID-19) Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled Trial Yanfen Guan, Amy Puenpatom, Matthew G Johnson, Ying Zhang, Yujie Zhao, Joseph Surber, et al. (+12)
188 [GO] 2023―Jul―18 In Support of Universal Admission Testing for SARS-CoV-2 During Significant Community Transmission Chanu Rhee, Michael Klompas, Theodore R Pak, Julia R Köhler
189 [GO] 2023―Jul―18 Long COVID: Alice Evans, brucellosis, and reflections on infectious causes of chronic disease Tara C Smith
190 [GO] 2023―Jul―14 Asymptomatic testing of hospital admissions for SARS-CoV-2: Is it OK to stop? Karen Brust, Takaaki Kobayashi, Daniel J Diekema
191 [GO] 2023―Jul―12 Lessons from COVID-19 for Pandemic Preparedness: Proceedings from a Multi-Stakeholder Think Tank Shanti Narayanasamy, Lesley H Curtis, Adrian F Hernandez, Christopher W Woods, M Anthony Moody, Mark Sulkowski, et al. (+19)
192 [GO] 2023―Jul―07 SARS-CoV-2 Case-Definitions Must Include Clinical Criteria: Reply to Kojima et al. Lao-Tzu Allan-Blitz, Jeffrey D Klausner
193 [GO] 2023―Jul―05 Trends in Inpatient Antibiotic Use Among Adults Hospitalized During the Coronavirus Disease 2019 Pandemic in Argentina, Brazil, and Chile, 2018-2021 Twisha S Patel, Olivia L McGovern, Garrett Mahon, Hanako Osuka, Icaro Boszczowski, Jose M Munita, et al. (+16)
194 [GO] 2023―Jul―05 A 7-Year Brazilian National Perspective on Plasmid-Mediated Carbapenem Resistance in Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Complex and the Impact of the Coronavirus Disease 2019 Pandemic on Their Occurrence Carlos R V Kiffer, Thais F T Rezende, Daniela Testoni Costa-Nobre, Ana Sílvia Scavacini Marinonio, Lucas Hidemitsu Shiguenaga, Debora Nicole Oliveira Kulek, et al. (+9)
195 [GO] 2023―Jul―05 Antibiotic Consumption During the Coronavirus Disease 2019 Pandemic and Emergence of Carbapenemase-Producing Klebsiella pneumoniae Lineages Among Inpatients in a Chilean Hospital: A Time-Series Study and Phylogenomic Analysis Kasim Allel, Anne Peters, José Conejeros, José R W Martínez, Maria Spencer-Sandino, Roberto Riquelme-Neira, et al. (+11)
196 [GO] 2023―Jul―05 Prescribing of Outpatient Antibiotics Commonly Used for Respiratory Infections Among Adults Before and During the Coronavirus Disease 2019 Pandemic in Brazil Dipesh Solanky, Olivia L McGovern, Jonathan R Edwards, Garrett Mahon, Twisha S Patel, Fernanda C Lessa, et al. (+2)
197 [GO] 2023―Jun―30 Active Surveillance and Contact Precautions for Preventing Methicillin-Resistant Staphylococcus aureus Healthcare-Associated Infections during the COVID-19 Pandemic Martin E Evans, Loretta A Simbartl, Brian P McCauley, Linda K Flarida, Makoto M Jones, Anthony D Harris, et al. (+5)
198 [GO] 2023―Jun―29 A multicenter retrospective cohort study to characterize patients hospitalized with MIS-A and COVID-19 in the United States, 2020-2021 Michael Melgar, Joseph Y Abrams, Shana Godfred-Cato, Ami B Shah, Amit Garg, Andrew Strunk, et al. (+29)
199 [GO] 2023―Jun―29 Correspondence in relation to the recently published paper: Efficacy of cognitive behavioral therapy targeting severe fatigue following COVID-19: results of a randomized controlled trial by Kuut and colleagues. Joan S Crawford
200 [GO] 2023―Jun―29 Oral Nirmatrelvir and Ritonavir for Covid-19 in Vaccinated, Non-Hospitalized Adults, Ages 18-50 Years Jeremy Samuel Faust, Ashish Kumar, Jui Shah, Sumanth Khadke, Sourbha S Dani, Sarju Ganatra, Paul E Sax
201 [GO] 2023―Jun―29 Omicron variant-specific serological imprinting following BA.1 or BA.4/5 bivalent vaccination and previous SARS-CoV-2 infection: A cohort study Eva A M Baerends, Joanne Reekie, Signe R Andreasen, Nina B Stærke, Dorthe Raben, Henrik Nielsen, et al. (+19)
202 [GO] 2023―Jun―23 Maintaining the Utility of COVID-19 Pandemic Severity Surveillance: Evaluation of Trends in Attributable Deaths and Development and Validation of a Measurement Tool Caitlin Trottier, Jennifer La, Lucy L Li, Majd Alsoubani, Austin D Vo, Nathanael R Fillmore, et al. (+3)
203 [GO] 2023―Jun―20 SARS-CoV-2 Antibody Replacement Therapy for Immunocompromised Patients Jonathon W Senefeld, Michael J Joyner
204 [GO] 2023―Jun―17 No immunological interference or safety concerns when adjuvanted recombinant zoster vaccine is coadministered with a COVID-19 mRNA-1273 booster vaccine in adults aged 50 years and older: A randomized trial Abdi Naficy, Adrienne Kuxhausen, Paola Pirrotta, Brett Leav, Jacqueline Miller, Kate Anteyi, et al. (+3)
205 [GO] 2023―Jun―17 Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Vinit Upasani, Katie Townsend, Mary Y Wu, Edward J Carr, Agnieszka Hobbs, Giulia Dowgier, et al. (+23)
206 [GO] 2023―Jun―09 One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19): A Randomized Controlled Phase 2 Trial Nikolaus Jilg, Kara W Chew, Mark J Giganti, Eric S Daar, David A Wohl, Arzhang Cyrus Javan, et al. (+32)
207 [GO] 2023―Jun―09 Long-term Real-world Protection Afforded by Third mRNA Doses Against Symptomatic SARS-COV-2 Infections, COVID-19-related Emergency Attendances and Hospitalizations Amongst Older Singaporeans During an Omicron XBB Wave Liang En Wee, Deanette Pang, Calvin Chiew, Janice Tan, Vernon Lee, Benjamin Ong, et al. (+2)
208 [GO] 2023―Jun―08 Glucose-6-phosphate dehydrogenase (G6PD) Deficiency and COVID-19 Ariel Israel, Matitiahu Berkovitch, Eugene Merzon, Avivit Golan-Cohen, Ilan Green, Eytan Ruppin, et al. (+2)
209 [GO] 2023―May―31 Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022 Noah Kojima, Katherine Adams, Wesley H Self, Manjusha Gaglani, Tresa McNeal, Shekhar Ghamande, et al. (+210)
210 [GO] 2023―May―31 Patients Hospitalized With Coronavirus Disease 2019: A Diverse Population Jens Lundgren
211 [GO] 2023―May―30 Correction to: Relative Effectiveness of Coronavirus Disease 2019 Vaccination and Booster Dose Combinations Among 18.9 Million Vaccinated Adults During the Early Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Period-United States, 1 January 2022 to 31 March 2022
212 [GO] 2023―May―23 A Randomized Controlled Study Assessing Convalescent Immunoglobulins versus Convalescent Plasma for Hospitalized COVID-19 Patients Yasmin Maor, Eilat Shinar, Marina Izak, Galia Rahav, Tal Brosh-Nissimov, Asa Kessler, et al. (+7)
213 [GO] 2023―May―22 Zinc for the treatment of COVID-19: Yet to prove its mettle? Pritheetha Gowthaman, Shawn Vasoo
214 [GO] 2023―May―19 Correction to: Association of Upper Respiratory Streptococcus pneumoniae Colonization With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Adults
215 [GO] 2023―May―19 Pre-existing autoimmunity is associated with increased severity of COVID-19: A retrospective cohort study using data from the National COVID Cohort Collaborative (N3C) Arjun S Yadaw, David K Sahner, Hythem Sidky, Behdad Afzali, Nathan Hotaling, Emily R Pfaff, et al. (+129)
216 [GO] 2023―May―11 Association of virus variation and vaccination status with post-acute sequelae after SARS-cov-2 infection Guangting Zeng, Yuchi Zhou
217 [GO] 2023―May―10 Increase in False Positive Fourth Generation HIV Tests in Patients with COVID-19 Disease Smitha Gudipati, Anita Shallal, Edward Peterson, Bernard Cook, Norman Markowitz
218 [GO] 2023―May―08 Efficacy of cognitive behavioral therapy targeting severe fatigue following COVID-19: results of a randomized controlled trial Tanja A Kuut, Fabiola Müller, Irene Csorba, Annemarie Braamse, Arnoud Aldenkamp, Brent Appelman, et al. (+14)
219 [GO] 2023―May―07 Real-World Effectiveness of Nirmatrelvir/Ritonavir on Covid-19-Associated Hospitalization Prevention: A Population-Based Cohort Study in the Province of Québec, Canada Jean-Luc Kaboré, Benoît Laffont, Mamadou Diop, Melanie R Tardif, Alexis F Turgeon, Jeannot Dumaresq, et al. (+7)
220 [GO] 2023―May―03 Vaccination Status and Trends in Adult COVID-19-Associated Hospitalizations by Race and Ethnicity, March 2020-August 2022 Jean Y Ko, Huong Pham, Onika Anglin, Shua J Chai, Nisha B Alden, James Meek, et al. (+26)
221 [GO] 2023―Apr―27 How Infectious Disease Experts Impacted the Coronavirus Disease 2019 Response: Lessons From the Front Lines Amesh Adalja, Daniel P McQuillen, Diane Meyer
222 [GO] 2023―Apr―20 Therapy with Allogeneic SARS-CoV-2-specific T-cells for Persistent COVID-19 in Immunocompromised Patients Ghady Haidar, Jana L Jacobs, Kailey Hughes Kramer, Asma Naqvi, Amy Heaps, Urvi Parikh, et al. (+23)
223 [GO] 2023―Apr―19 Condition-Dependent and Dynamic Impacts of Indoor Masking Policies for COVID-19 Mitigation: A Nationwide, Interrupted Time-Series Analysis Zeynep Ertem, Richard E Nelson, Elissa M Schechter-Perkins, Amera Al-Amery, Xilin Zhang, Westyn Branch-Elliman
224 [GO] 2023―Apr―19 Changes in population immunity against infection and severe disease from SARS-CoV-2 Omicron variants in the United States between December 2021 and November 2022 Fayette Klaassen, Melanie H Chitwood, Ted Cohen, Virginia E Pitzer, Marcus Russi, Nicole A Swartwood, et al. (+2)
225 [GO] 2023―Apr―12 Undiagnosed pulmonary TB and COVID in adults dying at home in a high TB burden setting, before and during pandemic COVID-19: an autopsy study Nadia Sabet, Tanvier Omar, Minja Milovanovic, Tebogo Magajane, Modiehi Mosala, Tumelo Moloantoa, et al. (+8)
226 [GO] 2023―Apr―11 COVID-19: Shehecheyanu Luis Ostrosky-Zeichner
227 [GO] 2023―Apr―10 Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial Angela R Branche, Nadine G Rouphael, Cecilia Losada, Lindsey R Baden, Evan J Anderson, Anne F Luetkemeyer, et al. (+30)
228 [GO] 2023―Mar―31 Evaluation of acebilustat, a selective inhibitor of leukotriene B4 biosynthesis, for treatment of outpatients with mild-moderate COVID-19 disease: A randomized, double-blind, placebo- controlled Phase 2 trial Joseph E Levitt, Haley Hedlin, Sophie Duong, Di Lu, Justin Lee, Bryan Bunning, et al. (+14)
229 [GO] 2023―Mar―31 COVID-19 Vaccination is Associated with Reduced Outpatient Antibiotic Prescribing In Older Adults with Confirmed SARS-CoV-2: A Population Wide Cohort Study Derek R MacFadden, Colleen Maxwell, Dawn Bowdish, Susan Bronskill, James Brooks, Kevin Brown, et al. (+16)
230 [GO] 2023―Mar―31 Your Outpatient has Coronavirus Disease 2019: What Are the Treatment Options in the Current Severe Acute Respiratory Syndrome Coronavirus 2 Variant Climate? William A Werbel, Ethel D Weld, Sonali D Advani, Payal K Patel, Maria E Sundaram, Varun K Phadke
231 [GO] 2023―Mar―29 Triple combination therapy with two antivirals and monoclonal antibodies for persistent or relapsed SARS-CoV-2 infection in immunocompromised patients Malgorzata Mikulska, Chiara Sepulcri, Chiara Dentone, Federica Magne, Elisa Balletto, Federico Baldi, et al. (+14)
232 [GO] 2023―Mar―29 COVID-19 convalescent plasma utilization in the United States: data from the National Inpatient Sample Evan M Bloch, Ruchika Goel, Xianming Zhu, Eshan U Patel, Shmuel Shoham, David J Sullivan, et al. (+3)
233 [GO] 2023―Mar―22 Isolation and quarantine for COVID-19 in the United States, 2020-2022 John E Oeltmann, Divya Vohra, Holly H Matulewicz, Nickolas DeLuca, Jonathan P Smith, Chandra Couzens, et al. (+12)
234 [GO] 2023―Mar―21 Complexity Interactions Between Nirmatrelvir/Ritonavir and Voriconazole in Patients With Coronavirus Disease 2019 Peile Wang, Han Xing, Xiaojian Zhang, Jing Yang
235 [GO] 2023―Mar―21 Infectious Complications of Lung Transplant for Coronavirus Disease 2019-Associated Lung Injury: A Single-Center Case-Control Cohort Study Rebecca Osborn, Maha Alamri, Rade Tomic, Michael G Ison
236 [GO] 2023―Mar―16 Appropriate outcome settings for the effectiveness of oral zinc treatment for Coronavirus Disease-2019 Nobuaki Mori, Jun Hirai, Nobuhiro Asai, Hiroshige Mikamo
237 [GO] 2023―Mar―15 Correction to: Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada
238 [GO] 2023―Mar―14 Opioid injection-associated bacterial infections in England, 2002-2021: a time series analysis of seasonal variation and the impact of COVID-19 Dan Lewer, Thomas D Brothers, Sara Croxford, Monica Desai, Eva Emanuel, Magdalena Harris, Vivian D Hope
239 [GO] 2023―Mar―11 Post-acute Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection by Viral Variant and Vaccination Status: A Multicenter Cross-sectional Study Christian R Kahlert, Carol Strahm, Sabine Güsewell, Alexia Cusini, Angela Brucher, Stephan Goppel, et al. (+45)
240 [GO] 2023―Mar―02 Correction to: Effectiveness of Paxlovid in Reducing Severe Coronavirus Disease 2019 and Mortality in High-Risk Patients
241 [GO] 2023―Mar―02 Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout Alexandra N Lea, Wendy A Leyden, Oleg Sofrygin, Ben J Marafino, Jacek Skarbinski, Sonia Napravnik, et al. (+16)
242 [GO] 2023―Mar―02 Question of Whether Tenofovir Disoproxil Fumarate/Emtricitabine Provides Protection Against Clinical Severity of Coronavirus Disease 2019 Julia del Amo
243 [GO] 2023―Mar―01 Correction to: Effectiveness of Messenger RNA-based Vaccines During the Emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant
244 [GO] 2023―Feb―21 The COVID-19 Rebound Study: A Prospective Cohort Study to Evaluate Viral and Symptom Rebound Differences in Participants Treated with Nirmatrelvir Plus Ritonavir Versus Untreated Controls Jay A Pandit, Jennifer M Radin, Danielle Chiang, Emily G Spencer, Jeff B Pawelek, Mira Diwan, et al. (+2)
245 [GO] 2023―Feb―21 Coronavirus Disease 2019 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-Analysis of Individual Participant Data From 5 Randomized Trials Adam C Levine, Yuriko Fukuta, Moises A Huaman, Jiangda Ou, Barry R Meisenberg, Bela Patel, et al. (+20)
246 [GO] 2023―Feb―21 Coronavirus Disease 2019 Convalescent Plasma Reaches the Slope of Enlightenment in the Gartner Hype Cycle Shmuel Shoham
247 [GO] 2023―Feb―17 Effect of Covid-19 lockdowns on identification of advanced HIV disease in outpatient clinics in Uganda Elizabeth Nalintya, Preethiya Sekar, Paul Kavuma, Joanita Kigozi, Martin Ssuna, Paul Kirumira, et al. (+9)
248 [GO] 2023―Feb―17 Longitudinal whole-genome sequence characterization of a persistent SARS-CoV-2 Omicron BA.5 infection in an immunocompromised patient successfully treated with sotrovimab 1000 mg. Francisco Tejerina, Rosalía Palomino, Pilar Catalan, Amadeo Sanz, Mercedes Marin, Felipe Lopez-Andujar, et al. (+8)
249 [GO] 2023―Feb―14 Successful combination treatment for persistent SARS-CoV-2 infection Ola Blennow, Jan Vesterbacka, Tuullikki Tovatt, Piotr Nowak
250 [GO] 2023―Feb―14 Zinc and Coronavirus Disease 2019 Harri Hemilä, Elizabeth Chalker
251 [GO] 2023―Feb―12 Infection-Induced Immunity Is Associated With Protection Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Decreased Infectivity Aaron M Frutos, Guillermina Kuan, Roger Lopez, Sergio Ojeda, Abigail Shotwell, Nery Sanchez, et al. (+6)
252 [GO] 2023―Feb―10 COVID-19 and Airborne Transmission: Science Rejected, Lives Lost. Can Society Do Better? Lidia Morawska, William Bahnfleth, Philomena M Bluyssen, Atze Boerstra, Giorgio Buonanno, Stephanie J Dancer, et al. (+27)
253 [GO] 2023―Feb―10 It Is Time to Determine Tocilizumab's Place in Coronavirus Disease 2019 (COVID-19)
254 [GO] 2023―Feb―09 One-year Outcomes of Lung Transplantation for COVID-19 Associated End Stage Lung Disease in the United States Kenji Okumura, Soma Jyothula, Thomas Kaleekal, Abhay Dhand
255 [GO] 2023―Feb―08 Relative effectiveness of COVID-19 vaccination and booster dose combinations among 18.9 million vaccinated adults during the early SARS-CoV-2 Omicron period - United States, January 1, 2022-March 31, 2022 Lyudmyla Kompaniyets, Ryan E Wiegand, Adewole C Oyalowo, Lara Bull-Otterson, Heartley Egwuogu, Trevor Thompson, et al. (+11)
256 [GO] 2023―Feb―08 Correction to: Coronavirus Disease 2019 [COVID-19] Breakthrough Infection and Post-Vaccination Neutralizing Antibodies Among Healthcare Workers in a Referral Hospital in Tokyo: A Case-Control Matching Study
257 [GO] 2023―Feb―06 Guidance on the use of convalescent plasma to treat immunocompromised patients with COVID-19 Evan M Bloch, Daniele Focosi, Shmuel Shoham, Jonathon Senefeld, Aaron A R Tobian, Lindsey R Baden, et al. (+16)
258 [GO] 2023―Feb―03 Correction to: Twice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial
259 [GO] 2023―Feb―02 Return to travel in the COVID-19 pandemic recovery period and implications for imported malaria: Reinforcing prevention, early diagnosis, and appropriate treatment of malaria Jonathan S Schultz, Kimberly E Mace, Kathrine R Tan
260 [GO] 2023―Jan―31 Research on the Development of Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern in People With Advanced Human Immunodeficiency Virus Disease Should Highlight Structural Conditions and Avoid Harmful Stereotypes Stephen Molldrem
261 [GO] 2023―Jan―31 Coronavirus Disease 2019 Pandemic-Associated Declines and Subsequent Increases in Hepatitis C Virus Treatment Prescriptions in Los Angeles County Cassidy Hernandez-Tamayo, Dima M Qato, Mirna Ponce Jewell, Prabhu Gounder, Jeffrey D Klausner
262 [GO] 2023―Jan―27 The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Antigen Testing Mary K Hayden, Kimberly E Hanson, Janet A Englund, Francesca Lee, Mark J Lee, Mark Loeb, et al. (+13)
263 [GO] 2023―Jan―27 Severe Fatigue and Persistent Symptoms at Three Months Following SARS-CoV-2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study Michael Gottlieb, Ralph Wang, Huihui Yu, Erica S Spatz, Juan Carlos Montoy, Robert Rodriguez, et al. (+103)
264 [GO] 2023―Jan―18 Correction to: Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Q, Canada
265 [GO] 2023―Jan―11 Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort Cecilia Bonazzetti, Beatrice Tazza, Dino Gibertoni, Zeno Pasquini, Natascia Caroccia, Francesca Fanì, et al. (+52)
266 [GO] 2023―Jan―08 Correction to: Longitudinal Immune Response to 3 Doses of Messenger RNA Vaccine Against Coronavirus Disease (COVID-19) in Pediatric Patients Receiving Chemotherapy for Cancer
267 [GO] 2023―Jan―08 Relationships between social vulnerability and COVID-19 vaccination coverage and vaccine effectiveness Alexandra F Dalton, Zachary A Weber, Katie S Allen, Edward Stenehjem, Stephanie A Irving, Talia L Spark, et al. (+36)
268 [GO] 2023―Jan―08 The Last Mile Problem - COVID-19 Vaccine Coverage Among the Most Socially Vulnerable Boghuma K Titanji
269 [GO] 2023―Jan―03 Three-day icatibant on top of standard care in patients with COVID-19 pneumonia (ICAT·COVID): a randomized, open-label, phase 2, proof-of-concept trial Pierre Malchair, Jordi Giol, Vanesa García, Orlando Rodríguez, José Carlos Ruibal, Alvaro Zarauza, et al. (+48)
270 [GO] 2022―Dec―31 Correction to: Potential Influence of Menstrual Status and Sex Hormones on Female Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Cross-sectional Multicenter Study in Wuhan, China
271 [GO] 2022―Dec―28 SARS-CoV-2 infection history and antibody response to three COVID-19 mRNA vaccine doses Meghan K Herring, James K Romine, Meredith G Wesley, Katherine D Ellingson, Sarang K Yoon, Alberto J Caban-Martinez, et al. (+29)
272 [GO] 2022―Dec―27 Three-month symptom profiles among symptomatic adults with positive and negative SARS-CoV-2 tests: a prospective cohort study from the INSPIRE group Erica S Spatz, Michael Gottlieb, Lauren E Wisk, Jill Anderson, Anna Marie Chang, Nicole L Gentile, et al. (+19)
273 [GO] 2022―Dec―20 The epidemiology of long COVID in US adults McKaylee M Robertson, Saba A Qasmieh, Sarah G Kulkarni, Chloe A Teasdale, Heidi Jones, Margaret McNairy, et al. (+2)
274 [GO] 2022―Dec―16 Impact of SARS-CoV-2 variants on inpatient clinical outcome Matthew L Robinson, C Paul Morris, Joshua F Betz, Yifan Zhang, Robert Bollinger, Natalie Wang, et al. (+11)
275 [GO] 2022―Dec―12 Epidemiology of human parainfluenza virus type 3 (HPIV-3) and respiratory syncytial virus (RSV) infections in the time of COVID-19: findings from a household cohort in Maryland Marissa K Hetrich, Jennifer Oliva, Kimberli Wanionek, Maria Deloria Knoll, Matthew Lamore, Ignacio Esteban, et al. (+3)
276 [GO] 2022―Dec―09 Comparison of levels of nasal, salivary, and plasma antibody to SARS-CoV-2 during natural infection and after vaccination Jeffrey I Cohen, Lesia Dropulic, Kening Wang, Krista Gangler, Kayla Morgan, Kelly Liepshutz, et al. (+10)
277 [GO] 2022―Dec―09 Developing mucosal vaccines for SARS-CoV-2: What will it take? Kathryn M Edwards, Kathleen M Neuzil
278 [GO] 2022―Dec―07 Efficacy and safety of ensitrelvir in patients with mild-to-moderate COVID-19: the phase 2b part of a randomized, placebo-controlled, phase 2/3 study Hiroshi Mukae, Hiroshi Yotsuyanagi, Norio Ohmagari, Yohei Doi, Hiroki Sakaguchi, Takuhiro Sonoyama, et al. (+5)
279 [GO] 2022―Dec―01 Correction to: Leveraging Serosurveillance and Postmortem Surveillance to Quantify the Impact of Coronavirus Disease 2019 in Africa
280 [GO] 2022―Nov―25 Evaluation of the United States definitions for COVID-19 community risk levels Sina Mokhtar, Alyssa S Parpia, Nathan C Lo, Martial L Ndeffo-Mbah
281 [GO] 2022―Nov―25 Impact of vaccination with SCB-2019 COVID-19 vaccine on transmission of SARS-CoV-2 infection: a household contact study in the Philippines Birkneh Tilahun Tadesse, Lulu Bravo, Florian Marks, Asma Binte Aziz, Young Ae You, Jonathan Sugimoto, et al. (+14)
282 [GO] 2022―Nov―25 Predictors of COVID-19 hospitalization after sotrovimab in hematologic malignancy patients during the BA.1 Omicron surge Judy Yan, Samantha N Steiger, Rich Kodama, Jerome Fender, Carrie Tan, Justin Laracy, et al. (+7)
283 [GO] 2022―Nov―22 AZD7442 (Tixagevimab/Cilgavimab) for Post-exposure Prophylaxis of Symptomatic COVID-19 Myron J Levin, Andrew Ustianowski, Steven Thomas, Alison Templeton, Yuan Yuan, Seth Seegobin, et al. (+15)
284 [GO] 2022―Nov―21 Monoclonal Antibodies as Long-Acting Products: What Are We Learning From Human Immunodeficiency Virus (HIV) and Coronavirus Disease 2019 (COVID-19)? Marina Caskey, Daniel R Kuritzkes
285 [GO] 2022―Nov―17 Persistence of SARS-CoV-2 to Explain Long COVID Is Not Consistent with the Available Data Armin Alaedini, Gary P Wormser
286 [GO] 2022―Nov―17 Association of upper respiratory Streptococcus pneumoniae colonization with SARS-CoV-2 infection among adults Anna M Parker, Nicole Jackson, Shevya Awasthi, Hanna Kim, Tess Alwan, Anne L Wyllie, et al. (+10)
287 [GO] 2022―Nov―16 Cardiovascular outcomes after tixagevimab and cilgavimab use for pre-exposure prophylaxis against COVID-19: a population-based propensity-matched cohort study Morgan Birabaharan, Eddie Hill, Maedha Begur, David C Kaelber, Thomas CS Martin, Sanjay R Mehta
288 [GO] 2022―Nov―14 Occupations Associated with SARS-CoV-2 Infection and Vaccination, U.S. Blood Donors, July 2021-December 2021 Melisa M Shah, Bryan R Spencer, Leora R Feldstein, James M Haynes, Tina J Benoit, Sharon H Saydah, et al. (+3)
289 [GO] 2022―Nov―11 VPM1002 as Prophylaxis Against Severe Respiratory Tract Infections Including COVID-19 in the Elderly: a phase III randomised, double-blind, placebo-controlled, multicenter clinical study Alexandra M Blossey, Sina Brückner, Marcus May, Gerald P Parzmair, Hitt Sharma, Umesh Shaligram, et al. (+4)
290 [GO] 2022―Nov―09 The Association Between Pre-Booster Vaccination Antibody Levels and the Risk of SARS-CoV-2 Infection Noam Barda, Michal Canetti, Mayan Gilboa, Keren Asraf, Victoria Indenboim, Yael Weiss-Ottolenghi, et al. (+8)
291 [GO] 2022―Nov―09 Maternal Antibody Response and Transplacental Transfer Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection or Vaccination in Pregnancy Sebastian Otero, Emily S Miller, Ashwin Sunderraj, Elisheva D Shanes, Allie Sakowicz, Jeffery A Goldstein, Leena B Mithal
292 [GO] 2022―Nov―03 Successful treatment of prolonged, severe COVID-19 lower respiratory tract disease in a B-cell ALL patient with an extended course of remdesivir and nirmatrelvir/ritonavir Emily S Ford, William Simmons, Ellora N Karmarkar, Leah H Yoke, Ayodale B Braimah, Johnnie J Orozco, et al. (+14)
293 [GO] 2022―Nov―03 MULTI-PARAMETRIC PREDICTION MODELS FOR COVID-19 VACCINE SELECTION: RESULTS OF A COMPARATIVE POPULATION-BASED COHORT STUDY Daniela Sieghart, Claudia A Hana, Helmuth Haslacher, Thomas Perkmann, Leonhard X Heinz, Clemens Fedrizzi, et al. (+22)
294 [GO] 2022―Nov―03 Real-time whole genome sequencing to guide patient-tailored therapy of SARS-CoV-2 infection Luke B Snell, Adela Medina-Alcolea, Themoula Charalampous, Christopher Alder, Tom G S Williams, Flavia Flaviani, et al. (+10)
295 [GO] 2022―Nov―03 Test 5- versus 10-day remdesivir treatment in immunocompromised patients with COVID-19 Victoria C Yan
296 [GO] 2022―Nov―03 Twice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial Saoussen Ben Abdallah, Yosra Mhalla, Imen Trabelsi, Adel Sekma, Rim Youssef, Khaoula Bel Haj Ali, et al. (+18)
297 [GO] 2022―Oct―31 Adverse Events Following Immunization with mRNA and Viral Vector Vaccines in Individuals with Previous SARS-CoV-2 Infection from the Canadian National Vaccine Safety Network Julie A Bettinger, Michael A Irvine, Hennady P Shulha, Louis Valiquette, Matthew P Muller, Otto G Vanderkooi, et al. (+8)
298 [GO] 2022―Oct―26 Differential patterns by area-level social determinants of health in COVID-19 related mortality and non-COVID-19 mortality: a population-based study of 11.8 million people in Ontario, Canada Linwei Wang, Andrew Calzavara, Stefan Baral, Janet Smylie, Adrienne K Chan, Beate Sander, et al. (+3)
299 [GO] 2022―Oct―25 Dual antiviral therapy for persistent COVID-19 and associated organizing pneumonia in an immunocompromised host Caitlin A Trottier, Beverly Wong, Rakhi Kohli, Cassidy Boomsma, Francis Magro, Sucharita Kher, et al. (+2)
300 [GO] 2022―Oct―25 A potential role for zinc to enhance treatment for COVID-19? Marco Vinceti, Tommaso Filippini, Susan Fairweather-Tait
301 [GO] 2022―Oct―25 Exhaled Breath Aerosol Shedding by Highly Transmissible Versus Prior SARS-CoV-2 Variants Jianyu Lai, Kristen K Coleman, S -H Sheldon Tai, Jennifer German, Filbert Hong, Barbara Albert, et al. (+12)
302 [GO] 2022―Oct―19 Distinguishing SARS-CoV-2 persistence and reinfection: A retrospective cohort study Sarah E Turbett, Christopher H Tomkins-Tinch, Melis N Anahtar, Caitlin M Dugdale, Emily P Hyle, Erica S Shenoy, et al. (+17)
303 [GO] 2022―Oct―17 Severity of COVID-19 Hospitalization Outcomes and Patient Disposition Differ by Disability Status and Disability Type Kristie E N Clarke, Kai Hong, Megan Schoonveld, Arlene I Greenspan, Martha Montgomery, JoAnn M Thierry
304 [GO] 2022―Oct―10 Nasal and Plasma SARS-CoV-2 RNA Levels are Associated with Timing of Symptom Resolution in the ACTIV-2 Trial of Non-hospitalized Adults with COVID-19 Yijia Li, Linda J Harrison, Kara W Chew, Judy S Currier, David A Wohl, Eric S Daar, et al. (+11)
305 [GO] 2022―Oct―10 Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial Paul T Heath, Eva P Galiza, David Neil Baxter, Marta Boffito, Duncan Browne, Fiona Burns, et al. (+39)
306 [GO] 2022―Oct―06 Strategies for using antigen rapid diagnostic tests to reduce transmission of SARS-CoV-2 in low- and middle-income countries: a mathematical modelling study applied to Zambia Alvin X Han, Sarah Girdwood, Shaukat Khan, Jilian A Sacks, Amy Toporowski, Naushin Huq, et al. (+3)
307 [GO] 2022―Oct―06 Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir Treatment Brian P Epling, Joseph M Rocco, Kristin L Boswell, Elizabeth Laidlaw, Frances Galindo, Anela Kellogg, et al. (+16)
308 [GO] 2022―Oct―03 Booster vaccination against SARS-CoV-2 induces potent immune responses in people with HIV Sarah Fidler, Julie Fox, Timothy Tipoe, Stephanie Longet, Tom Tipton, Movin Abeywickrema, et al. (+45)
309 [GO] 2022―Sep―30 Rapid selection of sotrovimab escape variants in SARS-CoV-2 Omicron infected immunocompromised patients Smaranda Gliga, Nadine Luebke, Alexander Killer, Henning Gruell, Andreas Walker, Alexander T Dilthey, et al. (+9)
310 [GO] 2022―Sep―29 Leveraging Serosurveillance and Postmortem Surveillance to Quantify the Impact of COVID-19 in Africa Nicole E Kogan, Shae Gantt, David Swerdlow, Cécile Viboud, Muhammed Semakula, Marc Lipsitch, Mauricio Santillana
311 [GO] 2022―Sep―21 The COVID-19 Pandemic Unmasked the Challenges Faced by Early-Stage Faculty in Infectious Diseases: A Call to Action Erin M Scherer, Martin Backer, Karen Carvajal, Lara Danziger-Isakov, Sharon Frey, Leigh M Howard, et al. (+11)
312 [GO] 2022―Sep―20 Effectiveness of mRNA-1273 vaccine booster against COVID-19 in immunocompetent adults Ana Florea, Lina S Sy, Lei Qian, Bradley K Ackerson, Yi Luo, Julia E Tubert, et al. (+7)
313 [GO] 2022―Sep―20 Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination and Booster on Coronavirus Disease 2019 (COVID-19) Symptom Severity Over Time in the COVID-OUT Trial David R Boulware, Thomas A Murray, Jennifer L Proper, Christopher J Tignanelli, John B Buse, David M Liebovitz, et al. (+27)
314 [GO] 2022―Sep―19 Associations of Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA-1273 Vaccine in COVE and TeenCOVE Trials Uma Siangphoe, Lindsey R Baden, Hana M El Sahly, Brandon Essink, Kashif Ali, Gary Berman, et al. (+8)
315 [GO] 2022―Sep―15 Dupilumab use is associated with protection from COVID-19 mortality: A retrospective analysis Alexandra N Donlan, Indika Mallawaarachi, Jennifer M Sasson, Robert Preissner, Johanna J Loomba, William A Petri
316 [GO] 2022―Sep―13 Remdesivir resistance in transplant recipients with persistent COVID-19 John I Hogan, Ralf Duerr, Dacia Dimartino, Christian Marier, Sarah E Hochman, Sapna Mehta, et al. (+2)
317 [GO] 2022―Sep―09 Qualitative Subgenomic RNA to Monitor the Response to Remdesivir in Hospitalized Patients with COVID-19: impact on the length of hospital stay and mortality Rodrigo ALONSO-NAVARRO, Genoveva CUESTA, Marta SANTOS, Celia CARDOZO, Verónica RICO, Nicole GARCIA-POUTON, et al. (+15)
318 [GO] 2022―Sep―08 Predictors of Time to COVID-19 Infection in the National Basketball Association: A Retrospective Case-Control Study Raphael E Cuomo, Zhuoran Li, Vidya Purushothaman, Chenna Basavapatna-Shankar, Matthew Nali, Tim K Mackey
319 [GO] 2022―Sep―07 Usage and awareness of antiviral medications for COVID-19 among individuals at risk for severe COVID-19, March 2021 to 1 August 2022 N Kojima, JD Klausner
320 [GO] 2022―Sep―06 Pregnancy status at the time of COVID-19 vaccination and incidence of SARS-CoV-2 infection Maria C Magnus, Siri E Håberg, Ellen Ø Carlsen, Jeffrey C Kwong, Sarah A Buchan, Deshayne B Fell
321 [GO] 2022―Sep―05 Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 Adarsh Bhimraj, Rebecca L Morgan, Amy Hirsch Shumaker, Lindsey Baden, Vincent Chi Chung Cheng, Kathryn M Edwards, et al. (+11)
322 [GO] 2022―Sep―02 Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae Zoe Swank, Yasmeen Senussi, Zachary Manickas-Hill, Xu G Yu, Jonathan Z Li, Galit Alter, David R Walt
323 [GO] 2022―Aug―31 Favipiravir in patients with early mild-to-moderate COVID-19: a randomized controlled trial Yoav Golan, Jesus Abraham Simon Campos, Rob Woolson, Donald Cilla, Rodolfo Hanabergh, Yaneicy Gonzales-Rojas, et al. (+3)
324 [GO] 2022―Aug―30 Clinical severity of Omicron SARS-CoV-2 variant relative to Delta in British Columbia, Canada: A retrospective analysis of whole genome sequenced cases Sean P Harrigan, James Wilton, Mei Chong, Younathan Abdia, Hector Velasquez Garcia, Caren Rose, et al. (+9)
325 [GO] 2022―Aug―29 Impact of the use of oral antiviral agents on the risk of hospitalization in community COVID-19 patients Terry Cheuk Fung Yip, Grace Chung Yan Lui, Mandy Sze Man Lai, Vincent Wai Sun Wong, Yee Kit Tse, Bosco Hon Ming Ma, et al. (+5)
326 [GO] 2022―Aug―29 When emulating a trial, do as the trialists do: Missteps in estimating relative effectiveness of a SARS-CoV-2 vaccine booster dose Kathleen E Wirth, Jessie K Edwards, Lydia Feinstein, Alexander Breskin
327 [GO] 2022―Aug―27 Persistence of SARS-CoV-2 omicron variant in children and utility of rapid antigen testing as an indicator of culturable virus Zoe M Lohse, Jerne J Shapiro, John A Lednicky, Melanie N Cash, Inyoung Jun, Carla N Mavian, et al. (+7)
328 [GO] 2022―Aug―23 The Disproportionate Impact of COVID-19 Pandemic on Healthcare-Associated Infections in Community Hospitals: Need for Expanding the Infectious Disease Workforce Sonali D Advani, Emily Sickbert-Bennett, Rebekah Moehring, Andrea Cromer, Yuliya Lokhnygina, Elizabeth Dodds-Ashley, et al. (+4)
329 [GO] 2022―Aug―20 Oral Nirmatrelvir and Ritonavir in Non-hospitalized Vaccinated Patients with Covid-19 Sarju Ganatra, Sourbha S Dani, Javaria Ahmad, Ashish Kumar, Jui Shah, George M Abraham, et al. (+3)
330 [GO] 2022―Aug―19 COVID-19 severity and risk of subsequent cardiovascular events Timothy L Wiemken, Leah J McGrath, Kathleen M Andersen, Farid Khan, Deepa Malhotra, Tamuno Alfred, et al. (+5)
331 [GO] 2022―Aug―17 Effectiveness of COVID-19 vaccines against hospitalization and death in Canada: A multiprovincial test-negative design study Sharifa Nasreen, Yossi Febriani, Héctor Alexander Velásquez García, Geng Zhang, Mina Tadrous, Sarah A Buchan, et al. (+6)
332 [GO] 2022―Aug―12 Impact of Seasonal Coronavirus Antibodies on SARS-CoV-2 Vaccine Responses in Solid Organ Transplant Recipients Andrew H Karaba, Weiqiang Zhou, Shuai Li, Tihitina Y Aytenfisu, Trevor S Johnston, Olivia Akinde, et al. (+14)
333 [GO] 2022―Aug―12 Symptom burden and immune dynamics 6 to 18 months following mild SARS-CoV-2 infection -a case-control study Elisabeth B Fjelltveit, Bjørn Blomberg, Kanika Kuwelker, Fan Zhou, Therese B Onyango, Karl A Brokstad, et al. (+7)
334 [GO] 2022―Aug―12 Estimating the period prevalence of SARS-CoV-2 infection during the Omicron (BA.1) surge in New York City (NYC), January 1-March 16, 2022 Saba A Qasmieh, McKaylee M Robertson, Chloe A Teasdale, Sarah G Kulkarni, Denis Nash
335 [GO] 2022―Aug―12 SARS-CoV-2 testing and detection during peripartum hospitalizations among a multi-center cohort of pregnant persons, March 2020-February 2021 Miranda J Delahoy, Flor Munoz, De Kun Li, Carmen Sofia Arriola, Nanette Lee Bond, Michael Daugherty, et al. (+16)
336 [GO] 2022―Aug―08 Readmissions, post-discharge mortality and sustained recovery among patients admitted to hospital with COVID-19 Kasper S Moestrup, Joanne Reekie, Adrian G Zucco, Tomas Ø Jensen, Jens Ulrik S Jensen, Lothar Wiese, et al. (+5)
337 [GO] 2022―Aug―05 COVID-19 burden among unaccompanied minors in United States custody Carlo Foppiano Palacios, Elizabeth W Tucker, Mark A Travassos
338 [GO] 2022―Aug―04 SARS-CoV-2 hyperimmune intravenous human immunoglobulins neutralizes Omicron subvariants BA.1, BA.2, BA.2.12.1, BA.3 and BA.4/BA.5 for treatment of COVID-19 Mayanka Awasthi, Hana Golding, Surender Khurana
339 [GO] 2022―Aug―04 Measuring work-related risk of COVID-19: comparison of COVID-19 incidence by occupation and industry - Wisconsin, September 2020-May 2021 Ian W Pray, Barbara Grajewski, Collin Morris, Komi Modji, Peter DeJonge, Katherine McCoy, et al. (+4)
340 [GO] 2022―Aug―04 BNT162b2 mRNA Vaccination Against COVID-19 is Associated with Decreased Likelihood of Multisystem Inflammatory Syndrome in U.S. Children Ages 5-18 Years Laura D Zambrano, Margaret M Newhams, Samantha M Olson, Natasha B Halasa, Ashley M Price, Amber O Orzel, et al. (+36)
341 [GO] 2022―Aug―04 Household transmission of SARS-CoV-2 from adult index cases living with and without HIV in South Africa, 2020-2021: a case-ascertained, prospective observational household transmission study Jackie Kleynhans, Sibongile Walaza, Neil A Martinson, Mzimasi Neti, Anne von Gottberg, Jinal N Bhiman, et al. (+13)
342 [GO] 2022―Aug―03 COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection during Delta-dominant and Omicron-dominant periods in Japan: a multi-center prospective case-control study (FASCINATE study) Takeshi Arashiro, Yuzo Arima, Hirokazu Muraoka, Akihiro Sato, Kunihiro Oba, Yuki Uehara, et al. (+20)
343 [GO] 2022―Aug―02 Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom Karina Doris Vihta1, Koen B Pouwels, Tim EA Peto1, Emma Pritchard, Thomas House, Ruth Studley, et al. (+9)
344 [GO] 2022―Aug―01 Validity of self-testing at home with rapid SARS-CoV-2 antibody detection by lateral flow immunoassay Christina J Atchison, Maya Moshe, Jonathan C Brown, Matthew Whitaker, Nathan C K Wong, Anil A Bharath, et al. (+9)
345 [GO] 2022―Aug―01 Reduced incidence of Long COVID referrals to the Cambridge University Teaching Hospital Long COVID clinic Benjamin A Krishna, Marina Metaxaki, Mark R Wills, Nyaradzai Sithole
346 [GO] 2022―Jul―30 Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe COVID-19: The PANCOVID Randomized Clinical Trial Rocío Montejano, Fernando de la Calle-Prieto, María Velasco, Carlos Guijarro, Javier Queiruga-Parada, María Jiménez-González, et al. (+25)
347 [GO] 2022―Jul―29 Association between AZD7442 (tixagevimab-cilgavimab) administration and SARS-CoV-2 infection, hospitalization and mortality Jennifer Kertes, Shirley Shapiro Ben David, Noya Engel-Zohar, Keren Rosen, Beatriz Hemo, Avner Kantor, et al. (+4)
348 [GO] 2022―Jul―28 Longitudinal Immune Response to 3 Doses of Messenger RNA Vaccine Against Coronavirus Disease (COVID-19) in Pediatric Patients Receiving Chemotherapy for Cancer Thomas Lehrnbecher, Ulrich Sack, Carsten Speckmann, Andreas H Groll, Andreas Boldt, Benjamin Siebald, et al. (+7)
349 [GO] 2022―Jul―23 Association of nirmatrelvir/ritonavir treatment on upper respiratory SARS-CoV-2 RT-PCR negative conversion rates among high-risk patients with COVID-19 Hongyan Li, Menghan Gao, Hailong You, Peng Zhang, Yuchen Pan, Nan Li, et al. (+14)
350 [GO] 2022―Jul―23 Clinical characteristics and outcome of immunocompromised patients with COVID-19 caused by the Omicron variant: a prospective observational study S Reshwan K Malahe, Rogier A S Hoek, Virgil A S H Dalm, Annoek E C Broers, Caroline M den Hoed, Olivier C Manintveld, et al. (+11)
351 [GO] 2022―Jul―23 Development of an effective immune response in adults with Down Syndrome after SARS-CoV-2 vaccination Laura Esparcia-Pinedo, Ayla Yarci-Carrión, Gloria Mateo-Jiménez, Noelia Ropero, Laura Gómez-Cabañas, Ángel Lancho-Sánchez, et al. (+8)
352 [GO] 2022―Jul―22 Protection Against the Omicron Variant Offered by Previous SARS-CoV-2 Infection: A Retrospective Cohort Study Michael B Rothberg, Priscilla Kim, Nabin K Shrestha, Lisa Kojima, Larisa G Tereshchenko
353 [GO] 2022―Jul―22 Sotrovimab resistance and viral persistence after treatment of immunocompromised patients infected with the SARS-CoV-2 Omicron variant Sammy Huygens, Bas Oude Munnink, Arvind Gharbharan, Marion Koopmans, Bart Rijnders
354 [GO] 2022―Jul―20 Effectiveness of COVID-19 vaccination against SARS-CoV-2 Infection among Residents of US Nursing Homes, Before and During the Delta variant Predominance, December 2020 - November 2021 Kelly M Hatfield, James Baggs, Hannah Wolford, Michael Fang, Ammarah A Sattar, Kelsey S Montgomery, et al. (+3)
355 [GO] 2022―Jul―12 Response to ‘Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome’ Kevin R Viel
356 [GO] 2022―Jul―09 Secondary sclerosing cholangitis following COVID-19 disease: a multicenter retrospective study Peter Hunyady, Lea Streller, Darius F Rüther, Sara Reinartz Groba, Dominik Bettinger, Daniel Fitting, et al. (+17)
357 [GO] 2022―Jul―07 Antibody and T-cell responses 6 months after COVID-19 mRNA-1273 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplant Jan Stephan F Sanders, A Lianne Messchendorp, Rory D de Vries, Carla C Baan, Debbie van Baarle, Rob van Binnendijk, et al. (+14)
358 [GO] 2022―Jul―06 Severity of SARS-CoV-2 Infection in Pregnancy in Ontario: A Matched Cohort Analysis Kiera R Murison, Alicia A Grima, Alison E Simmons, Ashleigh R Tuite, David N Fisman
359 [GO] 2022―Jul―06 Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection With accumulation of mutations in a patient with poorly controlled Human Immunodeficiency Virus infection Tongai G Maponga, Montenique Jeffries, Houriiyah Tegally, Andrew Sutherland, Eduan Wilkinson, Richard J Lessells, et al. (+4)
360 [GO] 2022―Jul―05 Lower Risk of Multisystem Inflammatory Syndrome in Children (MIS-C) with the Delta and Omicron variants of SARS-CoV-2 Jonathan M Cohen, Michael J Carter, C Ronny Cheung, Shamez Ladhani
361 [GO] 2022―Jul―05 Magnitude and determinants of SARS-CoV-2 household transmission: a longitudinal cohort study J Daniel Kelly, Scott Lu, Khamal Anglin, Miguel Garcia-Knight, Jesus Pineda-Ramirez, Sarah A Goldberg, et al. (+24)
362 [GO] 2022―Jul―02 Antibiotic Resistant Infections among COVID-19 Inpatients in U.S. Hospitals James Baggs, Ashley N Rose, Natalie L McCarthy, Hannah Wolford, Arjun Srinivasan, John A Jernigan, Sujan C Reddy
363 [GO] 2022―Jul―01 Utility of a Test to Return Strategy to Identify Individuals with COVID-19 in the Pre-Kindergarten through Grade 12 School Setting - District of Columbia, January 2022 Marsha E Samson, William L Still, Miguella Mark-Carew, Daniel K Jarris, Areej Idris, André van Zyl, et al. (+6)
364 [GO] 2022―Jun―30 SARS-CoV-2 Infections and Reinfections among Fully Vaccinated and Unvaccinated University Athletes - 15 States, January - November 2021 Mary K Good, Michaila Czarnik, Kimberly G Harmon, Doug Aukerman, Catherine S O’Neal, Carly Day, et al. (+4)
365 [GO] 2022―Jun―29 Increased Mortality among Persons with Symptomatic COVID-19 During the Period of SARS-CoV-2 B.1.617.2 (Delta Variant) Predominance-Alaska, November 2020-October 2021 Eric Q Mooring, Katherine Newell, Louisa Castrodale, Megan Tompkins, Morgan Frank, Joseph McLaughlin
366 [GO] 2022―Jun―28 Early treatment of high-risk hospitalized COVID-19 patients with a combination of interferon beta-1b and remdesivir: a phase 2 open-label randomized controlled trial Anthony Raymond Tam, Ricky Ruiqi Zhang, Kwok Cheung Lung, Raymond Liu, Ka Yi Leung, Danlei Liu, et al. (+20)
367 [GO] 2022―Jun―28 Vaccine coverage associated with ending a SARS-CoV-2 wave: a retrospective longitudinal analysis. Aharona Glatman-Freedman, Sarah F Feldman, Yael Hershkovitz, Zalman Kaufman, Rita Dichtiar, Lital Keinan-Boker, Michal Bromberg
368 [GO] 2022―Jun―27 Effectiveness of COVID-19 mRNA vaccines against infection during an outbreak of SARS-CoV-2 Beta (B.1.351) variant in a skilled nursing facility - Virginia, March-April 2021 Heidi L Moline, Amelia Keaton, Whitney Rice, Jasmine Varghese, Li Deng, Ansley Waters, et al. (+9)
369 [GO] 2022―Jun―24 Vaccines, Variants, and Vigilance: Strengthening the COVID-19 Public Health Response through Partnerships and Collaborations Preeta K Kutty, Matthew J Stuckey, Emilia H Koumans
370 [GO] 2022―Jun―24 The US COVID-19 surveillance environment: An ecological analysis of the relationship of testing adequacy in the context of vaccination Daesung Choi, Jannie Nielsen, Lance A. Waller, Shivani A. Patel
371 [GO] 2022―Jun―24 Prevalence of SARS-CoV-2 antibodies in the Mozambican population: a cross-sectional Serologic study in three cities, July-August 2020 Paulo Arnaldo, Nédio Mabunda, Peter Wesley Young, Tiffany Tran, Nádia Sitoe, Imelda Chelene, et al. (+7)
372 [GO] 2022―Jun―24 High Community Transmission of SARS-CoV-2 Associated with Decreased Contact Tracing Effectiveness for Identifying Persons at Elevated Risk of Infection - Vermont Brian F Borah, Julia Pringle, Michael Flaherty, John E Oeltmann, Patrick K Moonan, Patsy Kelso
373 [GO] 2022―Jun―24 SARS-CoV-2 in Africa: current considerations and future projections Olubukola T Idoko, Effua Usuf, Uduak Okomo, Chizoba Wonodi, Kondwani Jambo, Beate Kampmann, et al. (+2)
374 [GO] 2022―Jun―24 Advancing Precision Vaccinology by Molecular and Genomic Surveillance of SARS-CoV-2 in Germany, 2021 Djin-Ye Oh, Martin Hölzer, Sofia Paraskevopoulou, Maria Trofimova, Felix Hartkopf, Matthias Budt, et al. (+25)
375 [GO] 2022―Jun―23 Characterization of virologic rebound following nirmatrelvir-ritonavir treatment for COVID-19 Julie Boucau, Rockib Uddin, Caitlin Marino, James Regan, James P Flynn, Manish C Choudhary, et al. (+15)
376 [GO] 2022―Jun―23 COVID-19 vaccination coverage, intentions, attitudes and barriers by race/ethnicity, language of interview, and nativity, National Immunization Survey Adult COVID Module, April 22, 2021-January 29, 2022 Elizabeth C Ohlsen, David Yankey, Clelia Pezzi, Jennifer L Kriss, Peng Jun Lu, Mei Chuan Hung, et al. (+10)
377 [GO] 2022―Jun―23 Perinatally HIV-infected adolescents and young adults demonstrate distinct BNT162b2 mRNA COVID-19 vaccine immunogenicity Elena Morrocchi, Chiara Pighi, Giuseppe Rubens Pascucci, Nicola Cotugno, Chiara Medri, Donato Amodio, et al. (+11)
378 [GO] 2022―Jun―23 SARS-CoV-2 co-detection with influenza A and other respiratory viruses among school-aged children and their household members- March 12, 2020, to February 22, 2022, Dane County, Wisconsin Jonathan L Temte, Shari Barlow, Emily Temte, Maureen Goss, Allen Bateman, Kelsey Florek, Amra Uzicanin
379 [GO] 2022―Jun―23 Viral dynamics of Omicron and Delta SARS-CoV-2 variants with implications for timing of release from isolation: a longitudinal cohort study Tara C Bouton, Joseph Atarere, Jacquelyn Turcinovic, Scott Seitz, Cole Sher-Jan, Madison Gilbert, et al. (+11)
380 [GO] 2022―Jun―20 Hospitalized patients with severe COVID-19 during the Omicron wave in Israel - benefits of a fourth vaccine dose Tal Brosh-Nissimov, Khetam Hussein, Yonit Wiener-Well, Efrat Orenbuch-Harroch, Meital Elbaz, Shelly Lipman-Arens, et al. (+8)
381 [GO] 2022―Jun―20 Delayed Recognition of COVID-19 in New York City: A descriptive analysis of COVID-19 illness prior to February 29, 2020 Page Keating, Jessica Sell, Judy Chen, Joel Ackelsberg, Winfred Wu, Benjamin Tsoi, Don Weiss
382 [GO] 2022―Jun―20 A Retrospective Database Analysis of Before and After Social Distancing in Relation to Pediatric Infection Rate and Healthcare Services Usage During the COVID-19 Pandemic Ran Levy, Regev Cohen, Liat Lev-Shalem, Arik Eisenkraft, Tehila Fisher Yosef
383 [GO] 2022―Jun―20 SARS-CoV-2 Transmission Associated with an Indoor Music Event That Required Proof of Full Vaccination Against COVID-19 Prior to Entry-Seattle, July 2021 Mellisa Roskosky, Gwen Moni, Vance Kawakami, Joanie Lambert, Claire Brostrom-Smith, Holly Whitney, et al. (+5)
384 [GO] 2022―Jun―20 Virologic and Immunologic Characterization of COVID-19 Recrudescence after Nirmatrelvir/Ritonavir Treatment Aaron F Carlin, Alex E Clark, Antoine Chaillon, Aaron F Garretson, William Bray, Magali Porrachia, et al. (+3)
385 [GO] 2022―Jun―20 Presence of SARS-CoV-2 Antibodies among Vietnamese Healthcare Workers by Dosing Interval for ChAdOx1 nCoV-19 Vaccine Dien M Vu, Diep T B Vu, Thuy T T Do, Allison E Olmsted, Bach H Dao, Truc T Thai, et al. (+6)
386 [GO] 2022―Jun―20 Modeling the effectiveness of healthcare personnel reactive testing and screening for the SARS-CoV-2 Omicron variant within nursing homes Casey M Zipfel, Prabasaj Paul, Camden D Gowler, Sujan C Reddy, Nimalie D Stone, Kara Jacobs Slifka, Rachel B Slayton
387 [GO] 2022―Jun―19 Life-Threatening Complications of Influenza versus COVID-19 in U.S. Children Natasha B Halasa, Andrew J Spieker, Cameron C Young, Samantha M Olson, Margaret M Newhams, Justin Z Amarin, et al. (+36)
388 [GO] 2022―Jun―19 Increased deaths from fungal infections during the COVID-19 pandemic-National Vital Statistics System, United States, January 2020-December 2021 Jeremy A W Gold, Farida B Ahmad, Jodi A Cisewski, Lauren M Rossen, Alejandro J Montero, Kaitlin Benedict, et al. (+2)
389 [GO] 2022―Jun―19 COVID-19 Severity among Women of Reproductive Age with Symptomatic Laboratory-Confirmed SARS-CoV-2 by Pregnancy Status - United States, Jan 1, 2020 - Dec 25, 2021 Penelope Strid, Lauren B Zapata, Van T Tong, Laura D Zambrano, Kate R Woodworth, Aspen P Riser, et al. (+3)
390 [GO] 2022―Jun―19 Vaccine effectiveness of CanSino (Adv5-nCoV) COVID-19 vaccine among childcare workers - Mexico, March-December 2021 Vesta L Richardson, Martín Alejandro Camacho Franco, Aurora Bautista Márquez, Libny Martínez Valdez, Luis Enrique Castro Ceronio, Vicente Cruz Cruz, et al. (+5)
391 [GO] 2022―Jun―19 Kinetics of maternally-derived anti- SARS-CoV-2 antibodies in infants in relation to the timing of antenatal vaccination Amihai Rottenstreich, Gila Zarbiv, Esther Oiknine-Djian, Olesya Vorontsov, Roy Zigron, Geffen Kleinstern, et al. (+2)
392 [GO] 2022―Jun―19 Reported exposures among in-person workers with SARS-CoV-2 infection in 6 states, September 2020-June 2021 Hannah Free, Sara E Luckhaupt, Rachael M Billock, Matthew R Groenewold, Sherry Burrer, Marie Haring Sweeney, et al. (+16)
393 [GO] 2022―Jun―19 Integration of sequencing and epidemiological data for surveillance of SARS-CoV-2 infections in a tertiary-care hospital Manja Czech-Sioli, Thomas Günther, Alexis Robitaille, Hannes Roggenkamp, Henning Büttner, Daniela Indenbirken, et al. (+6)
394 [GO] 2022―Jun―19 Population immunity to pre-Omicron and Omicron SARS-CoV-2 variants in US states and counties through December 1, 2021 Fayette Klaassen, Melanie H Chitwood, Ted Cohen, Virginia E Pitzer, Marcus Russi, Nicole A Swartwood, et al. (+2)
395 [GO] 2022―Jun―14 Rebound Phenomenon after Nirmatrelvir/Ritonavir Treatment of Coronavirus Disease-2019 in High-Risk Persons Nischal Ranganath, John C. O’Horo, Douglas W. Challener, Sidna M. Tulledge-Scheitel, Marsha L. Pike, R. Michael O’Brien, et al. (+2)
396 [GO] 2022―Jun―10 Advancing the Science of Vaccine Safety during the COVID-19 Pandemic and Beyond: Launching an International Network of Special Immunization Services Karina A. Top, Robert T. Chen, Ofer Levy, Al Ozonoff, Bruce Carleton, Nigel Crawford, et al. (+5)
397 [GO] 2022―Jun―10 Multiplex Detection of Antibody Landscapes to SARS-CoV-2/Influenza/Common Human Coronaviruses Following Vaccination or Infection with SARS-CoV-2 and Influenza Zhu-Nan Li, Feng Liu, Stacie Jefferson, Lauren Horner, Paul Carney, Michael D. L. Johnson, et al. (+10)
398 [GO] 2022―Jun―10 Multisystem Inflammatory Syndrome in Children (MIS-C) During SARS-CoV-2 Delta and Omicron Variant Circulation- United States, July 2021 - January 2022 Allison D. Miller, Anna R. Yousaf, Ethan Bornstein, Michael J. Wu, Katherine Lindsey, Michael Melgar, et al. (+3)
399 [GO] 2022―Jun―10 Population-weighted seroprevalence from SARS-CoV-2 infection, vaccination, and hybrid immunity among U.S. blood donations from January-December 2021 Michael P. Busch, Susan L. Stramer, Mars Stone, Elaine A. Yu, Eduard Grebe, Edward Notari, et al. (+17)
400 [GO] 2022―Jun―10 Effectiveness of a second dose of an mRNA vaccine against SARS-CoV-2 Omicron infection in individuals previously infected by other variants Susana Monge, Ayelén Rojas-Benedicto, Carmen Olmedo, Elisa Martín-Merino, Clara Mazagatos, Aurora Limia, et al. (+3)
401 [GO] 2022―Jun―10 Association of Trends in SARS-CoV-2 Seroprevalence and State-Issued Nonpharmaceutical Interventions- United States, August 1, 2020 - March 30, 2021 Maureen J. Miller, Austin Himschoot, Natalie Fitch, Sucheta Jawalkar, Dane Freeman, Charity Hilton, et al. (+15)
402 [GO] 2022―Jun―10 Early detection of SARS-CoV-2 variants using traveler-based genomic surveillance at four US airports, September 2021- January 2022 Renee D. Wegrzyn, Grace D. Appiah, Robert Morfino, Scott R. Milford, Allison Taylor Walker, Ezra T. Ernst, et al. (+15)
403 [GO] 2022―Jun―10 Comparison of Waning Neutralizing Antibody Responses Against the Omicron Variant 6 Months After Natural SARS-CoV-2 Infection (With/Without subsequent COVID-19 Vaccination) Versus 2-dose COVID-19 Vaccination So Yun Lim, Soonju Park, Ji Yeun Kim, Seungtaek Kim, Youngmee Jee, Sung-Han Kim
404 [GO] 2022―Jun―10 Exposure Outcomes in Fully Vaccinated Healthcare Personnel with Known SARS-CoV-2 Exposure-Minnesota, January-August 2021 Abbey Ruhland, Ashley Fell, Stacy M Holzbauer, Paige D’Heilly, Kris Curtis, Holly Wick, et al. (+6)
405 [GO] 2022―Jun―10 Testing Frequency Matters | An Evaluation of the Diagnostic Performance of a SARS-CoV-2 Rapid Antigen Test in United States Correctional Facilities Margaret L. Lind, Olivia L. Schultes, Alexander J. Robertson, Amy J. Houde, Derek A.T. Cummings, Albert I. Ko, et al. (+2)
406 [GO] 2022―Jun―08 Effectiveness of the Ad26.COV2.S (Johnson & Johnson) COVID-19 Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States Nathaniel M. Lewis, Wesley H. Self, Manjusha Gaglani, Adit A. Ginde, David J. Douin, H. Keipp Talbot, et al. (+50)
407 [GO] 2022―Jun―08 SARS-CoV-2 Outbreak at a College with High COVID-19 Vaccination Coverage-Connecticut, August-September 2021 Stephen M. Bart, Christina C. Curtiss, Rebecca Earnest, Rachel Lobe-Costonis, Hanna Peterson, Caroline McWilliams, et al. (+5)
408 [GO] 2022―Jun―08 mRNA (BNT162b2) COVID-19 vaccination increased risk of Bell’s palsy: a nested case control and self-controlled case series study Eric Yuk Fai Wan, Celine Sze Ling Chui, Vanessa Wai Sei Ng, Yuan Wang, Vincent Ka Chun Yan, Ivan Chun Hang Lam, et al. (+19)
409 [GO] 2022―Jun―08 Immunogenicity of a third dose of BNT162b2 to ancestral SARS-CoV-2 & Omicron variant in adults who received two doses of inactivated vaccine Nancy H. L. Leung, Samuel M. S. Cheng, Mario Martín-Sánchez, Niki Y. M. Au, Yvonne Y. Ng, Leo L. H. Luk, et al. (+11)
410 [GO] 2022―Jun―08 Maternal and perinatal outcomes associated with SARS-CoV-2 infection during pregnancy, Florida, 2020-2021: A retrospective cohort study Timothy J. Doyle, Gebre-egziabhe Kiros, Emily N. Schmitt-Matzen, Randy Propper, Angela Thompson, Ghasi S. Phillips-Bell
411 [GO] 2022―Jun―08 MERS-CoV Infection Elicits Long-lasting Specific Antibody, T and B Cell Immune Responses in Recovered Individuals Rowa Y Alhabbab, Abdullah Algaissi, Ahmed Bakr Mahmoud, Almohanad A Alkayyal, Sawsan Al-Amri, Mohamed A Alfaleh, et al. (+13)
412 [GO] 2022―Jun―06 Nasal Spray of Neutralizing Monoclonal Antibody 35B5 Confers Potential Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern (VOCs): A Small-scale Clinical Trial Yao Lin, Shuai Yue, Yang Yang, Sen Yang, Zhiwei Pan, Xiaofan Yang, et al. (+16)
413 [GO] 2022―Jun―06 Durability of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Booster Vaccine Protection Against Omicron Among Healthcare Workers With a Vaccine Mandate Aaron Richterman, Amy Behrman, Patrick J Brennan, Judith A O’Donnell, Christopher K Snider, Krisda H Chaiyachati
414 [GO] 2022―Jun―02 Effectiveness of Paxlovid in Reducing Severe COVID-19 and Mortality in High Risk Patients Ronza Najjar-Debbiny, Naomi Gronich, Gabriel Weber, Johad Khoury, Maisam Amar, Nili Stein, et al. (+2)
415 [GO] 2022―May―31 Effectiveness of heterologous COVID-19 vaccine booster dosing in Brazilian healthcare workers, 2021 Alexandre R. Marra, João Luiz Miraglia, Daniel Tavares Malheiros, Yang Guozhang, Vanessa Damazio Teich, Elivane da Silva Victor, et al. (+19)
416 [GO] 2022―May―31 SARS-CoV-2 incidence and risk factors in a national, community-based prospective cohort of U.S. adults Denis Nash, Madhura S. Rane, McKaylee M. Robertson, Mindy Chang, Sarah Kulkarni Gorrell, Rebecca Zimba, et al. (+9)
417 [GO] 2022―May―31 Serum Neutralizing Antibody Titers 12 months after COVID-19 mRNA Vaccination: Correlation to Clinical Variables in an Adult, US-Population Min Zhao, Rebecca Slotkin, Amar H. Sheth, Lauren Pischel, Tassos C. Kyriakides, Brinda Emu, et al. (+10)
418 [GO] 2022―May―26 Relative Virulence of SARS-CoV-2 Among Vaccinated and Unvaccinated Individuals Hospitalized with SARS-CoV-2 Alicia A. Grima, Kiera R. Murison, Alison E. Simmons, Ashleigh R. Tuite, David N. Fisman
419 [GO] 2022―May―26 Early introduction and rise of the Omicron SARS-CoV-2 variant in highly vaccinated university populations Brittany A. Petros, Jacquelyn Turcinovic, Nicole L. Welch, Laura F. White, Eric D. Kolaczyk, Matthew R. Bauer, et al. (+24)
420 [GO] 2022―May―26 Generation of novel SARS-CoV-2 variants on B.1.1.7 lineage in three patients with advanced HIV disease Anna C. Riddell, Beatrix Kele, Kathryn Harris, Jon Bible, Maurice Murphy, Subathira Dakshina, et al. (+8)
421 [GO] 2022―May―24 Understanding ‘hybrid immunity’: comparison and predictors of humoral immune responses to SARS-CoV-2 infection and COVID-19 vaccines Nusrat J. Epsi, Stephanie A. Richard, David A. Lindholm, Katrin Mende, Anuradha Ganesan, Nikhil Huprikar, et al. (+30)
422 [GO] 2022―May―24 Duration of replication-competent SARS-CoV-2 shedding among patients with severe or critical coronavirus disease 2019 (COVID-19) Do Young Kim, Michael Y. Lin, Cheryl Jennings, Haiying Li, Jae Hyung Jung, Nicholas M. Moore, et al. (+5)
423 [GO] 2022―May―24 How drivers of seasonality in respiratory infections may impact vaccine strategy: a case study in how COVID-19 may help us solve one of influenza's biggest challenges Eric Lofgren, Elena N. Naumova, Jack Gorski, Yuri Naumov, Nina H. Fefferman
424 [GO] 2022―May―24 PAVING THE WAY TOWARDS PRECISION VACCINOLOGY: THE PARADIGM OF MYOCARDITIS AFTER COVID-19 VACCINATION Theano Lagousi, Ioanna Papadatou, Petros Strempas, Elena Chatzikalil, Vana Spoulou
425 [GO] 2022―May―24 Association of frailty, age, and biological sex with SARS-CoV-2 mRNA vaccine-induced immunity in older adults Janna R. Shapiro, Ioannis Sitaras, Han-Sol Park, Tihitina Y. Aytenfisu, Christopher Caputo, Maggie Li, et al. (+21)
426 [GO] 2022―May―24 Maternal and Neonatal SARS-CoV-2 Omicron Variant Neutralization after Antenatal mRNA Vaccination Amihai Rottenstreich, Olesya Vorontsov, Or Alfi, Gila Zarbiv, Esther Oiknine-Djian, Roy Zigron, et al. (+4)
427 [GO] 2022―May―24 Humoral and T-cell immune response after three doses of mRNA SARS-CoV-2 vaccines in fragile patients: the Italian VAX4FRAIL study Paolo Corradini, Chiara Agrati, Giovanni Apolone, Alberto Mantovani, Diana Giannarelli, Vincenzo Marasco, et al. (+21)
428 [GO] 2022―May―20 Comparison of influenza and COVID-19-associated hospitalizations among children < 18 years old in the United States-FluSurv-NET (October-April 2017-2021) and COVID-NET (October 2020-September 2021) Miranda J. Delahoy, Dawud Ujamaa, Christopher A. Taylor, Charisse Cummings, Onika Anglin, Rachel Holstein, et al. (+39)
429 [GO] 2022―May―20 Reduced Odds of SARS-CoV-2 Reinfection after Vaccination among New York City Adults, July-November 2021 Alison Levin-Rector, Lauren Firestein, Emily McGibbon, Jessica Sell, Sungwoo Lim, Ellen H. Lee, et al. (+4)
430 [GO] 2022―May―17 Protection of mRNA vaccines against hospitalized COVID-19 in adults over the first year following authorization in the United States Mark W. Tenforde, Wesley H. Self, Yuwei Zhu, Eric A. Naioti, Manjusha Gaglani, Adit A. Ginde, et al. (+54)
431 [GO] 2022―May―17 A Single Dose of BNT162b2 mRNA Vaccine Induces Airway Immunity in SARS-CoV-2 Naive and recovered COVID-19 subjects Emanuela MARTINUZZI, Jonathan BENZAQUEN, Olivier GUERIN, Sylvie LEROY, Thomas SIMON, Marius ILIE, et al. (+12)
432 [GO] 2022―May―17 Transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection: a double-blinded, phase 2 randomized, controlled trial Shmuel Shoham, Evan M Bloch, Arturo Casadevall, Daniel Hanley, Bryan Lau, Kelly Gebo, et al. (+50)
433 [GO] 2022―May―17 Implications of the SARS-CoV-2 pandemic on the epidemiology of pediatric Respiratory Syncytial Virus (RSV) infection Oludare A. Odumade, Simon D. van Haren, Asimenia Angelidou
434 [GO] 2022―May―10 Correction to: Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients Juliana de Castilhos, Eli Zamir, Theresa Hippchen, Roman Rohrbach, Sabine Schmidt, Silvana Hengler, et al. (+31)
435 [GO] 2022―May―05 SARS-CoV-2: First Human Challenge Study
436 [GO] 2022―May―05 Alpha variant coronavirus outbreak in a nursing home despite high vaccination coverage: molecular, epidemiological and immunological studies Kathrin Zürcher, Irene A Abela, Madlen Stange, Carole Dupont, Catrina Mugglin, Adrian Egli, et al. (+3)
437 [GO] 2022―May―03 Clinical Validation of a Novel T-cell Receptor Sequencing Assay for Identification of Recent or Prior SARS-CoV-2 Infection Sudeb C. Dalai, Jennifer N. Dines, Thomas M. Snyder, Rachel M. Gittelman, Tera Eerkes, Pashmi Vaney, et al. (+16)
438 [GO] 2022―Apr―26 Cumulative Incidence and Risk Factors for Severe COVID-19 in French People with Cystic Fibrosis Harriet Corvol, Sandra de Miranda, Clémence Dehillotte, Lydie Lemonnier, Raphael Chiron, Isabelle Danner-Boucher, et al. (+10)
439 [GO] 2022―Apr―26 Airflow patterns in double occupancy patient rooms may contribute to roommate-to-roommate transmission of severe acute respiratory syndrome coronavirus 2 Jennifer L. Cadnum, Annette L. Jencson, Heba Alhmidi, Trina F. Zabarsky, Curtis J. Donskey
440 [GO] 2022―Apr―23 Correction to: Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study Thomas Benfield, Jacob Bodilsen, Christian Brieghel, Zitta Barrella Harboe, Marie Helleberg, Claire Holm, et al. (+25)
441 [GO] 2022―Apr―20 Neutralization of SARS-CoV-2 Omicron and other variants in serum from children with vaccination-induced myocarditis Fatema Tuz Zahra, Gabrielle Grubbs, Kirsten Dummer, Adriana H. Tremoulet, Chisato Shimizu, Jane C. Burns, Surender Khurana
442 [GO] 2022―Apr―20 Favipiravir for treatment of outpatients with asymptomatic or uncomplicated COVID-19: a double-blind randomized, placebo-controlled, phase 2 trial Marisa Holubar, Aruna Subramanian, Natasha Purington, Haley Hedlin, Bryan Bunning, Katharine S. Walter, et al. (+20)
443 [GO] 2022―Apr―19 Comparison of hospitalized COVID-19 and influenza patients requiring supplemental oxygen in a cohort study: clinical impact and resource consumption Inmaculada López Montesinos, Itziar Arrieta-Aldea, Aitor Dicastillo, Flavio Zuccarino, Luisa Sorli, Roberto Guerri-Fernández, et al. (+20)
444 [GO] 2022―Apr―19 Impact of Vaccination and Early Monoclonal Antibody Therapy on COVID-19 Outcomes in Organ Transplant Recipients During the Omicron Wave Javier T. Solera, Berta G. Árbol, Abdullah Alshahrani, Ilona Bahinskaya, Nikki Marks, Atul Humar, Deepali Kumar
445 [GO] 2022―Apr―19 Enhanced infection-prevention measures including universal N95 usage and daily testing: the impact on SARS-CoV-2 transmission in cohorted hospital cubicles through successive Delta and Omicron waves Wee Liang En, Karrie Kwan-Ki Ko, Edwin Philip Conceicao, May Kyawt Aung, Aung Myat Oo, Yang Yong, et al. (+2)
446 [GO] 2022―Apr―18 Temporal Dynamics of Nasopharyngeal and Tracheal SARS-CoV-2 Cycle Thresholds in COVID-19 Patients with Tracheostomy Sallie M Long, Alexander Chern, Victoria Cooley, Sei Chung, Noah Z. Feit, Arryn Craney, et al. (+2)
447 [GO] 2022―Apr―18 Observations and perspectives on adaptive immunity to SARS-CoV-2 Jennifer Dan, Ricardo da Silva Antunes, Alba Grifoni, Daniela Weiskopf, Shane Crotty, Alessandro Sette
448 [GO] 2022―Apr―18 Effectiveness of Booster mRNA Vaccines against SARS-CoV-2 Infection in Elderly Population, South Korea, October 2021 - January 2022 Jia Kim, Young June Choe, Eun Jung Jang, Do Sang Lim, Yoo-Yeon Kim, Ryu Kyung Kim, et al. (+3)
449 [GO] 2022―Apr―13 Correction to: Increased Peripheral Blood Neutrophil Activation Phenotypes and Neutrophil Extracellular Trap Formation in Critically Ill Coronavirus Disease 2019 Patients: A Case Series and Review of the Literature Jorge A Masso-Silva, Alexander Moshensky, Michael T Y Lam, Mazen Odish, Arjun Patel, Le Xu, et al. (+28)
450 [GO] 2022―Apr―12 Associations between SARS-CoV-2 variants and risk of COVID-19 hospitalization among confirmed cases in Washington State: a retrospective cohort study Miguel I. Paredes, Stephanie M. Lunn, Michael Famulare, Lauren A. Frisbie, Ian Painter, Roy Burstein, et al. (+39)
451 [GO] 2022―Apr―12 Comparative Effectiveness of mRNA and Inactivated Whole Virus Vaccines against COVID-19 Infection and Severe Disease in Singapore M Premikha, Calvin J. Chiew, Wycliffe E. Wei, Yee-Sin Leo, Benjamin Ong, David Chien Lye, et al. (+2)
452 [GO] 2022―Apr―12 Investigation of A SARS-CoV-2 Delta (B.1.617.2) Variant Outbreak Among Residents of a Skilled Nursing Facility and Vaccine Effectiveness Analysis - Maricopa County, Arizona, June-July 2021 Ariella P Dale, Olivia Almendares, Brandon Howard, Eleanor Burnett, Siru Prasai, Melissa Arons, et al. (+10)
453 [GO] 2022―Apr―11 COVID-19 Disease Severity in Children Infected with the Omicron Variant Adeel A. Butt, Soha R. Dargham, Srusvin Loka, Riyazuddin M. Shaik, Hiam Chemaitelly, Patrick Tang, et al. (+13)
454 [GO] 2022―Apr―11 Reductions in Antibiotic Prescribing in Australia During the SARS-CoV-2 Pandemic: National Prescribing Data Jack Skeggs, Aleece MacPhail, Tony Korman, Ian Woolley, Jillian SY Lau
455 [GO] 2022―Apr―11 Risk factors and multidimensional assessment of long COVID fatigue: a nested case-control study Ili Margalit, Dana Yelin, Moshe Sagi, Maya Merav Rahat, Liron Sheena, Nadav Mizrahi, et al. (+16)
456 [GO] 2022―Apr―06 High SARS-CoV-2 household transmission rates detected by dense saliva sampling L M Kolodziej, S F L van Lelyveld, M E Haverkort, R Mariman, J G C Sluiter-Post, P Badoux, et al. (+11)
457 [GO] 2022―Apr―05 SARS-CoV-2 Naturally Acquired Immunity vs. Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: a Retrospective Cohort Study Sivan Gazit, Roei Shlezinger, Galit Perez, Roni Lotan, Asaf Peretz, Amir Ben-Tov, et al. (+6)
458 [GO] 2022―Apr―02 Humoral and cellular immune response elicited by mRNA vaccination against SARS-CoV-2 in people living with HIV (PLWH) receiving antiretroviral therapy (ART) according with current CD4 T-lymphocyte count Andrea Antinori, Stefania Cicalini, Silvia Meschi, Veronica Bordoni, Patrizia Lorenzini, Alessandra Vergori, et al. (+26)
459 [GO] 2022―Mar―23 Effects of Confounding Bias in COVID-19 and Influenza Vaccine Effectiveness Test-Negative Designs Due to Correlated Influenza and COVID-19 Vaccination Behaviors Margaret K Doll, Stacy M Pettigrew, Julia Ma, Aman Verma
460 [GO] 2022―Mar―18 SARS-CoV-2 adaptive immunity in nursing home residents following a third dose of the Comirnaty® COVID-19 vaccine Estela Giménez, Eliseo Albert, Joao Zulaica, Ignacio Torres, Luciana Rusu, Alicia Rodríguez Moreno, et al. (+12)
461 [GO] 2022―Mar―11 Incidence and prevalence of COVID-19 within a healthcare worker cohort during the first year of the SARS-CoV-2 pandemic Sarah B Doernberg, Marisa Holubar, Vivek Jain, Yingjie Weng, Di Lu, Jenna B Bollyky, et al. (+6)
462 [GO] 2022―Mar―11 Antibody-mediated Immunogenicity against SARS-CoV-2 following priming, boosting and hybrid immunity: insights from 11 months of follow-up of a healthcare worker cohort in Israel, December 2020-October 2021 Michael Edelstein, Karine Wiegler Beiruti, Hila Ben-Amram, Naor Bar-Zeev, Christian Sussan, Hani Asulin, et al. (+4)
463 [GO] 2022―Mar―11 Differential T cell immunity to SARS-CoV-2 in mRNA-1273 and BNT162b2 vaccinated individuals Kathleen M E Gallagher, Mark B Leick, Rebecca C Larson, Trisha R Berger, Katelin Katsis, Jennifer Y Yam, Marcela V Maus
464 [GO] 2022―Mar―09 Existence of immunological memory response in true sero-negative individuals post COVID-19 molecular diagnosis Yaniv Lustig, Ella Mendelson, Michal Mandelboim, Asaf Biber, Einav G Levin, Carmit Cohen, et al. (+2)
465 [GO] 2022―Mar―09 Seroprevalence of SARS-CoV-2 after the second wave in South Africa in HIV-infected and uninfected persons: a cross-sectional household survey Nicole Wolter, Stefano Tempia, Anne von Gottberg, Jinal N Bhiman, Sibongile Walaza, Jackie Kleynhans, et al. (+15)
466 [GO] 2022―Mar―09 Pharmacokinetics of ß-d-N4-hydroxycytidine, the parent nucleoside of prodrug molnupiravir, in non-plasma compartments of patients with SARS-CoV-2 infection Richard FitzGerald, Laura Dickinson, Laura Else, Thomas Fletcher, Colin Hale, Alieu Amara, et al. (+13)
467 [GO] 2022―Mar―09 Predictive value of isolated symptoms for diagnosis of SARS-CoV-2 infection in children tested during peak circulation of the delta variant Adrianna L Westbrook, Laura C Benedit, Jennifer K Frediani, Mark A Griffiths, Nabeel Y Khan, Joshua M Levy, et al. (+10)
468 [GO] 2022―Mar―08 SARS-CoV-2 in exhaled aerosol particles from covid-19 cases and its association to household transmission Malin Alsved, David Nygren, Sara Thuresson, Patrik Medstrand, Carl-Johan Fraenkel, Jakob Löndahl
469 [GO] 2022―Mar―08 Addressing the Elephant in the Room: Intravenous Injection of COVID-19 mRNA Chun Huan Yau, Yoshio Masuda, Qin Xiang Ng, Seth En Teoh
470 [GO] 2022―Mar―08 COVID-19’s Challenges to Infection Control Dogma Regarding Respiratory Virus Transmission Michael Klompas, Meghan Baker, Chanu Rhee
471 [GO] 2022―Mar―08 SARS-CoV-2 Delta vaccine breakthrough transmissibility in Alachua County, Florida Brittany Rife Magalis, Shannan Rich, Massimiliano S Tagliamonte, Carla Mavian, Melanie N Cash, Alberto Riva, et al. (+16)
472 [GO] 2022―Mar―08 Rapid spread of SARS-CoV-2 Omicron subvariant BA.2 in a single-source community outbreak Vincent Chi-Chung Cheng, Jonathan Daniel Ip, Allen Wing-Ho Chu, Anthony Raymond Tam, Wan-Mui Chan, Syed Muhammad Umer Abdullah, et al. (+12)
473 [GO] 2022―Mar―07 Reduced immune response to inactivated SARS-CoV-2 vaccine in a cohort of immunocompromised patients in Chile M Elvira Balcells, Nicole Le Corre, Josefina Durán, María Elena Ceballos, Cecilia Vizcaya, Sebastián Mondaca, et al. (+20)
474 [GO] 2022―Mar―03 Long-term health-related quality of life in non-hospitalised COVID-19 cases with confirmed SARS-CoV-2 infection in England: Longitudinal analysis and cross-sectional comparison with controls Frank G Sandmann, Elise Tessier, Joanne Lacy, Meaghan Kall, Edwin Van Leeuwen, Andre Charlett, et al. (+7)
475 [GO] 2022―Mar―03 Real-world incidence of breakthrough COVID-19 hospitalization after vaccination versus natural infection in a large, local, empaneled primary care population using time-to-event analysis Benjamin D Pollock, Curtis B Storlie, Aaron J Tande, Priya Sampathkumar
476 [GO] 2022―Mar―03 Age-related changes in the nasopharyngeal microbiome are associated with SARS-CoV-2 infection and symptoms among children, adolescents, and young adults Jillian H Hurst, Alexander W McCumber, Jhoanna N Aquino, Javier Rodriguez, Sarah M Heston, Debra J Lugo, et al. (+10)
477 [GO] 2022―Mar―03 Vaccine Effectiveness of Three vs. Two Doses of SARS-CoV-2 mRNA Vaccines in a High Risk National Population Adeel A Butt, Victor B Talisa, Peng Yan, Obaid S Shaikh, Saad B Omer, Florian B Mayr
478 [GO] 2022―Mar―02 Efficacy of Bacillus Calmette-Guérin vaccination against respiratory tract infections in the elderly during the Covid-19 pandemic Simone J C F M Moorlag, Esther Taks, Thijs ten Doesschate, Thomas W van der Vaart, Axel B Janssen, Lisa Müller, et al. (+15)
479 [GO] 2022―Mar―02 Impact of Multi-Component Support Strategies on HIV Virologic Suppression Rates during COVID-19: An Interrupted Time Series Analysis Matthew A Spinelli, Noelle Le Tourneau, David V Glidden, Ling Hsu, Matthew D Hickey, Elizabeth Imbert, et al. (+8)
480 [GO] 2022―Mar―01 Probable Animal-to-Human Transmission of SARS-CoV-2 Delta Variant AY.127 Causing a Pet Shop-Related COVID-19 Outbreak in Hong Kong Jasper Fuk-Woo Chan, Gilman Kit-Hang Siu, Shuofeng Yuan, Jonathan Daniel Ip, Jian-Piao Cai, Allen Wing-Ho Chu, et al. (+33)
481 [GO] 2022―Mar―01 SARS-CoV-2 placental infection is associated with massive perivillous fibrin deposition at the maternal-fetal interface: a preliminary study" Esin Kotiloglu-Karaa, Beatrix Kele, Raghavendran Kulasegaran-Shylini, Claire E Broad, Dola Owoyemi, Joanne Martin, et al. (+5)
482 [GO] 2022―Mar―01 Antibody response in immunocompromised patients after the administration of SARS-CoV-2 vaccine BNT162b2 or mRNA-1273: A randomised controlled trial Benjamin Speich, Frédérique Chammartin, Irene A Abela, Patrizia Amico, Marcel P Stoeckle, Anna L Eichenberger, et al. (+14)
483 [GO] 2022―Mar―01 Age-Specific Changes in Virulence Associated with SARS-CoV-2 Variants of Concern David N Fisman, Ashleigh R Tuite
484 [GO] 2022―Mar―01 Sustained impact of the COVID-2019 pandemic on HCV treatment initiations in the United States Martin Hoenigl, Daniela Abramovitz, Ricardo E Flores Ortega, Natasha K Martin, Nancy Reau
485 [GO] 2022―Feb―28 Airborne SARS-CoV-2 in hospitals - effects of aerosol-generating procedures, HEPA-filtration units, patient viral load and physical distance Sara Thuresson, Carl-Johan Fraenkel, Sviataslau Sasinovich, Jonathan Soldemyr, Anders Widell, Patrik Medstrand, et al. (+2)
486 [GO] 2022―Feb―28 Mechanically ventilated patients shed high titre live SARS-CoV2 for extended periods from both the upper and lower respiratory tract Zack Saud, Mark Ponsford, Kirsten Bentley, Jade M Cole, Manish Pandey, Stephen Jolles, et al. (+4)
487 [GO] 2022―Feb―25 Bringing Transmission of SARS-CoV-2 to the Surface: Is there a Role for Fomites? Peter Katona, Ravina Kullar, Kevin Zhang
488 [GO] 2022―Feb―24 Erratum to: Characterization of an Asymptomatic Cohort of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Individuals Outside of Wuhan, China Yubo Wang, Yong He, Jin Tong, Yalan Qin, Ting Xie, Jianghua Li, et al. (+5)
489 [GO] 2022―Feb―24 Measurement of SARS-CoV-2 antigens in plasma of pediatric patients with acute COVID-19 or MIS-C using an ultrasensitive and quantitative immunoassay George B Sigal, Tanya Novak, Anu Mathew, Janet Chou, Yubo Zhang, Navaratnam Manjula, et al. (+24)
490 [GO] 2022―Feb―24 Trends in SARS-CoV-2 seroprevalence in Massachusetts estimated from newborn screening specimens Kevin C Ma, Jaime E Hale, Yonatan H Grad, Galit Alter, Katherine Luzuriaga, Roger B Eaton, et al. (+9)
491 [GO] 2022―Feb―23 Delayed mortality among solid organ transplant recipients hospitalized for COVID-19 Madeleine R Heldman, Olivia S Kates, Kassem Safa, Camille N Kotton, Ashrit Multani, Sarah J Georgia, et al. (+34)
492 [GO] 2022―Feb―15 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections by intranasal or testicular inoculation induces testicular damage preventable by vaccination in golden Syrian hamsters Can Li, Zhanhong Ye, Anna Jin-Xia Zhang, Jasper Fuk-Woo Chan, Wenchen Song, Feifei Liu, et al. (+13)
493 [GO] 2022―Feb―14 The effect of gestational age at BNT162b2 mRNA vaccination on maternal and neonatal SARS-CoV-2 antibody levels Amihai Rottenstreich, Gila Zarbiv, Esther Oiknine-Djian, Olesya Vorontsov, Roy Zigron, Geffen Kleinstern, et al. (+2)
494 [GO] 2022―Feb―14 Reproduction Numbers of SARS-CoV-2 Variants: A Systematic Review and Meta-analysis Zhanwei Du, Caifen Liu, Chunyu Wang, Lingfeng Xu, Mingda Xu, Lin Wang, et al. (+5)
495 [GO] 2022―Feb―11 Self-Assessed Severity as a Determinant of COVID-19 Symptom Specificity: A Longitudinal Cohort Study Anna Bershteyn, Angela M Dahl, Tracy Q Dong, Meagan E Deming, Connie L Celum, Helen Y Chu, et al. (+20)
496 [GO] 2022―Feb―11 Inequities in COVID-19 vaccination rates among adolescents in Massachusetts: a cross-sectional study David X Gao, Lloyd D Fisher, Donald R Miller, Alan C Geller
497 [GO] 2022―Feb―08 Comparing Covid-19 pandemic waves in hospitalized patients - a retrospective, multicenter, cohort study Yaron Niv, Noa Eliakim-Raz, Yaron Bar-Lavi, Manfred Green, Jacob Dreiher, Amit Hupert, et al. (+10)
498 [GO] 2022―Feb―08 Household transmission of SARS-CoV-2 Alpha variant - United States, 2021 Marisa A P Donnelly, Meagan R Chuey, Raymond Soto, Noah G Schwartz, Victoria T Chu, Stacey L Konkle, et al. (+34)
499 [GO] 2022―Jan―29 A Link Between Obesity and Coronavirus Disease 2019
500 [GO] 2022―Jan―26 Modeling the impact of vaccination strategies for nursing homes in the context of increased SARS-CoV-2 community transmission and variants Inga Holmdahl, Rebecca Kahn, Kara Jacobs Slifka, Kathleen Dooling, Rachel B Slayton
501 [GO] 2022―Jan―26 Symptoms compatible with long-COVID in healthcare workers with and without SARS-CoV-2 infection - results of a prospective multicenter cohort Carol Strahm, Marco Seneghini, Sabine Güsewell, Thomas Egger, Onicio Leal, Angela Brucher, et al. (+20)
502 [GO] 2022―Jan―25 The direct and indirect effects of the COVID-19 pandemic on private healthcare utilization in South Africa, March 2020 - September 2021 Amanda C Perofsky, Stefano Tempia, Jeremy Bingham, Caroline Maslo, Mande Toubkin, Anchen Laubscher, et al. (+4)
503 [GO] 2022―Jan―24 SARS-CoV-2 Vaccination boosts Neutralizing Activity against Seasonal Human Coronaviruses Jan Lawrenz, Qinya Xie, Fabian Zech, Tatjana Weil, Alina Seidel, Daniela Krnavek, et al. (+4)
504 [GO] 2022―Jan―24 Long Term Accuracy of SARS-CoV-2 Interferon-γ Release Assay and its Application in Household Investigation Kanagavel Murugesan, Prasanna Jagannathan, Jonathan Altamirano, Yvonne A Maldonado, Hector F Bonilla, Karen B Jacobson, et al. (+7)
505 [GO] 2022―Jan―15 Impact of COVID-19 on HIV Preexposure Prophylaxis Prescriptions in the United States - A Time Series Analysis Ya-Lin A Huang, Weiming Zhu, Jeffrey Wiener, Athena P Kourtis, H Irene Hall, Karen W Hoover
506 [GO] 2022―Jan―15 Lower Prevalence of SARS-CoV-2 Infection Among People Experiencing Homelessness Tested in Outdoor Encampments Compared with Overnight Shelters - Denver, Colorado, June - July 2020 Sarah E Rowan, David W McCormick, Karen A Wendel, Tracy Scott, Jesse Chavez-van de Hey, Kay Wilcox, et al. (+4)
507 [GO] 2022―Jan―14 Rapid detection and characterization of SARS-CoV-2 omicron variant in a returning traveler Mary Elizabeth Sexton, Jesse J Waggoner, Ludy R Carmola, Phuong-Vi Nguyen, Ethan Wang, Dara Khosravi, et al. (+14)
508 [GO] 2022―Jan―14 Contributions to the mitigation of the COVID-19 pandemic Stefan Pilz
509 [GO] 2022―Jan―13 Clinical characteristics and outcomes of COVID-19 in pregnant women: a propensity score matched analysis of the data from the COVID-19 Registry Japan Kensuke Shoji, Shinya Tsuzuki, Takayuki Akiyama, Nobuaki Matsunaga, Yusuke Asai, Setsuko Suzuki, et al. (+7)
510 [GO] 2022―Jan―13 Seroprevalence and risk factors for SARS-CoV-2 among incarcerated adult men in Q, Canada (2021) Nadine Kronfli, Camille Dussault, Mathieu Maheu-Giroux, Alexandros Halavrezos, Sylvie Chalifoux, Jessica Sherman, et al. (+5)
511 [GO] 2022―Jan―13 SARS-CoV-2 transmission dynamics and immune responses in a household of vaccinated persons Jamin Liu, Matthew T Laurie, Luis Rubio, Sara E Vazquez, Sara Sunshine, Anthea M Mitchell, et al. (+13)
512 [GO] 2022―Jan―12 Necessity of COVID-19 Vaccination in Persons Who Have Already Had COVID-19 Nabin K Shrestha, Patrick C Burke, Amy S Nowacki, Paul Terpeluk, Steven M Gordon
513 [GO] 2022―Jan―12 Trend in sensitivity of SARS-CoV-2 serology one year after mild and asymptomatic COVID-19: unpacking potential bias in seroprevalence studies Christopher R Bailie, Yeu-Yang Tseng, Louise Carolan, Martyn D Kirk, Suellen Nicholson, Annette Fox, Sheena G Sullivan
514 [GO] 2022―Jan―11 SARS-CoV-2 Environmental contamination in hospital rooms is uncommon using viral culture techniques Bobby G Warren, Alicia Nelson, Aaron Barrett, Bechtler Addison, Amanda Graves, Raquel Binder, et al. (+6)
515 [GO] 2022―Jan―05 Quantifying environmental mitigation of aerosol viral load in a controlled chamber with participants diagnosed with COVID-19 Hooman Parhizkar, Leslie Dietz, Andreas Olsen-Martinez, Patrick F Horve, Liliana Barnatan, Dale Northcutt, Kevin G Van Den Wymelenberg
516 [GO] 2022―Jan―03 COVID-19 mRNA vaccines delay the onset of breakthrough infections with less radiographic abnormalities Xin Li, Jacky Man-Chun Chan, Bosco Lam, David Christopher Lung, Kwok-Cheung Lung, Christina Kin-Yi Chow, et al. (+7)
517 [GO] 2022―Jan―01 Two cases of breakthrough SARS-CoV-2 infections caused by the Omicron variant (B.1.1.529 lineage) in international travelers to Japan Taketomo Maruki, Noriko Iwamoto, Kohei Kanda, Nobumasa Okumura, Gen Yamada, Masahiro Ishikane, et al. (+8)
518 [GO] 2021―Dec―31 Compassionate Use of REGEN-COV ® in Patients with COVID-19 and Immunodeficiency-Associated Antibody Disorders David Stein, Ernesto Oviedo-Orta, Wendy A Kampman, Jennifer McGinniss, George Betts, Margaret McDermott, et al. (+5)
519 [GO] 2021―Dec―22 COVID-19 breakthrough infection and post-vaccination neutralizing antibody among healthcare workers in a referral hospital in Tokyo: a case-control matching study Shohei Yamamoto, Kenji Maeda, Kouki Matsuda, Akihito Tanaka, Kumi Horii, Kaori Okudera, et al. (+9)
520 [GO] 2021―Dec―20 Predictors of SARS-CoV-2 infection following high-risk exposure Kristin L Andrejko, Jake Pry, Jennifer F Myers, John Openshaw, James Watt, Nozomi Birkett, et al. (+12)
521 [GO] 2021―Dec―18 Neutralizing Antibody Response to Pseudotype SARS-CoV-2 Differs between mRNA-1273 and BNT162b2 COVID-19 Vaccines and by History of SARS-CoV-2 Infection Harmony L Tyner, Jefferey L Burgess, Lauren Grant, Manjusha Gaglani, Jennifer L Kuntz, Allison L Naleway, et al. (+22)
522 [GO] 2021―Dec―15 Fair Allocation of Scarce Therapies for COVID-19 Govind Persad, Monica E Peek, Seema K Shah
523 [GO] 2021―Dec―15 Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients Lu Lu, Bobo Wing-Yee Mok, Lin-Lei Chen, Jacky Man-Chun Chan, Owen Tak-Yin Tsang, Bosco Hoi-Shiu Lam, et al. (+14)
524 [GO] 2021―Dec―13 Decline in Pneumococcal Disease in Young Children during the COVID-19 Pandemic in Israel Associated with Suppression of seasonal Respiratory Viruses, despite Persistent Pneumococcal Carriage: A Prospective Cohort Study Dana Danino, Shalom Ben-Shimol, Bart Adriaan Van Der Beek, Noga Givon-Lavi, Yonat Shemer Avni, David Greenberg, et al. (+2)
525 [GO] 2021―Dec―13 Real-World Effectiveness Of Remdesivir In Adults Hospitalized With Covid-19: A Retrospective, Multicenter Comparative Effectiveness Study Brian T Garibaldi, Kunbo Wang, Matthew L Robinson, Joshua Betz, G Caleb Alexander, Kathleen M Andersen, et al. (+7)
526 [GO] 2021―Dec―09 SARS-CoV-2 Delta outbreak among fully vaccinated nursing home residents likely initiated by a fully vaccinated staff member - Connecticut, July-August 2021 Stephen M Bart, Adora Harizaj, Claire L Pearson, Tiara Conteh, Erin Grogan, Randy Downing, et al. (+4)
527 [GO] 2021―Dec―09 Immunogenicity of SARS-CoV-2 infection and Ad26.CoV2.S vaccination in people living with HIV Khadija Khan, Gila Lustig, Mallory Bernstein, Derseree Archary, Sandile Cele, Farina Karim, et al. (+18)
528 [GO] 2021―Dec―09 Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons with Breakthrough SARS-CoV-2 Infection in a High-risk National Population Adeel A Butt, Peng Yan, Obaid S Shaikh, Florian B Mayr, Saad B Omer
529 [GO] 2021―Dec―09 Clinical performance of a standardized SARS-CoV-2 interferon-γ release assay for simple detection of T-cell responses after infection or vaccination Marta Fernández-González, Vanesa Agulló, Sergio Padilla, José Alberto García, Javier García-Abellán, Ángela Botella, et al. (+4)
530 [GO] 2021―Dec―09 Hyperinflammatory syndromes after SARS-CoV-2 mRNA vaccination in individuals with underlying immune dysregulation Joseph M Rocco, Christina Mallarino-Haeger, Attiya H Randolph, Susan M Ray, Marcos C Schechter, Christa S Zerbe, et al. (+2)
531 [GO] 2021―Dec―09 Longitudinal Analysis of Memory T cell Responses in Survivors of Middle East respiratory syndrome Hyoung-Shik Shin, Yeonjae Kim, Jihye Kang, Jihye Um, Jun-Sun Park, Wan Beom Park, et al. (+8)
532 [GO] 2021―Dec―06 Temporal Dynamics of Anti-Type 1 Interferon Autoantibodies in COVID-19 Patients Elana R Shaw, Lindsey B Rosen, Aristine Cheng, Kerry Dobbs, Ottavia M Delmonte, Elise M N Ferré, et al. (+7)
533 [GO] 2021―Dec―03 Differences in Post-mRNA Vaccination SARS-CoV-2 IgG Concentrations and Surrogate Virus Neutralization Test Response by HIV Status and Type of Vaccine: a Matched Case-Control Observational Study Matthew A Spinelli, Michael J Peluso, Kara L Lynch, Cassandra Yun, David V Glidden, Timothy J Henrich, et al. (+2)
534 [GO] 2021―Dec―01 Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naïve residents of nursing homes Pieter Pannus, Kristof Y Neven, Stéphane De Craeye, Leo Heyndrickx, Sara Vande Kerckhove, Daphnée Georges, et al. (+17)
535 [GO] 2021―Dec―01 Duration of SARS-CoV-2 Natural Immunity and Protection against the Delta Variant: A Retrospective Cohort Study Priscilla Kim, Steven M Gordon, Megan M Sheehan, Michael B Rothberg
536 [GO] 2021―Nov―15 Universal SARS-CoV-2 testing for obstetric inpatient units across the United States Jennifer Gilner, Namita Kansal, Joseph R Biggio, Shani Delaney, Chad A Grotegut, Erica Hardy, et al. (+14)
537 [GO] 2021―Nov―15 Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study Natacha Madelon, Kim Lauper, Gautier Breville, Irène Sabater Royo, Rachel Goldstein, Diego O Andrey, et al. (+8)
538 [GO] 2021―Nov―09 SARS-CoV-2 reinfection associates with unstable housing and occurs in the presence of antibodies David J Bean, Janet Monroe, Jacquelyn Turcinovic, Yvetane Moreau, John H Connor, Manish Sagar
539 [GO] 2021―Nov―01 Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination Yalile Perez, Emily R Levy, Avni Y Joshi, Abinash Virk, Martin Rodriguez-Porcel, Matthew Johnson, et al. (+4)
540 [GO] 2021―Oct―28 The removal of airborne SARS-CoV-2 and other microbial bioaerosols by air filtration on COVID-19 surge units Andrew Conway Morris, Katherine Sharrocks, Rachel Bousfield, Leanne Kermack, Mailis Maes, Ellen Higginson, et al. (+15)
541 [GO] 2021―Oct―26 Effectiveness of BNT162b2 mRNA COVID-19 vaccine against acquisitions of SARS-CoV-2 among health care workers in long-term care facilities: a prospective cohort study Khitam Muhsen, Nimrod Maimon, Ami Mizrahi, Omri Bodenneimer, Dani Cohen, Michal Maimon, et al. (+2)
542 [GO] 2021―Oct―23 Secondary Cases of Delta-Variant COVID-19 Among Vaccinated Healthcare Workers with Breakthrough Infections is Rare Sarah E Waldman, Tara Buehring, Daniel J Escobar, Shruti K Gohil, Ralph Gonzales, Susan S Huang, et al. (+6)
543 [GO] 2021―Oct―07 Lack of Antinuclear Antibodies in Convalescent COVID-19 Patients with Persistent Symptoms Michael J Peluso, Isaac J Thomas, Sadie E Munter, Steven G Deeks, Timothy J Henrich
544 [GO] 2021―Sep―30 Persistent COVID-19 in an immunocompromised host treated by SARS-CoV-2-specific monoclonal antibodies Benoit Bailly, Helene Péré, David Veyer, Ana Berceanu,  Etienne Daguindau, Pauline Roux, et al. (+17)
545 [GO] 2021―Sep―30 Changing patterns of bloodstream infections in the community and acute care across two COVID-19 epidemic waves: a retrospective analysis using data linkage Nina Zhu, Timothy M Rawson, Siddharth Mookerjee, James R Price, Frances Davies, Jonathan Otter, et al. (+5)
546 [GO] 2021―Sep―30 Remdesivir treatment in hospitalized patients with COVID-19: a comparative analysis of in-hospital all-cause mortality in a large multi-center observational cohort Essy Mozaffari, Aastha Chandak, Zhiji Zhang, Shuting Liang, Mark Thrun, Robert L Gottlieb, et al. (+6)
547 [GO] 2021―Sep―29 Corrigendum to: Correlation Between 3790 Quantitative Polymerase Chain Reaction-Positives Samples and Positive Cell Cultures, Including 1941 Severe Acute Respiratory Syndrome Coronavirus 2 Isolates Rita Jaafar, Sarah Aherfi, Nathalie Wurtz, Clio Grimaldier, Van Thuan Hoang, Philippe Colson, et al. (+2)
548 [GO] 2021―Sep―22 Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies Omar Hasan Ali, David Bomze, Lorenz Risch, Silvio D Brugger, Matthias Paprotny, Myriam Weber, et al. (+13)
549 [GO] 2021―Sep―21 WHO guidance to support HIV care models during the Covid-19 era Nathan Ford, Marco Vitoria, Meg Doherty
550 [GO] 2021―Sep―21 Safety and immunogenicity of a recombinant adenovirus type-5-vectored COVID-19 vaccine with a homologous prime-boost regimen in healthy participants aged 6 years and above: a randomised, double-blind, placebo-controlled, phase 2b trial Fengcai Zhu, Pengfei Jin, Tao Zhu, Wenjuan Wang, Huayue Ye, Hongxing Pan, et al. (+10)
551 [GO] 2021―Sep―21 Pharmacokinetics and Efficacy of Human Hyperimmune Intravenous Immunoglobulin Treatment of SARS-CoV-2 Infection in Adult Syrian Hamsters Charles B Stauft, Million Tegenge, Surender Khurana, Youri Lee, Prabhuanand Selvaraj, Hana Golding, et al. (+2)
552 [GO] 2021―Sep―20 Prior infection and age impacts antibody persistence after SARS-CoV-2 mRNA vaccine Elizabeth Fraley, Cas LeMaster, Santosh Khanal, Dithi Banerjee, Tomi Pastinen, Elin Grundberg, et al. (+2)
553 [GO] 2021―Sep―20 Understanding the Potential Impact of Different Drug Properties On SARS-CoV-2 Transmission and Disease Burden: A Modelling Analysis Charles Whittaker, Oliver J Watson, Carlos Alvarez-Moreno, Nasikarn Angkasekwinai, Adhiratha Boonyasiri, Luis Carlos Triana, et al. (+47)
554 [GO] 2021―Sep―17 Low Environmental Temperature Exacerbates Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Golden Syrian Hamsters Jasper Fuk-Woo Chan, Vincent Kwok-Man Poon, Chris Chung-Sing Chan, Kenn Ka-Heng Chik, Jessica Oi-Ling Tsang, Zijiao Zou, et al. (+21)
555 [GO] 2021―Sep―16 Outcome heterogeneity in COVID-19 patients receiving tocilizumab Man Man Niu, Yue Cao, Rui Xue Li, Guo Zhen Fan, Peng Hu
556 [GO] 2021―Sep―15 Is COVID-19 Less Deadly Now? -- Trends of In-Hospital Mortality Among Hospitalized COVID-19 Patients in the United States Rena C Moon, Rachel H Mackey, Zhun Cao, Seth Emont, Laura L Schott, Julie Gayle, et al. (+2)
557 [GO] 2021―Sep―13 Randomized study of rivaroxaban vs. placebo on disease progression and symptoms resolution in high-risk adults with mild COVID-19 Jintanat Ananworanich, Robin Mogg, Michael W Dunne, Mohamed Bassyouni, Consuela Vera David, Erika Gonzalez, et al. (+5)
558 [GO] 2021―Sep―10 Reinfections are more frequent than currently considered in countries with high incidence of COVID-19 cases due to stringent definitions Luis Pampa-Espinoza, Javier Silva-Valencia, Manuel Fernández, Carlos Padilla-Rojas, Lely Solari
559 [GO] 2021―Sep―09 Projected long-term impact of the COVID-19 pandemic on hepatitis C outcomes in the United States: a modelling study Joshua A Barocas, Alexandra Savinkina, Sara Lodi, Rachel L Epstein, Tara C Bouton, Heather Sperring, et al. (+5)
560 [GO] 2021―Sep―08 False COVID-19 cases due to contamination by inactivated virus vaccine Kelvin Kai-Wang To, Xin Li, David Christopher Lung, Jonathan Daniel Ip, Wan-Mui Chan, Allen Wing-Ho Chu, et al. (+12)
561 [GO] 2021―Sep―06 Severity of SARS-CoV-2 alpha variant (B.1.1.7) in England Daniel J Grint, Kevin Wing, Catherine Houlihan, Hamish P Gibbs, Stephen J W Evans, Elizabeth Williamson, et al. (+31)
562 [GO] 2021―Sep―02 Evolution of COVID-19 symptoms during the first 12 months after illness onset Elke Wynberg, Hugo D G van Willigen, Maartje Dijkstra, Anders Boyd, Neeltje A Kootstra, Joost G van den Aardweg, et al. (+7)
563 [GO] 2021―Sep―02 Rapid emergence and spread of SARS-CoV-2 gamma (P.1) variant in Haiti Massimiliano S Tagliamonte, Carla Mavian, Kayvan Zainabadi, Melanie N Cash, John A Lednicky, Brittany Rife Magalis, et al. (+8)
564 [GO] 2021―Sep―02 Similar antibody responses against SARS-CoV-2 in HIV uninfected and infected individuals on antiretroviral therapy during the first South African infection wave Jumari Snyman, Shi-Hsia Hwa, Robert Krause, Daniel Muema, Tarylee Reddy, Yashica Ganga, et al. (+4)
565 [GO] 2021―Sep―02 Association of E484K spike protein mutation with SARS-CoV-2 infection in vaccinated persons---Maryland, January - May 2021 Kenneth A Feder, Ami Patel, Venkata R Vepachedu, Catherine Dominguez, Eric N Keller, Liore Klein, et al. (+11)
566 [GO] 2021―Sep―01 Health Care Personnel (HCP) attitudes about COVID-19 vaccination after emergency use authorization Jana Shaw, Samantha Hanley, Telisa Stewart, Daniel A Salmon, Christine Ortiz, Paula M Trief, et al. (+4)
567 [GO] 2021―Aug―31 Latino Household Transmission of SARS-CoV-2 Diego A Martinez, Eili Y Klein, Cassandra Parent, Diana Prieto, Benjamin F Bigelow, Ronald E Saxton, Kathleen R Page
568 [GO] 2021―Aug―30 Single-dose mRNA vaccine effectiveness against SARS-CoV-2 in healthcare workers extending 16 weeks post-vaccination: a test-negative design from Q, Canada Sara Carazo, Denis Talbot, Nicole Boulianne, Marc Brisson, Rodica Gilca, Geneviève Deceuninck, et al. (+10)
569 [GO] 2021―Aug―28 Estimating the latent period of coronavirus disease 2019 (COVID-19) Hualei Xin, Yu Li, Peng Wu, Zhili Li, Eric H Y Lau, Ying Qin, et al. (+4)
570 [GO] 2021―Aug―28 It’s hard to measure success while caring for surges in COVID-19 hospitalizations Lindsey Gottlieb, Scott K Fridkin
571 [GO] 2021―Aug―28 Insights from a murine model of COVID-19 mRNA vaccination-induced myopericarditis: Could accidental intravenous vaccine injection induce myopericarditis? Kirk U Knowlton
572 [GO] 2021―Aug―28 SARS-CoV-2 Reinfection: A Case Series from a 12-Month Longitudinal Occupational Cohort Christina D Mack, Caroline Tai, Robby Sikka, Yonatan H Grad, Lisa L Maragakis, Nathan D Grubaugh, et al. (+8)
573 [GO] 2021―Aug―21 Undetected and relatively sustained SARS-CoV-2 circulation worldwide during the year 2019 Stefano Petti
574 [GO] 2021―Aug―21 Clinical and virological features of SARS-CoV-2 variants of concern: a retrospective cohort study comparing B.1.1.7 (Alpha), B.1.315 (Beta), and B.1.617.2 (Delta) Sean Wei Xiang Ong, Calvin J Chiew, Li Wei Ang, Tze-Minn Mak, Lin Cui, Matthias Paul H S Toh, et al. (+10)
575 [GO] 2021―Aug―20 COVID-19 associated Mucormycosis (CAM): risk factors and mechanisms of disease Shivakumar Narayanan, Joel V Chua, John W Baddley
576 [GO] 2021―Aug―20 Optimal timing of remdesivir initiation in hospitalized COVID-19 patients administered with dexamethasone Carlos K H Wong, Kristy T K Lau, Ivan C H Au, Xi Xiong, Matthew S H Chung, Eric H Y Lau, Benjamin J Cowling
577 [GO] 2021―Aug―17 Intravenous injection of COVID-19 mRNA vaccine can induce acute myopericarditis in mouse model Can Li, Yanxia Chen, Yan Zhao, David Christopher Lung, Zhanhong Ye, Wenchen Song, et al. (+13)
578 [GO] 2021―Aug―17 Deconstructing the Treatment Effect of Remdesivir in the Adaptive COVID-19 Treatment Trial-1: Implications for Critical Care Resource Utilization Jonathan Fintzi, Tyler Bonnett, Daniel A Sweeney, Nikhil A Huprikar, Anuradha Ganesan, Maria G Frank, et al. (+4)
579 [GO] 2021―Aug―17 Post-vaccination COVID-19: A case-control study and genomic analysis of 119 breakthrough infections in partially vaccinated individuals Ioannis Baltas, Florencia A T Boshier, Charlotte A Williams, Nadua Bayzid, Marius Cotic, José Afonso Guerra-Assunção, et al. (+7)
580 [GO] 2021―Aug―17 Incidence, Clinical Characteristics, and Risk Factors of SARS-CoV-2 Infection among Pregnant Individuals in the United States Fatimah S Dawood, Michael Varner, Alan Tita, Gabriella Newes-Adeyi, Cynthia Gyamfi-Bannerman, Ashley Battarbee, et al. (+17)
581 [GO] 2021―Aug―17 Clinical spectrum of SARS-CoV-2 infection and protection from symptomatic re-infection Hannah E Maier, Guillermina Kuan, Saira Saborio, Fausto Andres Bustos Carrillo, Miguel Plazaola, Carlos Barilla, et al. (+13)
582 [GO] 2021―Aug―17 Pre-Hospital Administration of Remdesivir during a SARS-CoV-2 Outbreak in a Skilled Nursing Facility Megan A Dunay, Sarah L McClain, Rick L Holloway, Sarah L W Norris, Talie Bendixsen Randall, Caitlin E Mohr, et al. (+3)
583 [GO] 2021―Aug―13 Twelve-month systemic consequences of COVID-19 in patients discharged from hospital: a prospective cohort study in Wuhan, China Tingting Liu, Di Wu, Weiming Yan, Xiaojing Wang, Xiaoyun Zhang, Ke Ma, et al. (+21)
584 [GO] 2021―Aug―11 Heterologous ChAdOx1-S/BNT162b2 vaccination: neutralizing antibody response to SARS-CoV-2 Chloé Dimeglio, Fabrice Herin, Isabelle Da-Silva, Isabelle Jougla, Claire Pradere, Marion Porcheron, et al. (+3)
585 [GO] 2021―Aug―11 Household transmission of SARS-CoV-2 in the United States: living density, viral load, and disproportionate impact on communities of color Carla Cerami, Zachary R Popkin-Hall, Tyler Rapp, Kathleen Tompkins, Haoming Zhang, Meredith S Muller, et al. (+17)
586 [GO] 2021―Aug―11 Incidence, clinical presentation, relapses and outcome of SARS-CoV-2 infection in patients treated with anti-CD20 monoclonal antibodies Jorge Calderón-Parra, Elena Múñez-Rubio, Ana Fernández-Cruz, María Cristina García Sánchez, Esther Maderuelo-González, Marcos López-Dosil, et al. (+4)
587 [GO] 2021―Aug―10 Remdesivir for the prevention of invasive mechanical ventilation or death in COVID-19 - A post-hoc analysis of the Adaptive COVID-19 Treatment Trial-1 Cohort Data Catharine I Paules, Shannon K Gallagher, Rekha R Rapaka, Richard T Davey, Sarah B Doernberg, Robert Grossberg, et al. (+10)
588 [GO] 2021―Aug―09 SARS-CoV-2 Viremia is Associated with COVID-19 Severity and Predicts Clinical Outcomes Jana L Jacobs, William Bain, Asma Naqvi, Brittany Staines, Priscila M S Castanha, Haopu Yang, et al. (+21)
589 [GO] 2021―Aug―09 Improvements in SARS-CoV-2 Testing Cascade in the US: Data from Serial Cross-sectional Assessments Steven J Clipman, Amy Wesolowski, Shruti H Mehta, Sarah Cobey, Derek A T Cummings, Sunil S Solomon
590 [GO] 2021―Aug―08 The Impact of COVID-19 on Healthcare-Associated Infections Meghan A Baker, Kenneth E Sands, Susan S Huang, Ken Kleinman, Edward J Septimus, Neha Varma, et al. (+15)
591 [GO] 2021―Aug―06 Viral Load of SARS-CoV-2 in Respiratory Aerosols Emitted by COVID-19 Patients while Breathing, Talking, and Singing Kristen K Coleman, Douglas Jie Wen Tay, Kai Sen Tan, Sean Wei Xiang Ong, Than The Son, Ming Hui Koh, et al. (+9)
592 [GO] 2021―Aug―05 Suspected SARS-CoV-2 Reinfections: Incidence, Predictors, and Healthcare Use among Patients at 238 U.S. Healthcare Facilities, June 1, 2020- February 28, 2021 Alexander Lawandi, Sarah Warner, Junfeng Sun, Cumhur Y Demirkale, Robert L Danner, Michael Klompas, et al. (+6)
593 [GO] 2021―Aug―05 Effect of ivermectin in the treatment of COVID-19: A trial sequential analysis highlighted the requirement of additional randomized controlled trials Sunali Padhi, Abhijit Pati, Aditya K Panda
594 [GO] 2021―Aug―05 Need for more randomized controlled trials with rigorous methodology to confirm that ivermectin is not a viable option for the treatment of coronavirus disease Masahiro Banno, Yasushi Tsujimoto, Masahiro Ishikane
595 [GO] 2021―Aug―04 Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States Mark W Tenforde, Manish M Patel, Adit A Ginde, David J Douin, H Keipp Talbot, Jonathan D Casey, et al. (+51)
596 [GO] 2021―Aug―02 Improving Pandemic Response: Employing Mathematical Modeling to Confront COVID-19 Matthew Biggerstaff, Rachel B Slayton, Michael A Johansson, Jay C Butler
597 [GO] 2021―Aug―02 Differential anti-S antibody titers in vaccinated residents during an outbreak of SARS-CoV-2 variant B.1.351 (β) in an elderly nursing home Slim Fourati, Benoit Bailly, Anne Le Bouter, Luc Guilpain, Christophe Rodriguez, Jean-Michel Pawlotsky
598 [GO] 2021―Jul―28 Risk of Healthcare-Associated Transmission of SARS-CoV-2 in Hospitalized Cancer Patients Karin Chow, Anoshe Aslam, Tara McClure, Jessica Singh, Jacquelyn Burns, Tracy McMillen, et al. (+6)
599 [GO] 2021―Jul―27 Epidemiology and risk of COVID-19 among travelers at airport and port quarantine stations across Japan: a nationwide descriptive analysis and an individually matched case-control study Motoyuki Tsuboi, Masahiko Hachiya, Hiroshi Ohtsu, Hidechika Akashi, Chiaki Miyoshi, Tamami Umeda
600 [GO] 2021―Jul―26 Leveraging a preexisting global infectious disease network for local decision-making during a pandemic Jocelyn J Herstein, John J Lowe, Timo Wolf, Shawn Vasoo, Yee Sin Leo, BumSik Chin, et al. (+3)
601 [GO] 2021―Jul―23 COVID-19 Outbreak Associated with a Fitness Center - Minnesota, September-November 2020 Tara Suhs, Daniel Gerlach, Jacob Garfin, Alexandra Lorentz, Melanie Firestone, Meghan Sherden, et al. (+10)
602 [GO] 2021―Jul―23 Atypical severe organizing pneumonia following COVID-19 in an immunocompromised teenager Harriet Corvol, Aurelia Alimi, Blandine Prevost, Aurélie Schnuriger, Hubert Ducou Le Pointe, Jérome Rambaud, Marie-Dominique Tabone
603 [GO] 2021―Jul―23 Impact of SARS-CoV-2 variant-associated RBD mutations on the susceptibility to serum antibodies elicited by COVID-19 infection or vaccination Lin-Lei Chen, Lu Lu, Charlotte Yee-Ki Choi, Jian-Piao Cai, Hoi-Wah Tsoi, Allen Wing-Ho Chu, et al. (+14)
604 [GO] 2021―Jul―23 Neutralizing antibodies against SARS-CoV-2 variants induced by natural infection or vaccination: a systematic review and pooled meta-analysis Xinhua Chen, Zhiyuan Chen, Andrew S Azman, Ruijia Sun, Wanying Lu, Nan Zheng, et al. (+9)
605 [GO] 2021―Jul―21 Effects of treatment of COVID-19 with convalescent plasma in 25 B-cell depleted patients Arvind Gharbharan, Corine H GeurtsvanKessel, Carlijn C E Jordans, Marc Blaauw, Marjolein van der Klift, Robert-Jan Hassing, et al. (+11)
606 [GO] 2021―Jul―20 Prevention of COVID-19 by mRNA-based vaccines within the general population of California Kristin L Andrejko, Jake Pry, Jennifer F Myers, Nicholas P Jewell, John Openshaw, James Watt, et al. (+2)
607 [GO] 2021―Jul―15 The Value of Medical Registries and Observational Studies Early in Pandemics: The COVID-19 Experience Somaya Albhaisi, Richard P Wenzel
608 [GO] 2021―Jul―15 An Update on SARS-CoV-2 Diversity in the United States National Capital Region: Evolution of Novel and Variants of Concern C Paul Morris, Chun Huai Luo, Adannaya Amadi, Matthew Schwartz, Nicholas Gallagher, Stuart C Ray, et al. (+2)
609 [GO] 2021―Jul―14 Clinical improvement, outcomes, antiviral activity, and costs associated with early treatment with remdesivir for patients with COVID-19 Carlos K H Wong, Kristy T K Lau, Ivan C H Au, Xi Xiong, Eric H Y Lau, Benjamin J Cowling
610 [GO] 2021―Jul―14 Candidemia and Severe COVID-19 - Which Risk Factors are Modifiable? Todd McCarty
611 [GO] 2021―Jul―13 Deliberation, Dissent, and Distrust: Understanding distinct drivers of COVID-19 vaccine hesitancy in the United States Khai Hoan Tram, Sahar Saeed, Cory Bradley, Branson Fox, Ingrid Eshun-Wilson, Aaloke Mody, Elvin Geng
612 [GO] 2021―Jul―13 Evaluating Vaccine Efficacy Against SARS-CoV-2 Infection Dan-Yu Lin, Yu Gu, Donglin Zeng, Holly E Janes, Peter B Gilbert
613 [GO] 2021―Jul―09 Sequential Dengue and Covid-19. A case of viral Dr. Jekyll or Mr. Hyde? Jaime R Torres
614 [GO] 2021―Jul―08 Fecal SARS-CoV-2 RNA is associated with decreased COVID-19 survival Upasana Das Adhikari, George Eng, Mara Farcasanu, Laura E Avena, Manish C Choudhary, Virginia A Triant, et al. (+18)
615 [GO] 2021―Jul―08 SARS-CoV-2 cumulative incidence, United States, August-December 2020 Patrick Sean Sullivan, Aaron J Siegler, Kayoko Shioda, Eric W Hall, Heather Bradley, Travis Sanchez, et al. (+7)
616 [GO] 2021―Jul―08 Single-dose mRNA vaccine effectiveness against SARS-CoV-2, including Alpha and Gamma variants: a test-negative design in adults 70 years and older in British Columbia, Canada Danuta M Skowronski, Solmaz Setayeshgar, Macy Zou, Natalie Prystajecky, John R Tyson, Eleni Galanis, et al. (+9)
617 [GO] 2021―Jul―07 COVID-19 Outbreak Associated with a SARS-CoV-2 P.1 Lineage in a Long-Term Care Home after Implementation of a Vaccination Program - Ontario, April-May 2021 Chantal Williams, Dana Al-Bargash, Celeste Macalintal, Rebecca Stuart, Anu Seth, Julienne Latham, et al. (+9)
618 [GO] 2021―Jul―02 Long-Term Persistence of Spike Antibody and Predictive Modeling of Antibody Dynamics Following Infection with SARS-CoV-2 Louis Grandjean, Anja Saso, Arturo Torres Ortiz, Tanya Lam, James Hatcher, Rosie Thistlethwayte, et al. (+11)
619 [GO] 2021―Jul―01 Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study Jessica Seeßle, Tim Waterboer, Theresa Hippchen, Julia Simon, Marietta Kirchner, Adeline Lim, et al. (+2)
620 [GO] 2021―Jul―01 An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status Sheila F Lumley, Gillian Rodger, Bede Constantinides, Nicholas Sanderson, Kevin K Chau, Teresa L Street, et al. (+31)
621 [GO] 2021―Jun―29 Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study Issaka Sagara, John Woodford, Mamady Kone, Mahamadoun Hamady Assadou, Abdoulaye Katile, Oumar Attaher, et al. (+12)
622 [GO] 2021―Jun―26 Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection Anna Berbenyuk, Polina Bobkova, Semyon Bordyugov, Aleksandra Borisenko, Ekaterina Bugaiskaya, Olesya Druzhkova, et al. (+29)
623 [GO] 2021―Jun―25 Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials Yuani M Roman, Paula Alejandra Burela, Vinay Pasupuleti, Alejandro Piscoya, Jose E Vidal, Adrian V Hernandez
624 [GO] 2021―Jun―25 Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting Andreas Walker, Torsten Houwaart, Patrick Finzer, Lutz Ehlkes, Alona Tyshaieva, Maximilian Damagnez, et al. (+19)
625 [GO] 2021―Jun―25 Extensive SARS-CoV-2 transmission associated with low mortality in Kinshasa, Democratic Republic of Congo. For how long? Robert Colebunders, Chris Kenyon
626 [GO] 2021―Jun―23 Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State Abbye E McEwen, Seth Cohen, Chloe Bryson-Cahn, Catherine Liu, Steven A Pergam, John Lynch, et al. (+15)
627 [GO] 2021―Jun―22 Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience John Paul Verderese, Maria Stepanova, Brian Lam, Andrei Racila, Andrej Kolacevski, David Allen, et al. (+12)
628 [GO] 2021―Jun―22 Chronic asymptomatic SARS-CoV-2 infection in the immunocompromised patient: new challenges and urgent needs Lorenzo Lodi, Maria Moriondo, Alessandra Pucci, Laura Pisano, Silvia Ricci, Giuseppe Indolfi, Chiara Azzari
629 [GO] 2021―Jun―22 Poor Antibody Response after Two Doses of SARS-CoV-2 vaccine in Transplant Recipients Alessandra Mazzola, Eve Todesco, Sarah Drouin, Fanny Hazan, Stéphane Marot, Dominique Thabut, et al. (+5)
630 [GO] 2021―Jun―21 Comprehensive evaluation of the impact of sociodemographic inequalities on adverse outcomes and excess mortality during the COVID-19 pandemic in Mexico City Neftali Eduardo Antonio-Villa, Luisa Fernandez-Chirino, Julio Pisanty-Alatorre, Javier Mancilla-Galindo, Ashuin Kammar-García, Arsenio Vargas-Vázquez, et al. (+10)
631 [GO] 2021―Jun―21 Strong SARS-CoV-2-neutralizing antibody response of previously-infected healthcare workers given one dose of mRNA vaccine Chloé Dimeglio, Fabrice Herin, Isabelle Da-Silva, Marion Porcheron, Guillaume Martin-Blondel, Marcel Miedougé, Jacques Izopet
632 [GO] 2021―Jun―17 The landscape of candidemia during the COVID-19 pandemic Emma E Seagle, Brendan R Jackson, Shawn R Lockhart, Ourania Georgacopoulos, Natalie S Nunnally, Jeremy Roland, et al. (+14)
633 [GO] 2021―Jun―17 The Risk of SARS-CoV-2 Transmission from Patients with Undiagnosed Covid-19 to Roommates in a Large Academic Medical Center Abraar Karan, Michael Klompas, Robert Tucker, Meghan Baker, Vineeta Vaidya, Chanu Rhee
634 [GO] 2021―Jun―17 Children and SARS-CoV-2 transmission: a step closer to better understanding and evidence-based interventions? Danilo Buonsenso, Piero Valentini
635 [GO] 2021―Jun―16 Post-vaccination SARS-CoV-2 infections and incidence of presumptive B.1.427/B.1.429 variant among healthcare personnel at a northern California academic medical center Karen B Jacobson, Benjamin A Pinsky, Maria E Montez Rath, Hannah Wang, Jacob A Miller, Mehdi Skhiri, et al. (+6)
636 [GO] 2021―Jun―15 The risk of symptomatic infection during a second COVID-19 wave, in SARS-CoV-2 seropositive individuals Mattia Manica, Serena Pancheri, Piero Poletti, Giulia Giovanazzi, Giorgio Guzzetta, Filippo Trentini, et al. (+6)
637 [GO] 2021―Jun―14 Humoral and cellular immune responses against SARS-CoV-2 variants and human coronaviruses after single BNT162b2 vaccination Metodi V Stankov, Anne Cossmann, Agnes Bonifacius, Alexandra Dopfer-Jablonka, Gema Morillas Ramos, Nina Gödecke, et al. (+15)
638 [GO] 2021―Jun―10 The SARS-CoV-2 mRNA vaccine breakthrough infection phenotype includes significant symptoms, live virus shedding, and viral genetic diversity Simon D Pollett, Stephanie A Richard, Anthony C Fries, Mark P Simons, Katrin Mende, Tahaniyat Lalani, et al. (+15)
639 [GO] 2021―Jun―08 The Effect of Neutropenia and Filgrastim (G-CSF) in Cancer Patients With COVID-19 Infection Allen W Zhang, Sejal Morjaria, Anna Kaltsas, Tobias M Hohl, Rekha Parameswaran, Dhruvkumar Patel, et al. (+7)
640 [GO] 2021―Jun―08 Universal Use of N95s in Healthcare Settings when Community Covid-19 Rates are High Michael Klompas, Chanu Rhee, Meghan Baker
641 [GO] 2021―Jun―08 Improved survival among hospitalized patients with COVID-19 treated with remdesivir and dexamethasone. A nationwide population-based cohort study Thomas Benfield, Jacob Bodilsen, Christian Brieghel, Zitta Barrella Harboe, Marie Helleberg, Claire Holm, et al. (+25)
642 [GO] 2021―Jun―08 Use of U.S. Blood Donors for National Serosurveillance of SARS-CoV-2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program Mars Stone, Clara Di Germanio, David J Wright, Hasan Sulaeman, Honey Dave, Rebecca V Fink, et al. (+13)
643 [GO] 2021―Jun―04 High prevalence of anti-SARS-CoV-2 antibodies after the first wave of COVID-19 in Kinshasa, Democratic Republic of the Congo: results of a cross-sectional household-based survey Antoine N Nkuba, Sheila M Makiala, Emilande Guichet, Paul M Tshiminyi, Yannick M Bazitama, Marc K Yambayamba, et al. (+17)
644 [GO] 2021―Jun―04 Mathematical modeling to inform vaccination strategies and testing approaches for COVID-19 in nursing homes Rebecca Kahn, Inga Holmdahl, Sujan Reddy, John Jernigan, Michael J Mina, Rachel B Slayton
645 [GO] 2021―Jun―04 Reporting of Infectious Diseases in the United States During the COVID-19 Pandemic Matthew A Crane, Aleksandra Popovic, Rohan Panaparambil, Andrew I Stolbach, John A Romley, Khalil G Ghanem
646 [GO] 2021―Jun―03 Early Monoclonal Antibody Administration Can Reduce Both Hospitalizations and Mortality in High-Risk Outpatients with COVID-19 Jeffrey D Jenks, Saima Aslam, Lucy E Horton, Nancy Law, Ajay Bharti, Cathy Logan, et al. (+3)
647 [GO] 2021―Jun―03 Adverse Outcomes Associated with SARS-CoV-2 variant B.1.351 Infection in Vaccinated Residents of a Long Term Care Home, Ontario, Canada Ahmed Vanker, Allison McGeer, Gray O’Byrne, Ellen C R Snyder, David A Salisbury, Jennifer L Guthrie, et al. (+3)
648 [GO] 2021―Jun―03 Incidence and Characteristics of Delayed Injection Site Reaction to the mRNA-1273 SARS-CoV2 Vaccine (Moderna) in a Cohort of Hospital Employees Mark A Jacobson, Adam Zakaria, Zaw Maung, Colin Hart, Tim McCalmont, Marlys Fassett, Erin Amerson
649 [GO] 2021―Jun―02 The potential declining efficacy of the ChAdOx1 nCoV-19 vaccine(AZD1222) on inoculators with NSAIDs intake Hsin-Fu Yeh
650 [GO] 2021―May―29 Coronavirus disease 2019 (COVID-19) Versus Influenza in Hospitalized Adult Patients in the United States: Differences in Demographic and Severity Indicators H Keipp Talbot, Emily T Martin, Manjusha Gaglani, Donald B Middleton, Shekhar Ghamande, Fernanda P Silveira, et al. (+46)
651 [GO] 2021―May―27 Neutralization heterogeneity of United Kingdom and South-African SARS-CoV-2 variants in BNT162b2-vaccinated or convalescent COVID-19 healthcare workers Stéphane Marot, Isabelle Malet, Valentin Leducq, Basma Abdi, Elisa Teyssou, Cathia Soulie, et al. (+9)
652 [GO] 2021―May―27 Provider Satisfaction with Infectious Diseases Telemedicine Consults for Hospitalized Patients During the COVID-19 Pandemic Joseph E Canterino, Kaicheng Wang, Marjorie Golden
653 [GO] 2021―May―27 Outpatient Treatment of SARS-CoV-2 Infection to Prevent COVID-19 Progression Myron S Cohen, David A Wohl, William A Fischer, David J Smith, Joseph J Eron
654 [GO] 2021―May―26 Risk Factors for Death Among the First 80 543 COVID-19 Cases in China: Relationships Between Age, Underlying Disease, Case Severity, and Region Yanping Zhang, Wei Luo, Qun Li, Xijie Wang, Jin Chen, Qinfeng Song, et al. (+27)
655 [GO] 2021―May―25 Risk of reinfection after seroconversion to SARS-CoV-2: A population-based propensity-score matched cohort study Antonio Leidi, Flora Koegler, Roxane Dumont, Richard Dubos, María-Eugenia Zaballa, Giovanni Piumatti, et al. (+10)
656 [GO] 2021―May―24 Disparities in COVID-19 outcomes for African Americans: more studies are warranted Shiva Mehravaran, Hussien Ahmed, Yun-Chi Chen
657 [GO] 2021―May―24 Serial intervals and case isolation delays for COVID-19: a systematic review and meta-analysis Sheikh Taslim Ali, Amy Yeung, Songwei Shan, Lin Wang, Huizhi Gao, Zhanwei Du, et al. (+4)
658 [GO] 2021―May―05 Risk Factors For Infection And Health Impacts Of The Covid-19 Pandemic In People With Autoimmune Diseases Kathryn C Fitzgerald, Christopher A Mecoli, Morgan Douglas, Samantha Harris, Berna Aravidis, Jemima Albayda, et al. (+28)
659 [GO] 2021―May―05 Role of epithelial-endothelial cell interaction in the pathogenesis of SARS-CoV-2 infection Kenrie Pui-Yan Hui, Man-Chun Cheung, Ka-Ling Lai, Ka-Chun Ng, John Chi-Wang Ho, Malik Peiris, et al. (+2)
660 [GO] 2021―May―04 Interacting Epidemics in Amazonian Brazil: Prior Dengue Infection Associated with Increased COVID-19 Risk in a Population-Based Cohort Study Vanessa C Nicolete, Priscila T Rodrigues, Igor C Johansen, Rodrigo M Corder, Juliana Tonini, Marly A Cardoso, et al. (+6)
661 [GO] 2021―May―04 Combination therapy with tocilizumab and dexamethasone cost-effectively reduces Coronavirus disease 2019 mortality Pranay Sinha, Benjamin P Linas
662 [GO] 2021―Apr―27 Pre-market development times for innovative vaccines - to what extent are the COVID-19 vaccines outliers? Reed F Beall, Aaron S Kesselheim, Aidan Hollis
663 [GO] 2021―Apr―23 Re-infection with SARS-CoV-2 in Patients Undergoing Serial Laboratory Testing Adnan I Qureshi, William I Baskett, Wei Huang, Iryna Lobanova, S Hasan Naqvi, Chi-Ren Shyu
664 [GO] 2021―Apr―23 Substantial decline in invasive pneumococcal disease (IPD) during COVID-19 pandemic in Hong Kong Jade L L Teng, Kenny M N Fok, Ken P K Lin, Elaine Chan, Yuanchao Ma, Susanna K P Lau, Patrick C Y Woo
665 [GO] 2021―Apr―23 SARS-CoV-2 Sequence Characteristics of COVID-19 Persistence and Reinfection Manish C Choudhary, Charles R Crain, Xueting Qiu, William Hanage, Jonathan Z Li
666 [GO] 2021―Apr―23 Vaccinated and convalescent donor-derived SARS-CoV-2-specific T cells as adoptive immunotherapy for high-risk COVID-19 patients Penelope-Georgia Papayanni, Dimitrios Chasiotis, Kiriakos Koukoulias, Aphrodite Georgakopoulou, Anastasia Iatrou, Eleni Gavriilaki, et al. (+15)
667 [GO] 2021―Apr―23 Household exposure to SARS-CoV-2 and association with COVID-19 severity: a Danish nationwide cohort study Marcella M Broccia, Victoria Elizabeth V E, de Knegt, Elisabeth Helen Anna E H A, Mills, Amalie Lykkemark A L Møller, et al. (+17)
668 [GO] 2021―Apr―23 Effectiveness of mRNA COVID-19 vaccines against SARS-CoV-2 infection in a cohort of healthcare personnel Melanie D Swift, Laura E Breeher, Aaron J Tande, Christopher P Tommaso, Caitlin M Hainy, Haitao Chu, et al. (+3)
669 [GO] 2021―Apr―23 Disease severity and durability of the SARS-CoV-2 antibody response: A view through the lens of the second year of the pandemic Liise-anne Pirofski
670 [GO] 2021―Apr―22 Assess Ventilation When Determining Safe Distancing in Schools to Control COVID-19 Transmission Richard M Lynch, Elissa Favata, Michael Gochfeld
671 [GO] 2021―Apr―16 SARS-CoV-2 transmission in a Georgia school district - United States, December 2020-January 2021 Jenna R Gettings, Jeremy A W Gold, Anne Kimball, Kaitlin Forsberg, Colleen Scott, Anna Uehara, et al. (+44)
672 [GO] 2021―Apr―07 Ultra-sensitive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection for the Diagnosis of Coronavirus Disease 2019 (COVID-19) in Upper Respiratory Samples Hannah Wang, Catherine A Hogan, Michelle Verghese, Daniel Solis, Mamdouh Sibai, ChunHong Huang, et al. (+3)
673 [GO] 2021―Mar―30 Estimation of secondary household attack rates for emergent spike L452R SARS-CoV-2 variants detected by genomic surveillance at a community-based testing site in San Francisco James Peng, Jamin Liu, Sabrina A Mann, Anthea M Mitchell, Matthew T Laurie, Sara Sunshine, et al. (+23)
674 [GO] 2021―Mar―29 Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) among Health Care Workers-Zambia, July 2020 Sombo Fwoloshi, Jonas Z Hines, Danielle T Barradas, Samuel Yingst, Mpanji Siwingwa, Lameck Chirwa, et al. (+23)
675 [GO] 2021―Mar―24 Assessing asymptomatic, pre-symptomatic and symptomatic transmission risk of SARS-CoV-2 Peng Wu, Fengfeng Liu, Zhaorui Chang, Yun Lin, Minrui Ren, Canjun Zheng, et al. (+16)
676 [GO] 2021―Mar―24 Associations between measures of social distancing and SARS-CoV-2 seropositivity: a nationwide population-based study in the Netherlands Eric R A Vos, Michiel van Boven, Gerco den Hartog, Jantien A Backer, Don Klinkenberg, Cheyenne C E van Hagen, et al. (+5)
677 [GO] 2021―Mar―23 The essential role of DSMBs in ensuring the ethics of global vaccine trials to address COVID-19 Lisa Eckstein, Annette Rid, Dorcas Kamuya, Seema K Shah
678 [GO] 2021―Mar―19 Corrigendum to: A Case of 2019 Novel Coronavirus in a Pregnant Woman With Preterm Delivery
679 [GO] 2021―Mar―17 Changing Epidemiology of Respiratory Syncytial Virus in Australia - delayed re-emergence in Victoria compared to WA/NSW after prolonged lock-down for COVID-19 Sarah McNab, Lien Anh Ha Do, Vanessa Clifford, Nigel W Crawford, Andrew Daley, Kim Mulholland, et al. (+5)
680 [GO] 2021―Mar―16 National Changes in Outpatient Systemic Antibiotic Use During the Coronavirus Disease 2019 Pandemic in Australia Janet K Sluggett, Yen H Dinh, Steven L Wesselingh, Maria C Inacio, Gillian E Caughey
681 [GO] 2021―Mar―16 Antibody Dynamics, Seroreversion, and Persistence After SARS-CoV-2: Another Answer Gregory A Poland
682 [GO] 2021―Mar―12 Reinfection Rates among Patients who Previously Tested Positive for COVID-19: a Retrospective Cohort Study Megan M Sheehan, Anita J Reddy, Michael B Rothberg
683 [GO] 2021―Mar―10 Transmission of SARS-CoV-2 infection among children in summer schools applying stringent control measures in Barcelona, Spain Iolanda Jordan, Mariona Fernandez de Sevilla, Victoria Fumado, Quique Bassat, Elisenda Bonet-Carne, Claudia Fortuny, et al. (+29)
684 [GO] 2021―Mar―09 Effectiveness of three versus six feet of physical distancing for controlling spread of COVID-19 among primary and secondary students and staff: A retrospective, state-wide cohort study Polly van den Berg, Elissa M Schechter-Perkins, Rebecca S Jack, Isabella Epshtein, Richard Nelson, Emily Oster, Westyn Branch-Elliman
685 [GO] 2021―Mar―09 Impact of the COVID-19 Vaccine on Asymptomatic Infection Among Patients Undergoing Pre-Procedural COVID-19 Molecular Screening Aaron J Tande, Benjamin D Pollock, Nilay D Shah, Gianrico Farrugia, Abinash Virk, Melanie Swift, et al. (+3)
686 [GO] 2021―Mar―09 Trends in Prescribing of Antibiotics and Drugs Investigated for COVID-19 Treatment in U.S. Nursing Home Residents During the COVID-19 Pandemic Katryna A Gouin, Stephen Creasy, Mary Beckerson, Martha Wdowicki, Lauri A Hicks, Jennifer N Lind, et al. (+3)
687 [GO] 2021―Mar―09 Evaluating the Long-Term Efficacy of COVID-19 Vaccines Dan-Yu Lin, Donglin Zeng, Peter B Gilbert
688 [GO] 2021―Mar―09 Transmission of SARS-CoV-2 from asymptomatic and presymptomatic individuals in healthcare settings despite medical masks and eye protection Michael Klompas, Meghan A Baker, Diane Griesbach, Robert Tucker, Glen R Gallagher, Andrew S Lang, et al. (+5)
689 [GO] 2021―Mar―09 Household SARS-CoV-2 transmission and children: a network prospective study Antoni Soriano-Arandes, Anna Gatell, Pepe Serrano, Mireia Biosca, Ferran Campillo, Ramon Capdevila, et al. (+111)
690 [GO] 2021―Mar―08 COVID-19 Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients Nitipong Permpalung, Teresa Po-Yu Chiang, Allan B Massie, Sean X Zhang, Robin K Avery, Saman Nematollahi, et al. (+3)
691 [GO] 2021―Mar―08 SARS-CoV-2 Episode 2? A sequel nobody wants to see Anne Piantadosi
692 [GO] 2021―Feb―23 Reduced Vitamin K Status and Coronavirus Disease 2019: An Epiphenomenon of Impaired Kidney Function? Dion Groothof, Adrian Post, Reinold O B Gans, Stephan J L Bakker
693 [GO] 2021―Feb―23 Difference in SARS-CoV-2 attack rate between children and adults may reflect bias Zoë Hyde
694 [GO] 2021―Feb―15 Plasma metabolomic profiling of patients recovered from COVID-19 with pulmonary sequelae 3 months after discharge Juanjuan Xu, Mei Zhou, Ping Luo, Zhengrong Yin, Sufei Wang, Tingting Liao, et al. (+8)
695 [GO] 2021―Feb―11 Indirect HIV morbidity and mortality due to COVID-19 Natasha Bell, Margherita Bracchi, Alessia Dalla Pria, Mark Nelson, Marta Boffito
696 [GO] 2021―Feb―10 Severe reinfection with South African SARS-CoV-2 variant 501Y.V2: A case report Noémie Zucman, Fabrice Uhel, Diane Descamps, Damien Roux, Jean-Damien Ricard
697 [GO] 2021―Feb―04 The Impact of State Mask-Wearing Requirements on the Growth of COVID-19 Cases in the United States Peter F Rebeiro, David M Aronoff, M Kevin Smith
698 [GO] 2021―Feb―03 Thrombosis and COVID-19: Controversies and (Tentative) Conclusions Jean M Connors, Toshiaki Iba, Rajesh T Gandhi
699 [GO] 2021―Feb―03 Understanding Drivers of COVID-19 Vaccine Hesitancy Among Blacks Florence Momplaisir, Norrisa Haynes, Hervette Nkwihoreze, Maria Nelson, Rachel M Werner, John Jemmott
700 [GO] 2021―Feb―03 SARS-CoV-2 setting-specific transmission rates: a systematic review and meta-analysis Hayley A Thompson, Andria Mousa, Amy Dighe, Han Fu, Alberto Arnedo-Pena, Peter Barrett, et al. (+18)
701 [GO] 2021―Jan―28 The Olympiad of SARS-CoV-2 vaccinology: Fundamentals to Complement Technical Frontiers Robert L Gottlieb, Cedric W Spak
702 [GO] 2021―Jan―27 The impact of vaccination on COVID-19 outbreaks in the United States Seyed M Moghadas, Thomas N Vilches, Kevin Zhang, Chad R Wells, Affan Shoukat, Burton H Singer, et al. (+5)
703 [GO] 2021―Jan―27 COVID-19 symptoms and SARS-CoV-2 antibody positivity in a large survey of first responders and healthcare personnel, May-July 2020 Lara J Akinbami, Lyle R Petersen, Samira Sami, Nga Vuong, Susan L Lukacs, Lisa Mackey, et al. (+2)
704 [GO] 2021―Jan―25 Antioxidant therapy in COVID-19: The crucial role of early treatment and antioxidant typology Domenico Lapenna
705 [GO] 2021―Jan―25 Intractable COVID-19 and Prolonged SARS-CoV-2 Replication in a CAR-T-cell Therapy Recipient: A Case Study Matthew K Hensley, William G Bain, Jana Jacobs, Sham Nambulli, Urvi Parikh, Anthony Cillo, et al. (+27)
706 [GO] 2021―Jan―17 Evaluation of SARS-CoV-2 transmission mitigation strategies on a university campus using an agent-based network model Ravi Goyal, John Hotchkiss, Robert T Schooley, Victor De Gruttola, Natasha K Martin
707 [GO] 2021―Jan―15 Population-based Estimates of COVID-19-like Illness, COVID-19 Illness, and Rates of Case Ascertainment, Hospitalizations, and Deaths - Non-Institutionalized New York City Residents, March-April 2020 Karen A Alroy, Aldo Crossa, Christine Dominianni, Jessica Sell, Katherine Bartley, Michael Sanderson, et al. (+10)
708 [GO] 2021―Jan―15 Airborne Transmission of SARS-CoV-2: What We Know Jonathan M Samet, Kimberly Prather, Georges Benjamin, Seema Lakdawala, John-Martin Lowe, Arthur Reingold, et al. (+2)
709 [GO] 2021―Jan―02 Prospective Longitudinal Serosurvey of Health Care Workers in the First Wave of the SARS-CoV-2 Pandemic in a Quaternary Care Hospital in Munich, Germany Tobias Weinberger, Julius Steffen, Andreas Osterman, Tonina T Mueller, Maximilian Muenchhoff, Paul R Wratil, et al. (+9)
710 [GO] 2021―Jan―01 SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses Andrea Pilotto, Stefano Masciocchi, Irene Volonghi, Valeria De Giuli, Francesca Caprioli, Sara Mariotto, et al. (+18)
711 [GO] 2021―Jan―01 SARS-CoV-2 immunity and reinfection Jennifer Dan, Sanjay Mehta
712 [GO] 2020―Dec―21 Suppression of SARS-CoV-2 after a second wave in Victoria, Australia Michelle L Giles, Euan M Wallace, Charles Alpren, Nicole Brady, Simon Crouch, Finn Romanes, et al. (+2)
713 [GO] 2020―Dec―18 Impact of Sex and Metabolic Comorbidities on COVID-19 Mortality Risk Across Age Groups: 66,646 Inpatients Across 613 U.S. Hospitals Katherine E Goodman, Laurence S Magder, Jonathan D Baghdadi, Lisa Pineles, Andrea R Levine, Eli N Perencevich, Anthony D Harris
714 [GO] 2020―Dec―18 Reinfection with SARS-CoV-2: Implications for Vaccines Jeffrey I Cohen, Peter D Burbelo
715 [GO] 2020―Dec―15 HIV care models during the COVID-19 era Giovanni Guaraldi, Jovana Milic, Esteban Martinez, Adeeba Kamarulzaman, Cristina Mussini, Laura Waters, et al. (+4)
716 [GO] 2020―Dec―15 A tale of two studies: Study design and our understanding of SARS-CoV-2 seroprevalence Ross M Boyce, Bonnie E Shook-Sa, Allison E Aiello
717 [GO] 2020―Dec―10 Differential household attack rates mirror the ability to control Covid-19 Alex R Cook, Borame L Dickens, Annelies Wilder-Smith
718 [GO] 2020―Dec―10 Compiling Observational Research During a Pandemic: A Necessary Bridge Rebekah W Moehring, Thomas L Holland
719 [GO] 2020―Dec―08 Paradoxes and uncertainties of immunomodulatory treatments in the fight against COVID-19 Laurent Kaiser, Diem-Lan Vu-Cantero, Christiane S Eberhardt
720 [GO] 2020―Dec―05 Co-infection, SARS-CoV-2 and influenza: an evolving puzzle Sara Covin, George W Rutherford
721 [GO] 2020―Dec―02 Viral cultures for COVID-19 infectious potential assessment - a systematic review T Jefferson, E A Spencer, J Brassey, C Heneghan
722 [GO] 2020―Dec―02 Effects of human behaviour changes during the COVID-19 pandemic on influenza spread in Hong Kong Nan Zhang, Wei Jia, Hao Lei, Peihua Wang, Pengcheng Zhao, Yong Guo, et al. (+7)
723 [GO] 2020―Dec―02 Determining the infectious potential of individuals with positive RT-PCR SARS-CoV-2 tests Peter Doshi, John H Powers
724 [GO] 2020―Dec―01 Characteristics of Adults aged 18-49 Years without Underlying Conditions Hospitalized with Laboratory-Confirmed COVID-19 in the United States, COVID-NET - March-August 2020 Daniel Owusu, Lindsay Kim, Alissa O’Halloran, Michael Whitaker, Alexandra M Piasecki, Arthur Reingold, et al. (+17)
725 [GO] 2020―Dec―01 Improving surveillance estimates of COVID-19 incidence in the United States Eli S Rosenberg, Heather M Bradley
726 [GO] 2020―Dec―01 Dose-response effects of hydroxychloroquine on prophylaxis against SARS-CoV-2 / COVID-19 infection Fabricio S Neves
727 [GO] 2020―Dec―01 Absence of SARS-CoV-2 neutralizing activity in pre-pandemic sera from individuals with recent seasonal coronavirus infection Daniel Poston, Yiska Weisblum, Helen Wise, Kate Templeton, Sara Jenks, Theodora Hatziioannou, Paul Bieniasz
728 [GO] 2020―Dec―01 Is there an association between SARS-CoV-2 and Streptococcus pneumoniae? Leigh M Howard
729 [GO] 2020―Nov―30 A practical and economic approach for assessing potential SARS-CoV-2 transmission risk in COVID-19 patients John A Lednicky
730 [GO] 2020―Nov―27 COVID-19 infection among people with HIV in New York City: A population-level analysis of linked surveillance data Sarah L Braunstein, Rachael Lazar, Amanda Wahnich, Demetre C Daskalakis, Oni J Blackstock
731 [GO] 2020―Nov―26 The COVID-19 Pan-Syndemic - will we ever learn? Srivatsan Padmanabhan
732 [GO] 2020―Nov―23 Estimated incidence of COVID-19 illness and hospitalization - United States, February-September, 2020 Heather Reese, A Danielle Iuliano, Neha N Patel, Shikha Garg, Lindsay Kim, Benjamin J Silk, et al. (+3)
733 [GO] 2020―Nov―20 Comprehensive health assessment three months after recovery from acute COVID-19 Bram van den Borst, Jeannette B Peters, Monique Brink, Yvonne Schoon, Chantal P Bleeker-Rovers, Henk Schers, et al. (+8)
734 [GO] 2020―Nov―19 Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019 Jee-Soo Lee, So Yeon Kim, Taek Soo Kim, Ki Ho Hong, Nam-Hee Ryoo, Jaehyeon Lee, et al. (+15)
735 [GO] 2020―Nov―18 A High Percentage of People with HIV on Antiretroviral Therapy Experience Detectable Low-Level Plasma HIV-1 RNA Following COVID-19 Michael J Peluso, Sonia Bakkour, Michael P Busch, Steven G Deeks, Timothy J Henrich
736 [GO] 2020―Nov―17 SARS-CoV-2 Antibody Testing: Important but Imperfect Jack T Stapleton
737 [GO] 2020―Nov―12 COVID-19 disease spectrum in children - first insights from Africa Ben J Marais
738 [GO] 2020―Nov―10 Establishing a New Normal for Hospital Care: A Whole of Hospital Approach to COVID-19 Brandon X Lum, Eugene H Liu, Sophia Archuleta, Jyoti Somani, Natasha Bagdasarian, Catherine S Koh, et al. (+4)
739 [GO] 2020―Nov―10 Susceptibility to Sars-COV-2 Infection Among Children And Adults: A Seroprevalence Study of Family Households in the Barcelona Metropolitan Region, Spain Pedro Brotons, Cristian Launes, Elena Buetas, Vicky Fumado, Desiree Henares, Mariona Fernandez de Sevilla, et al. (+10)
740 [GO] 2020―Nov―06 Persons with HIV and the COVID-19 Pandemic: A Viral Synergy of Biology and Sociology Lauren F Collins
741 [GO] 2020―Nov―06 Hydroxychloroquine for Prevention of SARS-CoV-2 Infection: challenges to trial conduct during the global pandemic Jason D Goldman
742 [GO] 2020―Nov―04 Prevalence of IgG against SARS-CoV-2 and evaluation of a rapid MEDsan IgG test in children seeking medical care Klara M Posfay-Barbe, Diego O Andrey, Julien Virzi, Patrick Cohen, Fiona Pigny, Ana R Goncalves, et al. (+6)
743 [GO] 2020―Nov―04 The Effect of SARS-CoV-2 Mitigation Strategies on Seasonal Respiratory Viruses: A Tale of Two Large Metropolitan Centers in the United States Amy C Sherman, Ahmed Babiker, Andrew J Sieben, Alexander Pyden, James Steinberg, Colleen S Kraft, et al. (+2)
744 [GO] 2020―Nov―01 Beyond the 405 and the 5: Geographic variations and factors associated with SARS-CoV-2 positivity rates in Los Angeles County Tara Vijayan, Michael Shin, Paul C Adamson, Christina Harris, Teresa Seeman, Keith C Norris, David Goodman-Meza
745 [GO] 2020―Oct―29 Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls Andrea Mastrangelo, Bruno Nicolò Germinario, Marica Ferrante, Claudia Frangi, Raffaele Li Voti, Camilla Muccini, et al. (+37)
746 [GO] 2020―Oct―27 The Low Case Fatality Rate of COVID-19 in Hong Kong Could Be Deceptive Christian HOFFMANN, Eva WOLF
747 [GO] 2020―Oct―27 Response to the COVID-19 pandemic among people experiencing homelessness in congregant living settings in San Diego, CA Hanna Marquez, Christian Ramers, Adam Northrup, Aaron Tam, Jie Liu, Sarah Rojas, et al. (+6)
748 [GO] 2020―Oct―27 Dose-response Relation Deduced for Coronaviruses from COVID-19, SARS and MERS Meta-analysis Results and its Application for Infection Risk Assessment of Aerosol Transmission Xiaole Zhang, Jing Wang
749 [GO] 2020―Oct―27 Unravelling the modes of transmission of SARS-CoV-2 during a nursing home outbreak: looking beyond the church super-spread event Helene A C M Voeten, Reina S Sikkema, Marjolein Damen, Bas B Oude Munnink, Carla Arends, Ellen Stobberingh, et al. (+3)
750 [GO] 2020―Oct―27 Isolation or De-isolation: Measuring the Infectivity of SARS-CoV-2? Hung-Chih Yang
751 [GO] 2020―Oct―23 COVID-19 - Lessons Learned and Questions Remaining Ferric C Fang, Constance A Benson, Carlos del Rio, Kathryn M Edwards, Vance G Fowler, Jr., et al. (+10)
752 [GO] 2020―Oct―23 COVID-19 and preventative medicine for HIV infected children Lorato Anderson, Miguela Caniza
753 [GO] 2020―Oct―23 A concern regarding estimated sensitivities and specificities of nasopharyngeal and saliva specimens for SARS-CoV-2 infection Kentaro Iwata, Kenichi Yoshimura
754 [GO] 2020―Oct―21 Outcomes of COVID-19 related hospitalization among people with HIV in the ISARIC WHO Clinical Characterization Protocol (UK): a prospective observational study Anna Maria Geretti, Alexander J Stockdale, Sophie H Kelly, Muge Cevik, Simon Collins, Laura Waters, et al. (+8)
755 [GO] 2020―Oct―20 Biomarker Research and Development for Coronavirus Disease 2019 (COVID-19): European Medical Research Infrastructures Call for Global Coordination Emanuela Oldoni, Alain van Gool, Laura García Bermejo, Andreas Scherer, Michaela Th Mayrhofer, Francesco Florindi, et al. (+6)
756 [GO] 2020―Oct―20 Specific re-distribution of SARS-CoV-2 variants in the respiratory system and intestinal tract Pengcheng Du, Chuan Song, Rui Li, Yangzi Song, Jiarui Li, Nan Ding, et al. (+12)
757 [GO] 2020―Oct―16 Favipiravir as an antiviral agent in COVID-19: same script, different cast? Nicolas Dauby
758 [GO] 2020―Oct―16 Self-Collected Oral Fluid and Nasal Swab Specimens Demonstrate Comparable Sensitivity to Clinician-Collected Nasopharyngeal Swab Specimens for the Detection of SARS-CoV-2 N Kojima, F Turner, V Slepnev, A Bacelar, L Deming, S Kodeboyina, J D Klausner
759 [GO] 2020―Oct―15 Candida auris: a latent threat to critically ill patients with COVID-19 Jose Y Rodriguez, Patrice Le Pape, Olga Lopez, Kelin Esquea, Anny L Labiosa, Carlos Alvarez-Moreno
760 [GO] 2020―Oct―15 Candidaemia in COVID-19, a link to disease pathology or increased clinical pressures? P Lewis White, Rishi Dhillon, Brendan Healy, Matthew P Wise, Matthijs Backs
761 [GO] 2020―Oct―15 Estimating total excess mortality during a COVID-19 outbreak in Stockholm, Sweden Ville N Pimenoff, Miriam Elfström, Iacopo Baussano, Mikael Björnstedt, Joakim Dillner
762 [GO] 2020―Oct―15 Transmission of SARS-CoV-2 via Contaminated Surfaces: What is to be Done? Craig S Conover
763 [GO] 2020―Oct―15 Hospital transfers across U.S. regions to address the “space” shortage in a pandemic: a public good George L Anesi
764 [GO] 2020―Oct―14 An overlooked role for fecal transmission of SARS-CoV-2? Justin Lessler
765 [GO] 2020―Oct―13 The inherent problems with the generalizability of the CALL score: towards reliable clinical prediction models for COVID-19 Takashi Yoshioka, Satoshi Funada, Yan Luo
766 [GO] 2020―Oct―13 Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial Radha Rajasingham, Ananta S Bangdiwala, Melanie R Nicol, Caleb P Skipper, Katelyn A Pastick, Margaret L Axelrod, et al. (+16)
767 [GO] 2020―Oct―12 Survival analysis of treatment efficacy in comparative COVID-19 studies Zachary R McCaw, Lu Tian, Dae Hyun Kim, A Russell Localio, Lee-Jen Wei
768 [GO] 2020―Oct―12 Longitudinal Profile of Laboratory Parameters and Their Application in the Prediction for Fatal Outcome Among Patients Infected With SARS-CoV-2: A Retrospective Cohort Study Hao-Long Zeng, Qing-Bin Lu, Qing Yang, Xu Wang, Dao-Yuan Yue, Lei-Ke Zhang, et al. (+3)
769 [GO] 2020―Oct―10 Improving Antimicrobial Stewardship in Critically-Ill Patients with COVID-19 Daniel R Stevenson, Manpreet Sahemey, Joaquim Cevallos Morales, Juan Martín-Lázaro, Ruaridh Buchanan, Robert Serafino Wani
770 [GO] 2020―Oct―10 Sewage as a Possible Transmission Vehicle During a Coronavirus Disease 2019 Outbreak in a Densely populated Community: Guangzhou, China, April 2020 Jun Yuan, Zongqiu Chen, Chenghua Gong, Hui Liu, Baisheng Li, Kuibiao Li, et al. (+10)
771 [GO] 2020―Oct―08 The Impact of Social Distancing for SARS-CoV-2 on Respiratory Syncytial Virus and Influenza Burden Kathryn M Edwards
772 [GO] 2020―Oct―07 Learning more about what can make COVID-19 deadly: Insights from the Atlanta Metropolitan Area Brian D McCauley, Juan M Ortega-Legaspi
773 [GO] 2020―Oct―07 Convalescent plasma for patients with severe COVID-19: a matched cohort study Ralph Rogers, Fadi Shehadeh, Evangelia K Mylona, Josiah Rich, Marguerite Neill, Francine Touzard-Romo, et al. (+6)
774 [GO] 2020―Oct―07 Interferon-gamma release assay for accurate detection of SARS-CoV-2 T cell response Kanagavel Murugesan, Prasanna Jagannathan, Tho D Pham, Suchitra Pandey, Hector F Bonilla, Karen Jacobson, et al. (+7)
775 [GO] 2020―Oct―07 Inter-Region Transfers for Pandemic Surges Kenneth A Michelson, Chris A Rees, Jayshree Sarathy, Paige VonAchen, Michael Wornow, Michael C Monuteaux, Mark I Neuman
776 [GO] 2020―Oct―06 StopCOVID cohort: An observational study of 3,480 patients admitted to the Sechenov University hospital network in Moscow city for suspected COVID-19 infection Daniel Munblit, Nikita A Nekliudov, Polina Bugaeva, Oleg Blyuss, Maria Kislova, Ekaterina Listovskaya, et al. (+22)
777 [GO] 2020―Oct―06 Re-infection with SARS-CoV-2: What Goes Around May Come Back Around Arthur Y Kim, Rajesh T Gandhi
778 [GO] 2020―Oct―01 Survival of SARS-CoV-2 and influenza virus on the human skin: Importance of hand hygiene in COVID-19 Ryohei Hirose, Hiroshi Ikegaya, Yuji Naito, Naoto Watanabe, Takuma Yoshida, Risa Bandou, et al. (+3)
779 [GO] 2020―Oct―01 SARS-CoV-2 seroprevalence survey among 17,971 healthcare and administrative personnel at hospitals, pre-hospital services, and specialist practitioners in the Central Denmark Region Sanne Jespersen, Susan Mikkelsen, Thomas Greve, Kathrine Agergård Kaspersen, Martin Tolstrup, Jens Kjærgaard Boldsen, et al. (+8)
780 [GO] 2020―Sep―29 Severe COVID-19 is associated with elevated serum IgA and antiphospholipid IgA-antibodies Omar Hasan Ali, David Bomze, Lorenz Risch, Silvio D Brugger, Matthias Paprotny, Myriam Weber, et al. (+13)
781 [GO] 2020―Sep―28 COVID-19 Disparities: A call for equity in health outcomes and clinical research Benjamin P Linas, Chinazo O Cunningham
782 [GO] 2020―Sep―28 ABO Blood Group Correlations With COVID-19: Cohort Choice Makes A Difference Daniele Focosi, Maria Carla Iorio, Maria Lanza
783 [GO] 2020―Sep―28 The natural history of SARS-CoV-2 infection: a composite but incomplete picture Jaiprasath Sachithanandham, Chloe L Thio, Ashwin Balagopal
784 [GO] 2020―Sep―25 Clinical epidemiology of hospitalized patients with COVID-19 in Japan: Report of the COVID-19 REGISTRY JAPAN Nobuaki Matsunaga, Kayoko Hayakawa, Mari Terada, Hiroshi Ohtsu, Yusuke Asai, Shinya Tsuzuki, et al. (+15)
785 [GO] 2020―Sep―25 Health-care workers with COVID-19 living in Mexico City: clinical characterization and related outcomes Neftali Eduardo Antonio-Villa, Omar Yaxmehen Bello-Chavolla, Arsenio Vargas-Vázquez, Carlos A Fermín-Martínez, Alejandro Márquez-Salinas, Jessica Paola Bahena-López
786 [GO] 2020―Sep―25 Correlation between 3790 qPCR positives samples and positive cell cultures including 1941 SARS-CoV-2 isolates Rita Jaafar, Sarah Aherfi, Nathalie Wurtz, Clio Grimaldier, Van Thuan Hoang, Philippe Colson, et al. (+2)
787 [GO] 2020―Sep―25 Mass screening of asymptomatic persons for SARS-CoV-2 using saliva Isao Yokota, Peter Y Shane, Kazufumi Okada, Yoko Unoki, Yichi Yang, Tasuku Inao, et al. (+7)
788 [GO] 2020―Sep―24 Assessment of the Haemophagocytic lymphohistiocytosis HScore in patients with COVID-19 Kristina E N Clark, William D Nevin, Tabitha Mahungu, Helen Lachmann, Animesh Singh
789 [GO] 2020―Sep―23 Lessons Learned from the Re-emergent COVID-19 Cases in Areas of Long Reported No Community Transmission Yasmine Ibrahim, Akshay Raut, Joseph Varney, Anmol Sidhu, Vinh Dong, Tien Huy Nguyen
790 [GO] 2020―Sep―22 Predictors at admission of mechanical ventilation and death in an observational cohort of adults hospitalized with COVID-19 Brendan R Jackson, Jeremy A W Gold, Pavithra Natarajan, John Rossow, Robyn Neblett Fanfair, Juliana da Silva, et al. (+23)
791 [GO] 2020―Sep―22 Menopause status and COVID-19 Felice Gersh, Carl J Lavie, James H O’Keefe
792 [GO] 2020―Sep―22 Serum antibody profile of a patient with COVID-19 reinfection Kelvin Kai-Wang To, Ivan Fan-Ngai Hung, Kwok-Hung Chan, Shuofeng Yuan, Wing-Kin To, Dominic Ngai-Chong Tsang, et al. (+4)
793 [GO] 2020―Sep―21 Double-blind, randomized, placebo-controlled trial with N-acetylcysteine for treatment of severe acute respiratory syndrome caused by COVID-19 Julio Cesar Garcia de Alencar, Claudia de Lucena Moreira, Alicia Dudy Müller, Cleuber Esteves Chaves, Marina Akemi Fukuhara, Elizabeth Aparecida da Silva, et al. (+10)
794 [GO] 2020―Sep―21 Decreased mortality in COVID-19 patients treated with Tocilizumab: a rapid systematic review and meta-analysis of observational studies Jishnu Malgie, Jan W Schoones, Bart G Pijls
795 [GO] 2020―Sep―21 Asymptomatic reinfection in two healthcare workers from India with genetically distinct SARS-CoV-2 Vivek Gupta, Rahul C Bhoyar, Abhinav Jain, Saurabh Srivastava, Rashmi Upadhayay, Mohamed Imran, et al. (+8)
796 [GO] 2020―Sep―21 SARS-CoV-2 transmission dynamics should inform policy Muge Cevik, Julia L Marcus, Caroline Buckee, Tara C Smith
797 [GO] 2020―Sep―17 The Impact of Sociodemographic Factors, Comorbidities and Physiologic Response on 30-day Mortality in COVID-19 Patients in Metropolitan Detroit Joseph Miller, Raef A Fadel, Amy Tang, Giuseppe Perrotta, Erica Herc, Sandeep Soman, et al. (+6)
798 [GO] 2020―Sep―17 3D Printing in Medicine: COVID-19 Testing with 3D Printed Nasopharyngeal Swabs Frank J Rybicki
799 [GO] 2020―Sep―17 Risk Factors for COVID-19-associated hospitalization: COVID-19-Associated Hospitalization Surveillance Network and Behavioral Risk Factor Surveillance System Jean Y Ko, Melissa L Danielson, Machell Town, Gordana Derado, Kurt J Greenlund, Pam Daily Kirley, et al. (+16)
800 [GO] 2020―Sep―17 Corticosteroid-related in-hospital hyperglycemia: does it negate mortality benefits in COVID-19? Chia Siang Kow, Syed Shahzad Hasan
801 [GO] 2020―Sep―17 A Case of Early Re-infection with SARS-CoV-2 Derek Larson, Sterling L Brodniak, Logan J Voegtly, Regina Z Cer, Lindsay A Glang, Francisco J Malagon, et al. (+6)
802 [GO] 2020―Sep―17 Clinical Impact, Costs, and Cost-Effectiveness of Expanded SARS-CoV-2 Testing in Massachusetts Anne M Neilan, Elena Losina, Audrey C Bangs, Clare Flanagan, Christopher Panella, G Ege Eskibozkurt, et al. (+11)
803 [GO] 2020―Sep―17 Whole-genome sequencing to track SARS-CoV-2 transmission in nosocomial outbreaks Mary Lucey, Guerrino Macori, Niamh Mullane, Una Sutton-Fitzpatrick, Gabriel Gonzalez, Suzie Coughlan, et al. (+4)
804 [GO] 2020―Sep―17 Infant Outcomes Following Maternal Infection with SARS-CoV-2: First Report from the PRIORITY Study Valerie J Flaherman, Yalda Afshar, John Boscardin, Roberta L Keller, Anne Mardy, Mary K Prahl, et al. (+8)
805 [GO] 2020―Sep―16 SARS-CoV-2 spreads to lymph nodes and strongly expands CD4+ TEMRA cells in a patient with mild COVID-19 Ernesto Roldán-Santiago, Amparo Benito-Berlinches, Laura Martínez-García, Carmen Quereda, Eulalia Rodríguez-Martín, Pilar Pérez-Elías, et al. (+8)
806 [GO] 2020―Sep―16 Warp Speed for COVID-19 Vaccines: Why are Children Stuck in Neutral? Evan J Anderson, James D Campbell, C Buddy Creech, Robert Frenck, Satoshi Kamidani, Flor M Munoz, et al. (+2)
807 [GO] 2020―Sep―16 American Politics and the Spread of SARS-CoV-2 Jason H Wasfy
808 [GO] 2020―Sep―16 Carving out a niche for SARS-CoV-2 plasma RNA testing Benjamin A Pinsky, Catherine A Hogan
809 [GO] 2020―Sep―15 Lung ultrasonography for risk stratification in patients with COVID-19: a prospective observational cohort study Thomas Brahier, Jean-Yves Meuwly, Olivier Pantet, Marie-Josée Brochu Vez, Hélène Gerhard Donnet, Mary-Anne Hartley, et al. (+2)
810 [GO] 2020―Sep―13 A Psychological Perspective on the Association between Critical Care Resource Availability and Emotional Wellness during the COVID-19 Pandemic Nadine J Kaslow, DeJuan T White, Sarah C Cook
811 [GO] 2020―Sep―12 Viral genomics to inform infection control response in occupational COVID-19 transmission Naomi C A Whyler, Norelle L Sherry, Courtney R Lane, Torsten Seemann, Patiyan Andersson, Michelle Sait, et al. (+4)
812 [GO] 2020―Sep―12 Saliva is not a useful diagnostic specimen in children with Coronavirus Disease 2019 Chia Yin Chong, Kai-Qian Kam, Jiahui Li, Matthias Maiwald, Liat Hui Loo, Karen Donceras Nadua, et al. (+3)
813 [GO] 2020―Sep―11 Tuberculosis Elimination in the Era of COVID-19: A Moving Target Navisha Dookie, Nesri Padayatchi, Kogieleum Naidoo
814 [GO] 2020―Sep―11 Systematically mapping clinical features of infections with classical endemic human coronaviruses Pengfei Li, Aqsa Ikram, Maikel P Peppelenbosch, Zhongren Ma, Qiuwei Pan
815 [GO] 2020―Sep―11 Kinetics of SARS-CoV-2 Antibody Avidity Maturation and Association with Disease Severity Yiqi Ruben Luo, Indrani Chakraborty, Cassandra Yun, Alan H B Wu, Kara L Lynch
816 [GO] 2020―Sep―10 Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19:Serologic Testing Kimberly E Hanson, Angela M Caliendo, Cesar A Arias, Janet A Englund, Mary K Hayden, Mark J Lee, et al. (+11)
817 [GO] 2020―Sep―09 Structural vulnerability to COVID-19 among Latinx communities in the United States Valeria D Cantos, Paulina A Rebolledo
818 [GO] 2020―Sep―09 Social Disadvantage, Politics, and SARS-CoV-2 Trends: A County-Level Analysis of United States Data Ahmad Mourad, Nicholas A Turner, Arthur W Baker, Nwora Lance Okeke, Shanti Narayanasamy, Robert Rolfe, et al. (+3)
819 [GO] 2020―Sep―08 3D Printed Alternative to the Standard Synthetic Flocked Nasopharyngeal Swabs Used for COVID-19 testing Summer J Decker, Todd A Goldstein, Jonathan M Ford, Michael N Teng, Robert S Pugliese, Gregory J Berry, et al. (+16)
820 [GO] 2020―Sep―07 Detection of SARS-CoV-2 RNA in Blood of Patients with COVID-19: What Does It Mean? Jana L Jacobs, John W Mellors
821 [GO] 2020―Sep―04 COVID-19 and HIV spotlight the U.S. imperative for permanent affordable housing Elise D Riley, Matthew D Hickey, Elizabeth Imbert, Angelo A Clemenzi-Allen, Monica Gandhi
822 [GO] 2020―Sep―04 Common pediatric respiratory infectious diseases may serve as an early predictor for SARS-CoV-2 new wave of infections David Dawei Yang, Naïm Ouldali, Vincent Gajdos, Roxane Thomas-Sertillanges, Loganayagi Vasante, David Skurnik, François Angoulvant
823 [GO] 2020―Sep―04 Reconsidering assumptions of adolescent and young adult SARS-CoV-2 transmission dynamics Vincent Guilamo-Ramos, Adam Benzekri, Marco Thimm-Kaiser, Andrew Hidalgo, David C Perlman
824 [GO] 2020―Sep―02 SARS-CoV-2 RNA in plasma is associated with ICU admission and mortality in patients hospitalized with COVID-19 Christian Prebensen, Peder L My hre, Christine Jonassen, Anbjørg Rangberg, Anita Blomfeldt, My Svensson, et al. (+2)
825 [GO] 2020―Sep―02 Invasive Fungal Disease complicating COVID-19: when it rains it pours Martin Hoenigl
826 [GO] 2020―Sep―01 No One Likes a Stick up Their Nose: Making the Case for Saliva-Based Testing for COVID-19 Farhana Ali, Daniel A Sweeney
827 [GO] 2020―Sep―01 Rapid real-time tracking of non-pharmaceutical interventions and their association with SARS-CoV-2 positivity: The COVID-19 Pandemic Pulse Study Steven J Clipman, Amy P Wesolowski, Dustin G Gibson, Smisha Agarwal, Anastasia S Lambrou, Gregory D Kirk, et al. (+3)
828 [GO] 2020―Sep―01 Healthcare professionals’ perceptions of critical care resource availability and factors associated with mental well-being during COVID-19: Results from a US survey Monisha Sharma, Claire J Creutzfeldt, Ariane Lewis, Pratik V Patel, Christiane Hartog, Gemi E Jannotta, et al. (+6)
829 [GO] 2020―Sep―01 Risk factors for SARS-CoV-2 detection in blood of critically ill patients Niccolò Buetti, Juliette Patrier, Quentin Le Hingrat, Ambre Loiodice, Lila Bouadma, Benoit Visseaux, Jean-François Timsit
830 [GO] 2020―Sep―01 Symptomatic SARS-CoV-2 reinfection by a phylogenetically distinct strain Jan Van Elslande, Pieter Vermeersch, Kris Vandervoort, Tony Wawina-Bokalanga, Bert Vanmechelen, Elke Wollants, et al. (+5)
831 [GO] 2020―Sep―01 SARS-CoV-2 surveillance in decedents in a large, urban medical examiner’s office Andrew F Brouwer, Jeffrey L Myers, Emily T Martin, Kristine E Konopka, Adam S Lauring, Marisa C Eisenberg, et al. (+4)
832 [GO] 2020―Aug―29 COVID-19: First data from Africa W D Francois Venter, Jeremy Nel
833 [GO] 2020―Aug―26 Reduced vitamin K status as a potentially modifiable risk factor of severe COVID-19 Anton S M Dofferhoff, Ianthe Piscaer, Leon J Schurgers, Margot P J Visser, Jody M W van den Ouweland, Pim A de Jong, et al. (+11)
834 [GO] 2020―Aug―24 COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing Kelvin Kai-Wang To, Ivan Fan-Ngai Hung, Jonathan Daniel Ip, Allen Wing-Ho Chu, Wan-Mui Chan, Anthony Raymond Tam, et al. (+14)
835 [GO] 2020―Aug―24 Methylprednisolone for COVID-19: Was Benjamin Rush prescient? Jeffrey L Lennox
836 [GO] 2020―Aug―20 How Do Presenting Symptoms and Outcomes Differ by Race/Ethnicity Among Hospitalized Patients with COVID-19 Infection? Experience in Massachusetts Thomas R McCarty, Kelly E Hathorn, Walker D Redd, Nicolette J Rodriguez, Joyce C Zhou, Ahmad Najdat Bazarbashi, et al. (+6)
837 [GO] 2020―Aug―19 Empiric Antibacterial Therapy and Community-onset Bacterial Co-infection in Patients Hospitalized with COVID-19: A Multi-Hospital Cohort Study Valerie M Vaughn, Tejal Gandhi, Lindsay A Petty, Payal K Patel, Hallie C Prescott, Anurag N Malani, et al. (+4)
838 [GO] 2020―Aug―18 Prevalence of SARS-CoV-2 asymptomatic infections in two large academic health systems in Wisconsin Frida Rivera, Nasia Safdar, Nathan Ledeboer, Grace Schaack, Derrick J Chen, L Silvia Munoz-Price
839 [GO] 2020―Aug―17 The challenge of managing COVID-19 associated pulmonary aspergillosis Roger J Brüggemann, Frank L van de Veerdonk, Paul E Verweij
840 [GO] 2020―Aug―17 Evaluating the Efficacy of Therapies in COVID-19 Patients Dan-Yu Lin, Donglin Zeng, Joseph J Eron
841 [GO] 2020―Aug―14 Insights on COVID-19 epidemiology from a historic cruise ship quarantine Takuya Yamagishi, Yohei Doi
842 [GO] 2020―Aug―13 Baricitinib: Impact on COVID-19 coagulopathy? Sarah C J Jorgensen, Lisa Burry, Christopher L Y Tse, Linda D Dresser
843 [GO] 2020―Aug―13 Response to Correspondence: Baricitinib - Impact on COVID-19 Coagulopathy? Jorgensen et. al. Boghuma K Titanji, Monica M Farley, Raymond F Schinazi, Vincent C Marconi
844 [GO] 2020―Aug―13 Response to Correspondence: Baricitinib as Treatment of COVID-19 Friend or Foe of the Pancreas? Cerda-Contreras et.al Boghuma K Titanji, Monica M Farley, Raymond F Schinazi, Vincent C Marconi
845 [GO] 2020―Aug―13 Baricitinib as treatment for COVID-19: friend or foe of the pancreas? Christopher Cerda-Contreras, Laura Nuzzolo-Shihadeh, Adrián Camacho-Ortiz, Eduardo Perez-Alba
846 [GO] 2020―Aug―13 Potential antigenic cross-reactivity between SARS-CoV-2 and Dengue viruses Yaniv Lustig, Shlomit Keler, Rachel Kolodny, Nir Ben-Tal, Danit Atias-Varon, Ekaterina Shlush, et al. (+6)
847 [GO] 2020―Aug―10 COVID-19, organ transplantation, and the nuances of immunomodulation: lessons learned and what comes next Ghady Haidar
848 [GO] 2020―Aug―10 Gut microbiota and COVID-19: A superfluous diagnostic biomarker or therapeutic target? Emily Klann, Shannan Rich, Volker Mai
849 [GO] 2020―Aug―10 Influenza vaccination: an ally to mitigate influenza-associated risks during the coronavirus pandemics Francisca González-Rubio, Ignatios Ioakeim-Skoufa, Beatriz Poblador-Plou, Antonio Gimeno-Miguel, Alexandra Prados-Torres
850 [GO] 2020―Aug―10 Untangling SARS-CoV-2 epidemic control - lessons from Vietnam Frank G Cobelens, Vanessa C Harris
851 [GO] 2020―Aug―07 COVID-19 and Children: Adding Another Piece to the Puzzle Elizabeth H Ristagno, Kristina A Bryant
852 [GO] 2020―Aug―07 AVIFAVIR for Treatment of Patients with Moderate COVID-19: Interim Results of a Phase II/III Multicenter Randomized Clinical Trial Andrey A Ivashchenko, Kirill A Dmitriev, Natalia V Vostokova, Valeria N Azarova, Andrew A Blinow, Alina N Egorova, et al. (+15)
853 [GO] 2020―Aug―06 What should be the ideal definite COVID-19 case definition? Oguz Resat Sipahi
854 [GO] 2020―Aug―06 Posterior oropharyngeal salivafor the detection of SARS-CoV-2 Marie Pierre Otto, Chrystelle Darles, Elodie Valero, Patrick Benner, Fabien Dutasta, Frédéric Janvier
855 [GO] 2020―Aug―06 Cerebrospinal fluid features in SARS-CoV-2 RT-PCR positive patients Mathilde Bellon, Cecilia Schweblin, Nathalie Lambeng, Pascal Cherpillod, Jessica Vazquez, Patrice H Lalive, et al. (+2)
856 [GO] 2020―Aug―05 Alveolar SARS-CoV-2 viral load is tightly correlated with severity in COVID-19 ARDS Mathieu Blot, Marine Jacquier, Catherine Manoha, Lionel Piroth, Pierre-Emmanuel Charles
857 [GO] 2020―Aug―04 Unique SARS-CoV-2 clusters causing a large COVID-19 outbreak in Hong Kong Kelvin Kai-Wang To, Wan-Mui Chan, Jonathan Daniel Ip, Allen Wing-Ho Chu, Anthony Raymond Tam, Raymond Liu, et al. (+13)
858 [GO] 2020―Aug―04 Evaluation of COVID-19 RT-qPCR tests in multi-sample pools Atul Gang, Jaya Gang
859 [GO] 2020―Aug―03 SARS-CoV-2 viral load in the upper respiratory tract of children and adults with early acute COVID-19 Stéphanie Baggio, Arnaud G L’Huillier, Sabine Yerly, Mathilde Bellon, Noémie Wagner, Marie Rohr, et al. (+6)
860 [GO] 2020―Aug―03 Why contact tracing efforts have failed to curb COVID-19 transmission in much of the U.S Eva Clark, Elizabeth Y Chiao, E Susan Amirian
861 [GO] 2020―Aug―03 Comparing nasopharyngeal swab and early morning saliva for the identification of SARS-CoV-2 Mohan Rao, Fairuz A Rashid, Fashihah S A H Sabri, Nur Nadia Jamil, Rozainanee Zain, Rohaidah Hashim, et al. (+4)
862 [GO] 2020―Jul―31 Coronavirus Disease 2019 (COVID-19) Outbreak in a San Francisco Homeless Shelter Elizabeth Imbert, Patrick M Kinley, Ashley Scarborough, Caroline Cawley, Madeline Sankaran, Sarah N Cox, et al. (+4)
863 [GO] 2020―Jul―31 To Toci or Not to Toci for COVID-19: Is That Still the Question? Guang-Shing Cheng, Joshua A Hill
864 [GO] 2020―Jul―31 The Multidimensional Challenge of Treating COVID-19: Remdesivir is a Foot in the Door Rajesh T Gandhi
865 [GO] 2020―Jul―31 The first 100 days of SARS-CoV-2 control in Vietnam Quang Thai Pham, Maia A Rabaa, Huy Luong Duong, Quang Tan Dang, Dai Quang Tran, Ha-Linh Quach, et al. (+13)
866 [GO] 2020―Jul―31 Longitudinal dynamics of the neutralizing antibody response to SARS-CoV-2 infection Kai Wang, Quan-Xin Long, Hai-Jun Deng, Jie Hu, Qing-Zhu Gao, Gui-Ji Zhang, et al. (+6)
867 [GO] 2020―Jul―24 Infectious Diseases Society of America Guidelines on Infection Prevention for Health Care Personnel Caring for Patients with Suspected or Known COVID-19 John B Lynch, Perica Davitkov, Deverick J Anderson, Adarsh Bhimraj, Vincent Chi-Chung  Cheng, Judith Guzman-Cottrill, et al. (+12)
868 [GO] 2020―Jul―24 Diagnosing SARS-CoV-2 Related Multisystem Inflammatory Syndrome in Children (MIS-C): Focus on the Gastrointestinal Tract and the Myocardium Anne H Rowley
869 [GO] 2020―Jul―22 Remdesivir for Severe COVID-19 versus a Cohort Receiving Standard of Care Susan A Olender, Katherine K Perez, Alan S Go, Bindu Balani, Eboni G Price-Haywood, Nirav S Shah, et al. (+27)
870 [GO] 2020―Jul―20 Potential Influence of Menstrual Status and Sex Hormones on female SARS-CoV-2 Infection: A Cross-sectional Study from Multicentre in Wuhan, China Ting Ding, Jinjin Zhang, Tian Wang, Pengfei Cui, Zhe Chen, Jingjing Jiang, et al. (+11)
871 [GO] 2020―Jul―17 Pan-Family Assays for Rapid Viral Screening: Reducing Delays in Public Health Responses During Pandemics Michael Erlichster, Gursharan Chana, Daniela Zantomio, Benjamin Goudey, Efstratios Skafidas
872 [GO] 2020―Jul―16 Systematic testing for influenza and COVID-19 among patients with respiratory illness Brendan Flannery, Jennifer K Meece, John V Williams, Emily T Martin, Manjusha Gaglani, Michael L Jackson, H Keipp Talbot
873 [GO] 2020―Jul―16 Lessons from Mass-Testing for COVID-19 in Long Term Care Facilities for the Elderly in San Francisco Janice K Louie, Hyman M Scott, Amie DuBois, Natalya Sturtz, Wendy Lu, Juliet Stoltey, et al. (+6)
874 [GO] 2020―Jul―16 Mitigation of a COVID-19 Outbreak in a Nursing Home Through Serial Testing of Residents and Staff Daniel J Escobar, Maria Lanzi, Pouné Saberi, Ruby Love, Darren R Linkin, John J Kelly, et al. (+4)
875 [GO] 2020―Jul―15 Response System for and Epidemiological Features of COVID-19 in Gyeongsangnam-do Province in South Korea Yu Mi Wi, Su Jin Lim, Si-Ho Kim, Seungjin Lim, Su Jin Lee, Byung-Han Ryu, et al. (+6)
876 [GO] 2020―Jul―14 Risk Factors for Intensive Care Unit Admission and In-hospital Mortality among Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET) Lindsay Kim, Shikha Garg, Alissa O’Halloran, Michael Whitaker, Huong Pham, Evan J Anderson, et al. (+20)
877 [GO] 2020―Jul―13 Excess soluble fms-like tyrosine kinase 1 correlates with endothelial dysfunction and organ failure in critically ill COVID-19 patients Vincent Dupont, Lukshe Kanagaratnam, Antoine Goury, Gaël Poitevin, Mathieu Bard, Gauthier Julien, et al. (+5)
878 [GO] 2020―Jul―13 SARS-CoV-2 infects and damages the mature and immature olfactory sensory neurons of hamsters Anna Jinxia Zhang, Andrew Chak-Yiu Lee, Hin Chu, Jasper Fuk-Woo Chan, Zhimeng Fan, Can Li, et al. (+10)
879 [GO] 2020―Jul―10 Tocilizumab for treatment of mechanically ventilated patients with COVID-19 Emily C Somers, Gregory A Eschenauer, Jonathan P Troost, Jonathan L Golob, Tejal N Gandhi, Lu Wang, et al. (+16)
880 [GO] 2020―Jul―08 Personalized therapy approach for hospitalized patients with COVID-19 Carolina Garcia-Vidal, Estela Moreno-García, Marta Hernández-Meneses, Pedro Puerta-Alcalde, Mariana Chumbita, Nicole Garcia-Pouton, et al. (+11)
881 [GO] 2020―Jul―08 The Disproportionate Impact of COVID-19 on Racial and Ethnic Minorities in the United States Julius M Wilder
882 [GO] 2020―Jul―08 Natural transmission of bat-like SARS-CoV-2PRRA variants in COVID-19 patients Yik Chun Wong, Siu Ying Lau, Kelvin Kai Wang To, Bobo Wing Yee Mok, Xin Li, Pui Wang, et al. (+9)
883 [GO] 2020―Jul―08 Development and Validation of a Nomogram for Assessing Survival in Patients with COVID-19 Pneumonia Yi-Min Dong, Jia Sun, Yi-Xin Li, Qian Chen, Qing-Quan Liu, Zhou Sun, et al. (+11)
884 [GO] 2020―Jul―08 The practical challenges of making clinical use of the quantitative value for SARS-CoV-2 viral load across several dynamics Amy J Mathers
885 [GO] 2020―Jul―07 SARS-CoV-2 antibody prevalence in blood in a large school community subject to a Covid-19 outbreak: a cross-sectional study Juan Pablo Torres, Cecilia Piñera, Verónica De La Maza, Anne J Lagomarcino, Daniela Simian, Bárbara Torres, et al. (+3)
886 [GO] 2020―Jul―07 Microbiota and Covid-19. Which came first, the chicken or the egg? Maria Antonietta Marcialis, Flaminia Bardanzellu, Vassilios Fanos
887 [GO] 2020―Jul―07 Risk Factors for Healthcare Personnel Infection with Endemic Coronaviruses (HKU1, OC43, NL63, 229E): Results from the Respiratory Protection Effectiveness Clinical Trial (ResPECT) Derek A T Cummings, Lewis J Radonovich, Geoffrey J Gorse, Charlotte A Gaydos, Mary T Bessesen, Alexandria C Brown, et al. (+10)
888 [GO] 2020―Jul―07 Rapid Emergence of SARS-CoV-2 in the Greater New York Metropolitan Area: Geolocation, Demographics, Positivity Rates, and Hospitalization for 46,793 Persons Tested by Northwell Health Samuel B Reichberg, Partha P Mitra, Aya Haghamad, Girish Ramrattan, James M Crawford, Gregory J Berry, et al. (+7)
889 [GO] 2020―Jul―07 When hospitals Harm: Multi-modal entry of SARS-CoV-2 into inpatient healthcare Scott R Curry, Cassandra D Salgado
890 [GO] 2020―Jul―03 It is Time to Address Airborne Transmission of COVID-19 Lidia Morawska, Donald K Milton
891 [GO] 2020―Jul―03 Simple ‘Rule-of-6’ predicts severe COVID-19 disease Borame Sue Lee Dickens, Jue Tao Lim, Jere Wenn Low, Chun Kiat Lee, Yinxiaohe Sun, Haziq Bin Mohamad Nasir, et al. (+6)
892 [GO] 2020―Jul―02 The role of remdesivir in South Africa: preventing COVID-19 deaths through increasing ICU capacity Brooke E Nichols, Lise Jamieson, Sabrina R C Zhang, Gabriella A Rao, Sheetal Silal, Juliet R C Pulliam, et al. (+2)
893 [GO] 2020―Jul―02 Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for COVID-19 Patients - Nashville, Tennessee William B Stubblefield, H Keipp Talbot, Leora Feldstein, Mark W Tenforde, Mohammed Ata Ur Rasheed, Lisa Mills, et al. (+12)
894 [GO] 2020―Jul―02 Commentary: Rapid Testing of Healthcare Employees for COVID-19: What Can We Learn from the Seattle Experience? Kristina A Bryant, Pam Isaacs
895 [GO] 2020―Jul―02 Evaluating use cases for human challenge trials in accelerating SARS-CoV-2 vaccine development Linh Chi Nguyen, Christopher W Bakerlee, T Greg McKelvey, Sophie M Rose, Alexander J Norman, Nicholas Joseph, et al. (+8)
896 [GO] 2020―Jun―29 Immune modulation in COVID-19: Strategic considerations for personalized therapeutic intervention Mark W Hall, Ila Joshi, Luis Leal, Eng Eong Ooi
897 [GO] 2020―Jun―27 Rapid Reorganization of an Academic Infectious Diseases Program During the COVID-19 Pandemic in Detroit: A Novel Unit-Based Group Rounding Model Amit Vahia, Zohra S Chaudhry, Linda Kaljee, Tommy Parraga-Acosta, Smitha Gudipati, Gina Maki, et al. (+15)
898 [GO] 2020―Jun―27 Community Acquired Co-infection in COVID-19: A Retrospective Observational Experience Christopher J Lehmann, Mai T Pho, David Pitrak, Jessica P Ridgway, Natasha N Pettit
899 [GO] 2020―Jun―27 Impact of SARS-CoV-2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients with Coronavirus Disease 2019 Reed Magleby, Lars F Westblade, Alex Trzebucki, Matthew S Simon, Mangala Rajan, Joel Park, et al. (+3)
900 [GO] 2020―Jun―27 Pneumocystis Jirovecii Pneumonia and SARS-CoV-2 Co-Infection in newly diagnosed HIV-1 infection Sebastian Mang, Dominic Kaddu-Mulindwa, Carlos Metz, André Becker, Frederik Seiler, Sigrun Smola, et al. (+6)
901 [GO] 2020―Jun―25 Early Results from SARS-CoV-2 PCR testing of Healthcare Workers at an Academic Medical Center in New York City Arielle R Nagler, Eric R Goldberg, Maria E Aguero-Rosenfeld, Joan Cangiarella, Gary Kalkut, Carolyn Rooke Monahan, Robert J Cerfolio
902 [GO] 2020―Jun―24 COVID-19 in Immunocompromised Hosts: What We Know So Far Monica Fung,, Jennifer M Babik
903 [GO] 2020―Jun―23 Distribution of Transmission Potential during Non-Severe COVID-19 Illness Nabin K Shrestha, Francisco Marco Canosa, Amy S Nowacki, Gary W Procop, Sherilynn Vogel, Thomas G Fraser, et al. (+3)
904 [GO] 2020―Jun―23 Social distancing alters the clinical course of COVID-19 in young adults: A comparative cohort study Michel Bielecki, Roland Züst, Denise Siegrist, Daniele Meyerhofer, Giovanni Andrea Gerardo Crameri, Zeno Giovanni Stanga, et al. (+3)
905 [GO] 2020―Jun―23 COVID-19 pharmacologic treatments for children: research priorities and approach to pediatric studies Anthony J Garcia-Prats, Nicole Salazar-Austin, James H Conway, Kendra Radtke, Sylvia M LaCourse, Elizabeth Maleche-Obimbo, et al. (+3)
906 [GO] 2020―Jun―23 Investigating the sex differences in COVID-19: Another step forward, but many unanswered questions Philip Yang, Annette M Esper
907 [GO] 2020―Jun―23 Novel coronavirus 2019 transmission risk in educational settings Chee Fu Yung, Kai-qian Kam, Karen Donceras Nadua, Chia Yin Chong, Natalie Woon Hui Tan, Jiahui Li, et al. (+4)
908 [GO] 2020―Jun―23 SARS-CoV-2 infection in healthcare personnel with high-risk occupational exposure: evaluation of seven-day exclusion from work policy Helena C Maltezou, Xanthi Dedoukou, Maria Tseroni, Evi Tsonou, Vasileios Raftopoulos, Kalliopi Papadima, et al. (+5)
909 [GO] 2020―Jun―22 Use of Baricitinib in Patients with Moderate and Severe COVID-19 Boghuma K Titanji, Monica M Farley, Ashish Mehta, Randi Connor-Schuler, Abeer Moanna, Sushma K Cribbs, et al. (+7)
910 [GO] 2020―Jun―22 Covid-19 and People with HIV Infection: Outcomes for Hospitalized Patients in New York City Keith Sigel, Talia Swartz, Eddye Golden, Ishan Paranjpe, Sulaiman Somani, Felix Richter, et al. (+17)
911 [GO] 2020―Jun―22 Drug-induced liver injury in a COVID-19 patient: potential interaction of remdesivir with P-glycoprotein inhibitors Emiel Leegwater, Anne Strik, Erik B Wilms, Liesbeth B E Bosma, David M Burger, Thomas H Ottens, Cees van Nieuwkoop
912 [GO] 2020―Jun―22 Comparing Nasopharyngeal and Mid-Turbinate Nasal Swab Testing for the Identification of SARS-CoV-2 Swetha Pinninti, Connie Trieu, Sunil K Pati, Misty Latting, Joshua Cooper, Maria C Seleme, et al. (+4)
913 [GO] 2020―Jun―19 THE RIGHT TIME FOR STEROIDS IN COVID-19 Ana Fernández Cruz, Belén Ruiz-Antorán, Elena Múñez Rubio, Aránzazu Sancho López, Alejandro Callejas Díaz, Cristina Avendaño-Solá, Antonio Ramos Martínez
914 [GO] 2020―Jun―19 Managing COVID-19 spread with voluntary public-health measures: Sweden as a case study for pandemic control Shina C L Kamerlin, Peter M Kasson
915 [GO] 2020―Jun―19 Asymptomatic transmission and the infection fatality risk for COVID-19: Implications for school reopening Sten H Vermund, Virginia E Pitzer
916 [GO] 2020―Jun―19 Sensitivity of nasopharyngeal swabs and saliva for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Alainna J Jamal, Mohammad Mozafarihashjin, Eric Coomes, Jeff Powis, Angel X Li, Aimee Paterson, et al. (+13)
917 [GO] 2020―Jun―19 Posterior oropharyngeal saliva for the detection of SARS-CoV-2 Sally Cheuk, Ying WONG, Herman TSE, Hon Kei SIU, Tsz Shan KWONG, Man Yee Chu, et al. (+9)
918 [GO] 2020―Jun―19 Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors Christian Erikstrup, Christoffer Egeberg Hother, Ole Birger Vestager Pedersen, Kåre Mølbak, Robert Leo Skov, Dorte Kinggaard Holm, et al. (+16)
919 [GO] 2020―Jun―18 Loss of Taste and Smell as Distinguishing Symptoms of COVID-19 Patrick Dawson, Elizabeth M Rabold, Rebecca L Laws, Erin E Conners, Radhika Gharpure, Sherry Yin, et al. (+9)
920 [GO] 2020―Jun―18 Breastmilk and COVID-19: What Do We Know? David W Kimberlin, Karen M Puopolo
921 [GO] 2020―Jun―17 Social distancing measures: evidence of interruption of seasonal influenza activity and early lessons of the SARS-CoV-2 pandemic Andrew D Wiese, Jordan Everson, Carlos G Grijalva
922 [GO] 2020―Jun―16 High-dose but not low-dose corticosteroids potentially delay viral shedding of patients with COVID-19 Sijia Li, Zhigang Hu, Xinyu Song
923 [GO] 2020―Jun―16 COVID-19 and the RAAS George O A Naik
924 [GO] 2020―Jun―16 The Disproportionate Impact of COVID-19 on Racial and Ethnic Minorities in the United States Don Bambino Geno Tai, Aditya Shah, Chyke A Doubeni, Irene G Sia, Mark L Wieland
925 [GO] 2020―Jun―16 Clinical Presentation and Outcomes of Pregnant Women with COVID-19: A Systematic Review and Meta-Analysis Reem Matar, Layan Alrahmani, Nasser Monzer, Labib G Debiane, Elie Berbari, Jawad Fares, et al. (+2)
926 [GO] 2020―Jun―15 Nosocomial transmission of COVID-19: a retrospective study of 66 hospital-acquired cases in a London teaching hospital Hannah M Rickman, Tommy Rampling, Karen Shaw, Gema Martinez-Garcia, Leila Hail, Pietro Coen, et al. (+4)
927 [GO] 2020―Jun―15 Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia Stanley C Jordan, Phillip Zakowski, Hai P Tran, Ethan A Smith, Cyril Gaultier, Gregory Marks, et al. (+13)
928 [GO] 2020―Jun―13 Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19 Kimberly E Hanson, Angela M Caliendo, Cesar A Arias, Janet A Englund, Mark J Lee, Mark Loeb, et al. (+10)
929 [GO] 2020―Jun―12 Performance of oropharyngeal swab testing compared to nasopharyngeal swab testing for diagnosis of COVID-19 -United States, January-February 2020 Monita R Patel, Darin Carroll, Emily Ussery, Hilary Whitham, Christopher A Elkins, Judith Noble-Wang, et al. (+8)
930 [GO] 2020―Jun―12 Asymptomatic and symptomatic SARS-CoV-2 infections in close contacts of COVID-19 patients: a seroepidemiological study Hong-Jun Zhang, Ying-Ying Su, Shi-Lin Xu, Guo-Qing Chen, Chang-Cheng Li, Ren-Jie Jiang, et al. (+5)
931 [GO] 2020―Jun―08 Contact tracing: Essential to the public health response and our understanding of the epidemiology of COVID-19 Keri N Althoff, Sally B Coburn, Denis Nash
932 [GO] 2020―Jun―07 Pregnancy and Pandemic Disease Karen Palmore Beckerman
933 [GO] 2020―Jun―05 Pandemic Planning in Homeless Shelters: A pilot study of a COVID-19 testing and support program to mitigate the risk of COVID-19 outbreaks in congregate settings Claire Bodkin, Vaibhav Mokashi, Kerry Beal, Jill Wiwcharuk, Robin Lennox, Dale Guenter, et al. (+2)
934 [GO] 2020―Jun―05 COVID-19 : Pacific Islands challenges Simon Poignant, Laure Baudouin, Marc Vinclair, Sandrine Mons
935 [GO] 2020―Jun―05 The Laboratory Diagnosis of COVID-19-- Frequently-Asked Questions Ferric C Fang, Samia N Naccache, Alexander L Greninger
936 [GO] 2020―Jun―04 Can the SARS-CoV-2 PCR Cycle Threshold Value and Time from Symptom Onset to Testing Predict Infectivity? Matthew J Binnicker
937 [GO] 2020―Jun―03 Alterations of the Gut Microbiota in Patients with COVID-19 or H1N1 Influenza Silan Gu, Yanfei Chen, Zhengjie Wu, Yunbo Chen, Hainv Gao, Longxian Lv, et al. (+15)
938 [GO] 2020―Jun―03 Occurrence and Timing of Subsequent SARS-CoV-2 RT-PCR Positivity Among Initially Negative Patients Dustin R Long, Saurabh Gombar, Catherine A Hogan, Alexander L Greninger, Vikas O’Reilly Shah, Chloe Bryson-Cahn, et al. (+9)
939 [GO] 2020―Jun―03 On setting expectations for a SARS-CoV-2 Vaccine David H Canaday, Stefan Gravenstein
940 [GO] 2020―Jun―02 Neutralizing Antibodies Responses to SARS-CoV-2 in COVID-19 Inpatients and Convalescent Patients Xiaoli Wang, Xianghua Guo, Qianqian Xin, Yang Pan, Yaling Hu, Jing Li, et al. (+3)
941 [GO] 2020―Jun―02 COVID-19 pandemic: Impact caused by school closure and national lockdown on pediatric visits and admissions for viral and non-viral infections, a time series analysis François Angoulvant, Naïm Ouldali, David Dawei Yang, Mathilde Filser, Vincent Gajdos, Alexis Rybak, et al. (+7)
942 [GO] 2020―Jun―02 The natural history and transmission potential of asymptomatic SARS-CoV-2 infection Nguyen Van Vinh Chau, Vo Thanh Lam, Nguyen Thanh Dung, Lam Minh Yen, Ngo Ngoc Quang Minh, Le Manh Hung, et al. (+21)
943 [GO] 2020―Jun―02 The Importance of Advancing SARS-CoV-2 Vaccines in Children Carol M Kao, Walter A Orenstein, Evan J Anderson
944 [GO] 2020―May―29 The CALL score for predicting outcomes in patients with COVID-19 Elisa Grifoni, Alice Valoriani, Francesco Cei, Vieri Vannucchi, Federico Moroni, Lorenzo Pelagatti, et al. (+3)
945 [GO] 2020―May―29 Age-dependent gender differences of COVID-19 in mainland China: comparative study Jie Qian, Lin Zhao, Run-Ze Ye, Xiu-Jun Li, Yuan-Li Liu
946 [GO] 2020―May―29 COVID-19 outbreaks in U.S. immigrant detention centers: the urgent need to adopt CDC guidelines for prevention and evaluation John James Openshaw, Mark A Travassos
947 [GO] 2020―May―29 Household COVID-19 Prevalence Emmanuel Mandonnet, Jean-Michel Molina
948 [GO] 2020―May―29 From Easing Lockdowns to Scaling-Up Community-Based COVID-19 Screening, Testing, and Contact Tracing in Africa - Shared Approaches, Innovations, and Challenges to Minimize Morbidity and Mortality Jean B Nachega, Ashraf Grimwood, Hassan Mahomed, Geoffrey Fatti, Wolfgang Preiser, Oscar Kallay, et al. (+13)
949 [GO] 2020―May―29 Diligent medical activities of a publicly designated medical institution for infectious diseases pave the way for overcoming COVID-19: A positive message to people working at the cutting edge Tatsuya Nagano, Jun Arii, Mitsuhiro Nishimura, Naofumi Yoshida, Keiji Iida, Yoshihiro Nishimura, Yasuko Mori
950 [GO] 2020―May―29 Dose Optimization of Hydroxychloroquine for COVID-19: Do Blood Concentrations Matter? Matthew M Ippolito, Charles Flexner
951 [GO] 2020―May―29 COVID-19: Possible reasons for the increased prevalence of Olfactory and Gustatory dysfunction observed in European studies John Gourtsoyannis
952 [GO] 2020―May―29 It’s True Even in a Pandemic: Children are Not Merely Little Adults C Buddy Creech
953 [GO] 2020―May―28 Detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human breast milk of a mildly symptomatic patient with coronavirus disease 2019 (COVID-19) Patrick C K Tam, Kathleen M Ly, Max L Kernich, Nicola Spurrier, Diana Lawrence, David L Gordon, Emily C Tucker
954 [GO] 2020―May―28 Seroconversion rate and diagnostic accuracy of serological tests for COVID-19 Bharathnag Nagappa, Yamini Marimuthu
955 [GO] 2020―May―28 Surgical mask partition reduces the risk of non-contact transmission in a golden Syrian hamster model for Coronavirus Disease 2019 (COVID-19) Jasper Fuk-Woo Chan, Shuofeng Yuan, Anna Jinxia Zhang, Vincent Kwok-Man Poon, Chris Chung-Sing Chan, Andrew Chak-Yiu Lee, et al. (+13)
956 [GO] 2020―May―28 Monitoring COVID-19 through Trends in Influenza-like Illness and Laboratory-confirmed Influenza and COVID-19 - New York State, excluding New York City, January 1 - April 12, 2020 Eli S Rosenberg, Eric W Hall, Elizabeth M Rosenthal, Angela M Maxted, Donna L Gowie, Elizabeth M Dufort, et al. (+5)
957 [GO] 2020―May―28 Predictors for Severe COVID-19 Infection Ashish Bhargava, Elisa Akagi Fukushima, Miriam Levine, Wei Zhao, Farah Tanveer, Susanna M Szpunar, Louis Saravolatz
958 [GO] 2020―May―28 What is the role of SARS-CoV-2 PCR testing in discontinuation of transmission-based precautions for COVID-19 patients? Bahaa Abu Raya, David M Goldfarb, Manish Sadarangani
959 [GO] 2020―May―28 Clinical Outcomes of COVID-19 with Evidence-Based Supportive Care Derek T Larson, John H Sherner, Kia M Gallagher, Cynthia L Judy, Madison B Paul, Alexandra M Mahoney, Peter J Weina
960 [GO] 2020―May―28 Low prevalence of SARS-CoV-2 among pregnant and postpartum patients with universal screening in Seattle, Washington Sylvia M LaCourse, Alisa Kachikis, Michela Blain, LaVone E Simmons, James A Mays, Amber D Pattison, et al. (+25)
961 [GO] 2020―May―28 Towards a better case fatality estimate for SARS-CoV-2 during the early phase of the United States outbreak Jeremy Samuel Faust
962 [GO] 2020―May―28 A Conceptual Discussion about R0 of SARS-COV-2 in Healthcare Settings Laura TEMIME, Marie-Paule GUSTIN, Audrey DUVAL, Niccolò BUETTI, Pascal CRÉPEY, Didier GUILLEMOT, et al. (+5)
963 [GO] 2020―May―28 Maximum Daily Temperature, Precipitation, Ultra-Violet Light and Rates of Transmission of SARS-Cov-2 in the United States Shiv T Sehra, Justin D Salciccioli, Douglas J Wiebe, Shelby Fundin, Joshua F Baker
964 [GO] 2020―May―28 Impact of Public Health Interventions on Seasonal Influenza Activity During the SARS-CoV-2 Outbreak in Korea Hyunju Lee, Heeyoung Lee, Kyoung-Ho Song, Eu Suk Kim, Jeong Su Park, Jongtak Jung, et al. (+4)
965 [GO] 2020―May―27 Hospitalized patients with COVID-19 and HIV: a case series Kate Childs, Frank A Post, Claire Norcross, Zoë Ottaway, Elizabeth Hamlyn, Killian Quinn, et al. (+2)
966 [GO] 2020―May―26 Metatranscriptomic Characterization of COVID-19 Identified A Host Transcriptional Classifier Associated With Immune Signaling Haocheng Zhang, Jing-Wen Ai, Wenjiao Yang, Xian Zhou, Fusheng He, Shumei Xie, et al. (+9)
967 [GO] 2020―May―26 Asymptomatic transmission during the COVID-19 pandemic and implications for public health strategies Hanalise V Huff, Avantika Singh
968 [GO] 2020―May―26 Importance of Pediatric Inclusion in COVID-19 Therapeutic Trials Vanessa N Raabe, Jennifer Lighter, Arthur L Caplan, Adam J Ratner
969 [GO] 2020―May―25 Alterations in smell or taste - Classic COVID-19? Jason A Trubiano, Sara Vogrin, Jason C Kwong, Natasha Homes
970 [GO] 2020―May―25 The Urgent Need for Medicare Reimbursement for Home Infusion Antibiotics amidst a Pandemic Amber C Streifel, Monica K Sikka
971 [GO] 2020―May―22 Prognostic value of C-reactive protein in patients with COVID-19 Xiaomin Luo, Wei Zhou, Xiaojie Yan, Tangxi Guo, Benchao Wang, Hongxia Xia, et al. (+6)
972 [GO] 2020―May―22 Chronological Changes of Viral Shedding in Adult Inpatients with COVID-19 in Wuhan, China Jing-Tao Huang, Ruo-Xi Ran, Zhi-Hua Lv, Li-Na Feng, Chen-Yang Ran, Yong-Qing Tong, et al. (+10)
973 [GO] 2020―May―22 Whole nucleocapsid protein of SARS-CoV-2 may cause false positive results in serological assays Yutaro Yamaoka, Sundararaj S Jeremiah, Kei Miyakawa, Ryo Saji, Mototsugu Nishii, Ichiro Takeuchi, Akihide Ryo
974 [GO] 2020―May―21 Clinical Features and Outcomes of 105 Hospitalized patients with COVID-19 in Seattle, Washington Frederick S Buckner, Denise J McCulloch, Vidya Atluri, Michela Blain, Sarah A McGuffin, Arun K Nalla, et al. (+8)
975 [GO] 2020―May―21 Renin-angiotensin-aldosterone system inhibitors impact on COVID-19 mortality: What’s next for ACE2? Ankit B Patel, Ashish Verma
976 [GO] 2020―May―21 Predicting infectious SARS-CoV-2 from diagnostic samples Jared Bullard, Kerry Dust, Duane Funk, James E Strong, David Alexander, Lauren Garnett, et al. (+9)
977 [GO] 2020―May―21 Therapy with agents acting on the renin-angiotensin system and risk of SARS-CoV-2 infection Roberto Gnavi, Moreno Demaria, Roberta Picariello, Marco Dalmasso, Fulvio Ricceri, Giuseppe Costa
978 [GO] 2020―May―20 Thymosin alpha 1 (Tα1) reduces the mortality of severe COVID-19 by restoration of lymphocytopenia and reversion of exhausted T cells Yueping Liu, Yue Pang, Zhenhong Hu, Ming Wu, Chenhui Wang, Zeqing Feng, et al. (+10)
979 [GO] 2020―May―20 Associations of Early COVID-19 Cases in San Francisco with Domestic and International Travel Wei Gu, Xianding Deng, Kevin Reyes, Elaine Hsu, Candace Wang, Alicia Sotomayor-Gonzalez, et al. (+4)
980 [GO] 2020―May―20 Connecting hydroxychloroquine in vitro antiviral activity to in vivo concentration for prediction of antiviral effect: a critical step in treating COVID-19 patients Jianghong Fan, Xinyuan Zhang, Jiang Liu, Yuching Yang, Nan Zheng, Qi Liu, et al. (+5)
981 [GO] 2020―May―20 Association of renin-angiotensin-aldosterone system inhibitors with COVID-19-related outcomes in Korea: a nationwide population-based cohort study Sun-Young Jung, Jae Chol Choi, Seung-Hun You, Won-Young Kim
982 [GO] 2020―May―20 Influenza vaccine does not increase the risk of coronavirus or other non-influenza respiratory viruses: retrospective analysis from Canada, 2010-11 to 2016-17 Danuta M Skowronski, Macy Zou, Quinten Clarke, Catharine Chambers, James A Dickinson, Suzana Sabaiduc, et al. (+9)
983 [GO] 2020―May―20 Characterization of an asymptomatic cohort of SARS-COV-2 infected individuals outside of Wuhan, China Yubo Wang, Jin Tong, Yalan Qin, Ting Xie, Jianghua Li, Jianrong Li, et al. (+5)
984 [GO] 2020―May―19 To Interpret the SARS-CoV-2 Test, Consider the Cycle Threshold Value Michael R Tom, Michael J Mina
985 [GO] 2020―May―19 Where is the implementation science? An opportunity to apply principles during the COVID19 pandemic Stephanie Parks Taylor, Marc A Kowalkowski, Rinad S Beidas
986 [GO] 2020―May―18 Higher solar irradiance is associated with a lower incidence of COVID-19 Mar Guasp, Carlos Laredo, Xabier Urra
987 [GO] 2020―May―18 Symptomatic Infants have Higher Nasopharyngeal SARS-CoV-2 Viral Loads but Less Severe Disease than Older Children Philip Zachariah, Katia C Halabi, Candace L Johnson, Susan Whitter, Jorge Sepulveda, Daniel A Green
988 [GO] 2020―May―15 Early Short Course Corticosteroids in Hospitalized Patients with COVID-19 Raef Fadel, Austin R Morrison, Amit Vahia, Zachary R Smith, Zohra Chaudhry, Pallavi Bhargava, et al. (+4)
989 [GO] 2020―May―15 COVID-19: The New Caledonia experience Jad Kerbaj, Cecile Cazorla, Thierry De Greslan, Mathieu Serie, Ann-Claire Gourinat, Benoit Marot
990 [GO] 2020―May―15 Reduction of coronavirus burden with mass azithromycin distribution Thuy Doan, Armin Hinterwirth, Ahmed M Arzika, Lee Worden, Cindi Chen, Lina Zhong, et al. (+3)
991 [GO] 2020―May―12 An inflammatory profile correlates with decreased frequency of cytotoxic cells in COVID-19 Veronica Bordoni, Alessandra Sacchi, Eleonora Cimini, Stefania Notari, Germana Grassi, Eleonora Tartaglia, et al. (+16)
992 [GO] 2020―May―12 Clinical features and outcomes of HIV patients with coronavirus disease 2019 Cristina Gervasoni, Paola Meraviglia, Agostino Riva, Andrea Giacomelli, Letizia Oreni, Davide Minisci, et al. (+3)
993 [GO] 2020―May―12 Social media and the new world of scientific communication during the COVID19 pandemic S Pollett, C Rivers
994 [GO] 2020―May―11 Risk Factors of Severe Disease and Efficacy of Treatment in Patients Infected with COVID-19: A Systematic Review, Meta-Analysis and Meta-Regression Analysis John J Y Zhang, Keng Siang Lee, Li Wei Ang, Yee Sin Leo, Barnaby Edward Young
995 [GO] 2020―May―08 Monologue of a physician who tested persistently positive for COVID-19 Bing Qu, Jing Yang
996 [GO] 2020―May―08 COVID-19 Clinical Trial Oversight at a Major Academic Medical Center: Approach of the Michigan Medicine COVID-19 Clinical Trial Committees Kayte Spector-Bagdady, Peter D R Higgins, Anna S Lok
997 [GO] 2020―May―07 SARS-CoV-2 (COVID-19): What do we know about children? A systematic review Nisha S Mehta, Oliver T Mytton, Edward W S Mullins, Tom A Fowler, Catherine L Falconer, Orla B Murphy, et al. (+4)
998 [GO] 2020―May―07 Hydroxychloroquine in COVID-19 patients: what still needs to be known about the kinetics G Martin-Blondel, S Ruiz, M Murris, S Faguer, V Duhalde, F Eyvrard, et al. (+13)
999 [GO] 2020―May―07 The Effects of Pregnancy on Women with COVID-19: Maternal and Infant Outcomes David A Schwartz
1000 [GO] 2020―May―07 The SARS-CoV-2 epidemic in Zimbabwe: Quo vadis? Leolin Katsidzira, Lenon Gwaunza, James G Hakim
1001 [GO] 2020―May―07 Household Transmission of SARS-CoV-2, Zhuhai, China, 2020 Jian Wu, Yiying Huang, Changli Tu, Chunping Bi, Zhigang Chen, Liyun Luo, et al. (+9)
1002 [GO] 2020―May―05 Lessons from COVID-19 in children: Key hypotheses to guide preventative and therapeutic strategies Tulika Singh, Sarah M Heston, Stephanie N Langel, Maria Blasi, Jillian H Hurst, Genevieve G Fouda, et al. (+2)
1003 [GO] 2020―May―05 Association of higher body mass index (BMI) with severe coronavirus disease 2019 (COVID-19) in younger patients Sean Wei Xiang Ong, Barnaby Edward Young, Yee-Sin Leo, David Chien Lye
1004 [GO] 2020―May―05 COVID-19 Testing, Epidemic Features, Hospital Outcomes, and Household Prevalence, New York State-March 2020 Eli S Rosenberg, Elizabeth M Dufort, Debra S Blog, Eric W Hall, Dina Hoefer, Bryon P Backenson, et al. (+6)
1005 [GO] 2020―May―02 Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Hospitalized Patients in Wuhan, China Ling Hu, Shaoqiu Chen, Yuanyuan Fu, Zitong Gao, Hui Long, Jian-ming Wang, et al. (+14)
1006 [GO] 2020―May―01 Clinical and laboratory predictors of in-hospital mortality in patients with COVID-19: a cohort study in Wuhan, China Kun Wang, Peiyuan Zuo, Yuwei Liu, Meng Zhang, Xiaofang Zhao, Songpu Xie, et al. (+3)
1007 [GO] 2020―Apr―30 Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing Timothy M Rawson, Luke S P Moore, Nina Zhu, Nishanthy Ranganathan, Keira Skolimowska, Mark Gilchrist, et al. (+3)
1008 [GO] 2020―Apr―30 Role of serology in the COVID-19 pandemic Sean Stowell, Jeannette Guarner
1009 [GO] 2020―Apr―30 Early detection of SARS-CoV-2 antibodies in COVID-19 patients as a serologic marker of infection Rongqing Zhao, Maohua Li, Hao Song, Jianxin Chen, Wenlin Ren, Yingmei Feng, et al. (+23)
1010 [GO] 2020―Apr―30 Evaluation of COVID-19 RT-qPCR test in multi-sample pools Idan Yelin, Noga Aharony, Einat Shaer Tamar, Amir Argoetti, Esther Messer, Dina Berenbaum, et al. (+10)
1011 [GO] 2020―Apr―30 Still much to learn about the diagnostic role of SARS-CoV-2 antibody detection Simona Di Giambenedetto, Arturo Ciccullo, Brunella Posteraro, Francesca Lombardi, Alberto Borghetti, Maurizio Sanguinetti
1012 [GO] 2020―Apr―29 Olfactory and Gustatory Dysfunction in Coronavirus Disease 19 (COVID-19) Jan C Luers, Alexander C Rokohl, Niklas Loreck, Philomena A Wawer Matos, Max Augustin, Felix Dewald, et al. (+3)
1013 [GO] 2020―Apr―29 Throat Wash Testing and COVID-19 Disease: Should We Put Our Money Where Our Mouth Is? Farhana Ali, Daniel A Sweeney
1014 [GO] 2020―Apr―29 COVID-19, superinfections and antimicrobial development: What can we expect? Cornelius J Clancy, M Hong Nguyen
1015 [GO] 2020―Apr―24 Interactive web-based graphs of novel coronavirus COVID-19 cases and deaths per population by country Masashi Idogawa, Shoichiro Tange, Hiroshi Nakase, Takashi Tokino
1016 [GO] 2020―Apr―24 Working schedule, sleep quality and susceptibility to COVID-19 in healthcare workers Michael Belingheri, Maria Emilia Paladino, Michele Augusto Riva
1017 [GO] 2020―Apr―24 Contact tracing for COVID-19: An opportunity to reduce health disparities and End the HIV/AIDS Epidemic in the US Bohdan Nosyk, Wendy S Armstrong, Carlos del Rio
1018 [GO] 2020―Apr―23 Clinical impact of renin-angiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for COVID-19 Sara Tedeschi, Maddalena Giannella, Michele Bartoletti, Filippo Trapani, Marina Tadolini, Claudio Borghi, Pierluigi Viale
1019 [GO] 2020―Apr―23 Early risk factors for the duration of SARS-CoV-2 viral positivity in COVID-19 patients Aifen Lin, Ze-Bao He, Sheng Zhang, Jian-Gang Zhang, Xia Zhang, Wei-Hua Yan
1020 [GO] 2020―Apr―23 Access by English and Non-English Speakers Is Needed to COVID-19 Clinical Trials Mamta K Jain, Nancy Rollins, Raksha Jain
1021 [GO] 2020―Apr―23 Profile of IgG and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Jiuxin Qu, Chi Wu, Xiaoyong Li, Guobin Zhang, Zhaofang Jiang, Xiaohe Li, et al. (+2)
1022 [GO] 2020―Apr―23 First reported nosocomial outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a pediatric dialysis unit Vera Schwierzeck, Jens Christian König, Joachim Kühn, Alexander Mellmann, Carlos Luis Correa-Martínez, Heymut Omran, et al. (+3)
1023 [GO] 2020―Apr―22 Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 Adarsh Bhimraj, Rebecca L Morgan, Amy Hirsch Shumaker, Valery Lavergne, Lindsey Baden, Vincent Chi-Chung Cheng, et al. (+9)
1024 [GO] 2020―Apr―21 A case series of children with Coronavirus Disease 2019: what have we learned? Jasper Fuk-Woo Chan, Kelvin Kai-Wang To, Kwok-Yung Yuen
1025 [GO] 2020―Apr―20 Responding to the COVID-19 outbreak in Singapore: Staff Protection and Staff Temperature and Sickness Surveillance Systems Htet Lin Htun, Dwee Wee Lim, Win Mar Kyaw, Wan-Ning Janis Loh, Lay Tin Lee, Brenda Ang, Angela Chow
1026 [GO] 2020―Apr―18 Down-regulated gene expression spectrum and immune responses changed during the disease progression in COVID-19 patients Yabo Ouyang, Jiming Yin, Wenjing Wang, Hongbo Shi, Ying Shi, Bin Xu, et al. (+7)
1027 [GO] 2020―Apr―17 Antibody Detection and Dynamic Characteristics in Patients with COVID-19 Fei Xiang, Xiaorong Wang, Xinliang He, Zhenghong Peng, Bohan Yang, Jianchu Zhang, et al. (+7)
1028 [GO] 2020―Apr―17 Profile of RT-PCR for SARS-CoV-2: a preliminary study from 56 COVID-19 patients Ai Tang Xiao, Yi Xin Tong, Sheng Zhang
1029 [GO] 2020―Apr―17 Population movement, city closure in Wuhan and geographical expansion of the 2019-nCoV pneumonia infection in China in January 2020 Kun Liu, Siqi Ai, Shuxuan Song, Guanghu Zhu, Fei Tian, Huan Li, et al. (+6)
1030 [GO] 2020―Apr―17 Testing for SARS-CoV-2: Can We Stop at Two? Tau Hong Lee, Ray Junhao Lin, Raymond T P Lin, Timothy Barkham, Pooja Rao, Yee-Sin Leo, et al. (+2)
1031 [GO] 2020―Apr―16 The characteristics of household transmission of COVID-19 Wei Li, Bo Zhang, Jianhua Lu, Shihua Liu, Zhiqiang Chang, Peng Cao, et al. (+5)
1032 [GO] 2020―Apr―16 After Covid-19 Richard P Wenzel
1033 [GO] 2020―Apr―16 Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19 Thomas R O’Brien, David L Thomas, Sarah S Jackson, Ludmila Prokunina-Olsson, Raymond P Donnelly, Rune Hartmann
1034 [GO] 2020―Apr―16 The duration of viral shedding of discharged patients with severe COVID-19 Bo Zhou, Jianqing She, Yadan Wang, Xiancang Ma
1035 [GO] 2020―Apr―16 SARS-CoV-2 infection (COVID-19) in febrile infants without respiratory distress Michal Paret, Jennifer Lighter, Rebecca Pellett Madan, Vanessa N Raabe, Gail F Shust, Adam J Ratner
1036 [GO] 2020―Apr―16 Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients Xiaohua Chen, Binghong Zhao, Yueming Qu, Yurou Chen, Jie Xiong, Yong Feng, et al. (+6)
1037 [GO] 2020―Apr―16 Albert Camus’ ‘The COVID-19 Plague’ Revisited Carlos Franco-Paredes
1038 [GO] 2020―Apr―15 Comment of the potential risks of sexual and vertical transmission of Covid-19 infection Laura Scorzolini, Angela Corpolongo, Concetta Castilletti, Eleonora Lalle, Andrea Mariano, Emanuele Nicastri
1039 [GO] 2020―Apr―15 Sequential analysis of viral load in a neonate and her mother infected with SARS-CoV-2 Mi Seon Han, Moon-Woo Seong, Eun Young Heo, Ji Hong Park, Namhee Kim, Sue Shin, et al. (+3)
1040 [GO] 2020―Apr―14 A Tool to Early Predict Severe Corona Virus Disease 2019 (COVID-19) : A Multicenter Study using the Risk Nomogram in Wuhan and Guangdong, China Jiao Gong, Jingyi Ou, Xueping Qiu, Yusheng Jie, Yaqiong Chen, Lianxiong Yuan, et al. (+6)
1041 [GO] 2020―Apr―14 Importance of inclusion of pregnant and breastfeeding women in COVID-19 therapeutic trials Sylvia M LaCourse, Grace John-Stewart, Kristina M Adams Waldorf
1042 [GO] 2020―Apr―10 The changing patter of COVID-19 in China: A tempo-geographic analysis of the SARS-CoV-2 epidemic T Weiming, L Huipeng, M Gifty, W Zaisheng, C Weibin, W Dan, Y Rongbin
1043 [GO] 2020―Apr―10 Nonpharmaceutical interventions and epidemic intensity during the 2019 novel coronavirus disease pandemic Gang Qin, Lei Zhang, Cheng-Jun Yu
1044 [GO] 2020―Apr―09 Generalizability of COVID-19 Clinical Prediction Models Shubhada Hooli, Carina King
1045 [GO] 2020―Apr―09 Cluster of coronavirus disease 2019 (Covid-19) in the French Alps, 2020 Kostas Danis, Olivier Epaulard, Thomas Bénet, Alexandre Gaymard, Séphora Campoy, Elisabeth Bothelo-Nevers, et al. (+83)
1046 [GO] 2020―Apr―09 Good IgA bad IgG in SARS-CoV-2 infection? Marie C Béné, Marcelo de Carvalho, Marion Eveillard, Yannick Lebri
1047 [GO] 2020―Apr―08 Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19 Hin Chu, Jasper Fuk-Woo Chan, Yixin Wang, Terrence Tsz-Tai Yuen, Yue Chai, Yuxin Hou, et al. (+15)
1048 [GO] 2020―Apr―08 Asymptomatic and Presymptomatic Infectors: Hidden Sources of COVID-19 Disease Guanjian Li, Weiran Li, Xiaojin He, Yunxia Cao
1049 [GO] 2020―Apr―08 Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission Jennifer Lighter, Michael Phillips, Sarah Hochman, Stephanie Sterling, Diane Johnson, Fritz Francois, Anna Stachel
1050 [GO] 2020―Apr―08 Predictors of refractory Coronavirus disease (COVID-19) pneumonia Bahaa Abu-Raya
1051 [GO] 2020―Apr―08 Prediction for Progression Risk in Patients with COVID-19 Pneumonia: the CALL Score Dong Ji, Dawei Zhang, Jing Xu, Zhu Chen, Tieniu Yang, Peng Zhao, et al. (+7)
1052 [GO] 2020―Apr―08 Early virus clearance and delayed antibody response in a case of COVID-19 with a history of co-infection with HIV-1 and HCV Juanjuan Zhao, Xuejiao Liao, Haiyan Wang, Lanlan Wei, Mingzhao Xing, Lei Liu, Zheng Zhang
1053 [GO] 2020―Apr―08 Effect of throat washings on detection of 2019 novel coronavirus Wen-Liang Guo, Qian Jiang, Feng Ye, Shao-Qiang Li, Cheng Hong, Li-Yan Chen, Shi-Yue Li
1054 [GO] 2020―Apr―07 Inquiring into Benefits of Independent Activation of Non-Classical Renin-Angiotensin System in the Clinical Prognosis and Reduction of COVID-19 mortality Luis Miguel Álvarez-Aragón, Antonio Luis Cuesta-Muñoz, Inmaculada Álvarez-López
1055 [GO] 2020―Apr―07 PCR Assays Turned Positive in 25 Discharged COVID-19 Patients Jing Yuan, Shanglong Kou, Yanhua Liang, JianFeng Zeng, Yanchao Pan, Lei Liu
1056 [GO] 2020―Apr―04 Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients Sophie Perinel, Manon Launay, Élisabeth Botelho-Nevers, Éric Diconne, Aurore Louf-Durier, Raphaël Lachand, et al. (+5)
1057 [GO] 2020―Apr―03 Care for the psychological status of frontline medical staff fighting against COVID-19 Jing Huang, Fangkun Liu, Ziwei Teng, Jindong Chen, Jingping Zhao, Xiaoping Wang, Renrong Wu
1058 [GO] 2020―Apr―03 Lockdown contained the spread of 2019 novel coronavirus disease in Huangshi city, China: Early epidemiological findings Tuo Ji, Hai-Lian Chen, Jing Xu, Ling-Ning Wu, Jie-Jia Li, Kai Chen, Gang Qin
1059 [GO] 2020―Apr―02 New measures for COVID-19 response: a lesson from the Wenzhou experience Linhui Ruan, Min Wen, Qingrun Zeng, Chengshui Chen, Shengwei Huang, Su Yang, et al. (+9)
1060 [GO] 2020―Apr―01 SARS-CoV-2 is not detectable in the vaginal fluid of women with severe COVID-19 infection Lin Qiu, Xia Liu, Meng Xiao, Jing Xie, Wei Cao, Zhengyin Liu, et al. (+4)
1061 [GO] 2020―Apr―01 First Mildly Ill, Non-Hospitalized Case of Coronavirus Disease 2019 (COVID-19) Without Viral Transmission in the United States - Maricopa County, Arizona, 2020 Sarah E Scott, Karen Zabel, Jennifer Collins, Katherine C Hobbs, Melissa J Kretschmer, Mitchell Lach, et al. (+17)
1062 [GO] 2020―Apr―01 Gargle lavage as a safe and sensitive alternative to swab samples to diagnose COVID-19: a case report in Japan Makoto Saito, Eisuke Adachi, Seiya Yamayoshi, Michiko Koga, Kiyoko Iwatsuki-Horimoto, Yoshihiro Kawaoka, Hiroshi Yotsuyanagi
1063 [GO] 2020―Mar―31 The COVID-19 pandemic: we are all in this together Florence Momplaisir
1064 [GO] 2020―Mar―27 The Late Arrival of COVID-19 in Africa - Mitigating Pan-Continental Spread Jean B Nachega, Moussa Seydi, Alimuddin Zumla
1065 [GO] 2020―Mar―27 Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019 Juanjuan Zhao, Quan Yuan, Haiyan Wang, Wei Liu, Xuejiao Liao, Yingying Su, et al. (+19)
1066 [GO] 2020―Mar―27 Disparities in Age-Specific Morbidity and Mortality from SARS-CoV-2 in China and the Republic of Korea Joseph P Dudley, Nam Taek Lee
1067 [GO] 2020―Mar―27 Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients Fengting Yu, Liting Yan, Nan Wang, Siyuan Yang, Linghang Wang, Yunxia Tang, et al. (+9)
1068 [GO] 2020―Mar―26 Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility Jasper Fuk-Woo Chan, Anna Jinxia Zhang, Shuofeng Yuan, Vincent Kwok-Man Poon, Chris Chung-Sing Chan, Andrew Chak-Yiu Lee, et al. (+18)
1069 [GO] 2020―Mar―26 Spotlight on Jails: COVID-19 Mitigation Policies Needed Now Alysse G Wurcel, Emily Dauria, Nicholas Zaller, Ank Nijhawan, Curt Beckwith, Kathryn Nowotny, Lauren Brinkley-Rubinstein
1070 [GO] 2020―Mar―24 Is There an Association Between COVID-19 Mortality and the Renin-Angiotensin System-a Call for Epidemiologic Investigations Thomas C Hanff, Michael O Harhay, Tyler S Brown, Jordana B Cohen, Amir M Mohareb
1071 [GO] 2020―Mar―24 The first locally acquired novel case of 2019-nCoV infection in a healthcare worker in the Paris area Elise Klement, Nagisa Godefroy, Sonia Burrel, Dimitri Kornblum, Gentiane Monsel, Alexandre Bleibtreu, et al. (+5)
1072 [GO] 2020―Mar―24 Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study Andrea Giacomelli, Laura Pezzati, Federico Conti, Dario Bernacchia, Matteo Siano, Letizia Oreni, et al. (+6)
1073 [GO] 2020―Mar―21 Epidemiological and Clinical Predictors of COVID-19 Yinxiaohe Sun, Vanessa Koh, Kalisvar Marimuthu, Oon Tek Ng, Barnaby Young, Shawn Vasoo, et al. (+7)
1074 [GO] 2020―Mar―21 Could chloroquine /hydroxychloroquine be harmful in Coronavirus Disease 2019 (COVID-19) treatment? Maurizio Guastalegname, Alfredo Vallone
1075 [GO] 2020―Mar―20 A COVID-19 Transmission within a family cluster by presymptomatic infectors in China Guoqing Qian, Naibin Yang, Ada Hoi Yan Ma, Liping Wang, Guoxiang Li, Xueqin Chen, Xiaomin Chen
1076 [GO] 2020―Mar―19 Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19) Li Guo, Lili Ren, Siyuan Yang, Meng Xiao, De Chang, Fan Yang, et al. (+16)
1077 [GO] 2020―Mar―12 Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China Zhongliang Wang, Bohan Yang, Qianwen Li, Lu Wen, Ruiguang Zhang
1078 [GO] 2020―Mar―11 A case report of neonatal COVID-19 infection in China Shaoshuai Wang, Lili Guo, Ling Chen, Weiyong Liu, Yong Cao, Jingyi Zhang, Ling Feng
1079 [GO] 2020―Mar―11 Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China Pingzheng Mo, Yuanyuan Xing, Yu Xiao, Liping Deng, Qiu Zhao, Hongling Wang, et al. (+13)
1080 [GO] 2020―Mar―10 A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias Dahai Zhao, Feifei Yao, Lijie Wang, Ling Zheng, Yongjun Gao, Jun Ye, et al. (+3)
1081 [GO] 2020―Mar―09 Protecting Health Care Workers during the COVID-19 Coronavirus Outbreak -Lessons from Taiwan's SARS response Jonathan Schwartz, Chwan-Chuen King, Muh-Yong Yen
1082 [GO] 2020―Mar―09 A Novel Approach for a Novel Pathogen: using a home assessment team to evaluate patients for 2019 novel coronavirus (SARS-CoV-2) Chloe Bryson-Cahn, Jeffrey Duchin, Vanessa A Makarewicz, Meagan Kay, Krista Rietberg, Nathanael Napolitano, et al. (+3)
1083 [GO] 2020―Mar―06 “The Art of War” in the Era of Coronavirus Disease 2019 (COVID-19) Daniel N Maxwell, Trish M Perl, James B Cutrell
1084 [GO] 2020―Mar―06 Dysregulation of immune response in patients with COVID-19 in Wuhan, China Chuan Qin, Luoqi Zhou, Ziwei Hu, Shuoqi Zhang, Sheng Yang, Yu Tao, et al. (+5)
1085 [GO] 2020―Mar―06 In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Xueting Yao, Fei Ye, Miao Zhang, Cheng Cui, Baoying Huang, Peihua Niu, et al. (+9)
1086 [GO] 2020―Mar―03 Perinatal Transmission of COVID-19 Associated SARS-CoV-2: Should We Worry? Cuifang Fan, Di Lei, Congcong Fang, Chunyan Li, Ming Wang, Yuling Liu, et al. (+6)
1087 [GO] 2020―Mar―03 Diagnosis and Management of First Case of COVID-19 in Canada: Lessons applied from SARS Xavier Marchand-Senécal, Rob Kozak, Samira Mubareka, Natasha Salt, Jonathan B Gubbay, Alireza Eshaghi, et al. (+6)
1088 [GO] 2020―Feb―28 2019 novel coronavirus is undergoing active recombination Huiguang Yi
1089 [GO] 2020―Feb―27 A glimpse into the origins of genetic diversity in SARS-CoV-2 Joel O Wertheim
1090 [GO] 2020―Feb―26 Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study Jian Wu, Jun Liu, Xinguo Zhao, Chengyuan Liu, Wei Wang, Dawei Wang, et al. (+6)
1091 [GO] 2020―Feb―26 A case of 2019 Novel Coronavirus in a pregnant woman with preterm delivery Xiaotong Wang, Zhiqiang Zhou, Jianping Zhang, Fengfeng Zhu, Yongyan Tang, Xinghua Shen
1092 [GO] 2020―Feb―25 De-isolating COVID-19 Suspect Cases: A Continuing Challenge Jun-Yang Tay, Poh Lian Lim, Kalisvar Marimuthu, Sapna Pradip Sadarangani, Li Min Ling, Brenda Sze Peng Ang, et al. (+3)
1093 [GO] 2020―Feb―25 A Well Infant with Coronavirus Disease 2019 (COVID-19) with High Viral Load Kai-qian Kam, Chee Fu Yung, Lin Cui, Raymond Lin Tzer Pin, Tze Minn Mak, Matthias Maiwald, et al. (+5)
1094 [GO] 2020―Feb―25 Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients Zijie Shen, Yan Xiao, Lu Kang, Wentai Ma, Leisheng Shi, Li Zhang, et al. (+13)
1095 [GO] 2020―Feb―25 A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features Jiehao Cai, Jing Xu, Daojiong Lin, zhi Yang, Lei Xu, Zhenghai Qu, et al. (+13)
1096 [GO] 2020―Feb―10 Consistent detection of 2019 novel coronavirus in saliva Kelvin Kai-Wang To, Owen Tak-Yin Tsang, Cyril Chik-Yan Yip, Kwok-Hung Chan, Tak-Chiu Wu, Jacky M C Chan, et al. (+12)
1097 [GO] 2020―Jan―31 Origin and evolution of the 2019 novel coronavirus Liangsheng Zhang, Fu-ming Shen, Fei Chen, Zhenguo Lin
 [1] 

1097 Results       Page 1



[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.048 sec